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Abstract 
Lyme disease is the most prevalent arthropod-borne (tick) disease in North America. The 
disease is more prevalent in some Eastern and Central states than in Western states. The 
general problem is that, in southern California especially in Los Angeles County, both 
patients and practitioners fail to recognize the disease, resulting in misdiagnosis and 
delayed treatment. Consequently, the patient may develop the long-term, chronic Lyme 
disease (CLD). The purpose of this phenomenological study was to explore the impact of 
CLD on the health-promoting behaviors of ethnically diverse young adults from similar 
educational and socioeconomic backgrounds based on their lived experiences. The 
geographical focus of this study was restricted to Los Angeles County, California, 
because researchers have demonstrated a general lack of awareness of CLD as well as a 
gap when it comes to representing CLD clients from diverse ethical and socio-economic 
groupings. Data were collected from face-to-face semistructured interviews of 9 
participants, based on the health belief model constructs on an ethnically diverse group of 
young adults clinically diagnosed with CLD. Data were coded and explored for themes. 
Key results of the study include the existence of excellent health prior to CLD, marked 
declined in health status because of the disease not being recognized or properly treated, 
and the use of various modalities of treatment including conventional antibiotic treatment 
and complementary and alternative treatments to combat the disease. Social implications 
of this study include increased awareness of physicians and the community in the Los 
Angeles County of Lyme Disease as an emerging epidemic, development of preventive 
measures against this disease, and generation of rich data and propositions regarding 
CLD for further research. 
   
 
 
Health Promoting Behaviors of Young Adults with Chronic Lyme Disease 
by 
Patricia D. Bolivar  
 
MS, California State University Los Angeles, 2001 
BS, California State University Los Angeles, 1984 
 
 
Dissertation Submitted in Partial Fulfillment  
of the Requirements for the Degree of 
Doctor of Philosophy 
Public Health 
 
 
Walden University 
February 2018 
  
Dedication 
This work is dedicated to my children Janelle Sophia and Alexander Daniel Del 
Rosario. Thank you for your unconditional love and support. You have encouraged, 
motivated, and waited patiently for me to culminate this academic endeavor. I also 
dedicate this work to all those young adults in Southern California whose doctors told 
them it was all in their head, and to my Abba in heaven who watches over me and 
granted me this dream to become a reality.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Acknowledgements 
My dissertation process was a journey of extreme dedication, patience, and 
sacrifice yet tremendously gratifying. I express my gratitude first to my committee chair, 
Dr. Harold Griffin, for his encouragement, motivation, and guidance on qualitative 
research. I would also like to thank the other two members of my committee, Dr. Lee 
Bewley and Dr. Vincent Agboto, for their evaluations and guidance. 
When I embarked in this long and arduous journey, many friends, coworkers, and 
family members believed in me achieving this dream and I thank every one of them for 
their support, faith, and prayers; especially at a moment in the journey when I did not 
know if I was going to make it. I am grateful for my parents and siblings abroad who 
regularly checked on my progress and helped me keep focused. I also want to thank my 
colleagues who participated in my validation and verification panels, and my interrater 
who provided invaluable assistance and feedback in data coding and interpretation.  
Lastly, my deep appreciation goes to the research participants and amazing group 
of nine young adults who, despite their busy schedule of medical appointments and major 
health issues, committed their time to this research and provided candid and transparent 
description of their lived experiences with chronic Lyme disease. 
  
i 
 Table of Contents 
List of Tables................................................................................................................. vii  
List of Figures ............................................................................................................. viii 
Chapter 1: Introduction to the Study  ............................................................................... 1 
Introduction ............................................................................................................... 1 
Background ............................................................................................................... 2 
Problem Statement ..................................................................................................... 6 
Purpose of the Study .................................................................................................. 8 
Research Questions .................................................................................................... 9 
Theoretical Framework for the Study ....................................................................... 10 
Nature of the Study .................................................................................................. 12 
Definitions ............................................................................................................... 13 
Assumptions ............................................................................................................ 15 
Scope and Delimitations .......................................................................................... 16 
Limitations .............................................................................................................. 18 
Significance ............................................................................................................. 20 
Summary ................................................................................................................. 21 
Chapter 2: Literature Review ......................................................................................... 22 
Introduction ............................................................................................................. 22 
Literature Search Strategy ........................................................................................ 23 
Theoretical Foundation ............................................................................................ 26 
The Health Belief Model .................................................................................... 26 
The Health Belief Model Brief Description ........................................................ 27 
ii 
Dimensions of the Health Belief Model .............................................................. 28 
Limitations of the Health Belief Model .............................................................. 30 
Applications of the Health Belief Model ............................................................ 31 
Rationale for Using the Health Belief Model for the Current Study .................... 32 
Literature Review Related to Key Variables and/or Concepts ........................................ 33 
A Brief History of Lyme Disease ....................................................................... 33 
Ecology, Epidemiology and Transmission of Lyme Disease ............................... 40 
Lyme Disease in California ................................................................................ 50 
Symptoms and Disease Presentation................................................................... 51 
Unique Biological Characteristics of the Organism ............................................ 61 
Laboratory Diagnosis of Lyme Borreliosis ......................................................... 65 
Treatment of Lyme Disease............................................................................... 70 
Prevention .......................................................................................................... 74 
The Chronic Lyme Disease Controversy ............................................................ 75 
Summary ....................................................................................................................... 77 
Chapter 3: Research Method .......................................................................................... 80 
Introduction ............................................................................................................. 80 
Research Design and Rationale ................................................................................ 81 
Role of the Researcher ............................................................................................. 83 
Methodology ........................................................................................................... 84 
Population Sampling Methods, Size, and Contingency................................................... 84 
Inclusion/Exclusion Criteria ..................................................................................... 85 
Recruitment ............................................................................................................. 85  
iii 
Screening ................................................................................................................. 86 
Informed Consent .................................................................................................... 87 
Instrumentation ........................................................................................................ 88 
Instrument Content Validity ..................................................................................... 89 
Data Analysis Plan ................................................................................................... 92 
Issues of Trustworthiness ......................................................................................... 96 
Credibility (internal validity).................................................................................... 97 
Transferability (external validity) ............................................................................. 98 
Dependability (reliability) ........................................................................................ 99 
Confirmability (objectivity) ................................................................................... 100 
Ethical Procedures ................................................................................................. 101 
Summary ..................................................................................................................... 103 
Chapter 4: Results........................................................................................................ 104 
Introduction ........................................................................................................... 104 
Pilot Study ............................................................................................................. 106 
Setting ................................................................................................................... 108  
Demographics ........................................................................................................ 109 
Data Collection ...................................................................................................... 110 
Data Analysis ........................................................................................................ 113 
Evidence of Trustworthiness .................................................................................. 116 
Credibility ........................................................................................................ 116 
Transferability.................................................................................................. 117 
Dependability ................................................................................................... 117 
iv 
Confirmability.................................................................................................. 121 
Results ............................................................................................................. 121 
Research Question 1......................................................................................... 122 
Research Question 2......................................................................................... 128 
Research Question 3......................................................................................... 133 
Research Question 4......................................................................................... 136 
Research Question 5......................................................................................... 138 
Research Question 6......................................................................................... 142 
Summary ............................................................................................................... 147 
Chapter 5: Discussion, Conclusions, and Recommendations ........................................ 150 
Introduction ........................................................................................................... 150 
Interpretations of the Findings ............................................................................... 152  
Demographic Gaps in the Literature ................................................................. 152 
Changes in Health Status .................................................................................. 153 
Difficulties Being Diagnosed ........................................................................... 154 
Aspects Affected .............................................................................................. 156 
Treatment Modalities Effectiveness ................................................................. 157 
Prevention ........................................................................................................ 158 
Theoretical Framework .......................................................................................... 159  
Limitations of the Study ......................................................................................... 160 
Recommendations.................................................................................................. 162 
Implications ........................................................................................................... 164 
Potential Impact for Social change ................................................................... 164 
v 
Conclusions ........................................................................................................... 165 
References ......................................................................................................................... 167 
Appendix A: List of Bacteria Responsible for Lyme Disease ............................................. 201 
Appendix B: Complementary and Alternative Medicine Treatment of Lyme Disease ........ 202 
Appendix C: Informed Consent ......................................................................................... 203 
Appendix D: Recruitment Flyer ......................................................................................... 205 
Appendix E: Approval letter from the Los Angeles County Lyme Disease Association ..... 206 
Appendix F: Social Media Invitation to Study Participation ............................................... 207 
Appendix G: Respondent Screening Form ......................................................................... 208 
Appendix H: Interview Core Questions ............................................................................. 209 
Appendix I: Informed Consent Participant Log .................................................................. 213 
Appendix J: Content Validity Panel ................................................................................... 214 
Appendix K: Survey/Interview Validation Rubric for Expert Panel ................................... 215 
Appendix L: Completed VRP by Validation Panel ............................................................ 217 
Appendix M: Content Validity Panel and Results .............................................................. 220 
Appendix N: Original Core Interviews sent to Validation Panel for Review ...................... 221 
Appendix O: Participants Activity Log .............................................................................. 224 
Appendix P: Study Protocol .............................................................................................. 225 
Appendix Q: The National Institutes of Health Certificate of Completion .......................... 240 
Appendix R: Non-Disclosure Agreement for Transcription Services ................................. 241 
 
 
 
vi 
List of Tables 
Table 1. Data Analysis in Phenomenology ..................................................................... 94 
Table 2. Summary of Strategies to Determine Rigor .................................................... 101 
Table 3.  Participant Demographics ............................................................................. 110 
Table 4. Emerging Categories and Themes .................................................................. 121 
Table 5. List of Treatments .......................................................................................... 135 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
List of Figures 
 
Figure 1. Conceptualizing the health belief model.......................................................... 11 
Figure 2. Co-feeding and systemic transmission of Borrelia .......................................... 46 
Figure 3. Enzootic cycle Borrelia burgdorferi ................................................................ 48 
Figure 4. Typical spirochete ........................................................................................... 62 
Figure 5. Two-tiered serology for Lyme disease ............................................................ 67 
Figure 6. Examples of IgM and IgG Immunoblots ......................................................... 68 
Figure 7. Complementary and alternative medicine treatment and its actions ................. 73 
Figure 8. NVivo 36 codes used for transcripts coding .................................................. 120  
 
1 
 
Chapter 1: Introduction to the Study 
Introduction  
  Chronic Lyme disease (CLD) is a condition that describes a plethora of persistent 
symptoms lasting more than six months which develops when Lyme disease (LD) 
diagnosis is missed, or as results of inadequate length of antibiotic treatment 
(Borgersmans, Goderis, Vandevoorde, & Devroey, 2014). CLD symptoms range from 
fatigue and musculoskeletal pain to neurocognitive complaints placing those individuals 
diagnosed with the disease with a substantial clinical burden (Ali et al., 2014). Little is 
known about the health-promoting behaviors of young adults diagnosed with CLD. The 
purpose of this his phenomenological study, based on lived experiences of young adults 
from a diverse ethnic, educational, and socioeconomic background who reside in Los 
Angeles County afflicted with CLD, was to gather insights about their experiences, to 
bring awareness to the Los Angeles County community of the existence of the disease, 
and to elucidate the impact CLD has on their health behaviors.  
Social implications of this qualitative study include increased awareness of 
physicians and the community in the Los Angeles County of LD as an emerging 
epidemic (see Hui, 2008), development of preventive measures against this devastating 
disease, and generation of rich data and hypotheses about CLD for further research 
(Adrion, Aucott, Lemke, & Weiner, 2015). According to the California Lyme Disease 
Association (2015), most residents in Los Angeles County do not know about LD’s 
transmission, symptoms, and the danger of the presence of ticks. Subsequently, these 
residents may also not take precautions, check for ticks and tick bites after visiting 
mountain trails and parks, remove ticks properly, and are not informed to immediately 
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seek for health care assistance if the characteristic rash develops (California Lyme 
Disease Association, 2015). The perspectives of this group of participants may give 
healthcare providers and the public a deeper insight into the impact CLD has on the 
personal and professional lives, as well as in decision-making.  
In this chapter, I provide a detailed description of the background of the study and 
clearly present the problem statement. In addition, I present the purpose statement, 
research questions, theoretical framework, and nature of the study. I also provide concise 
definitions of key concepts or constructs in this chapter to clarify the meaning as the 
terms relate to CLD. In addition, I briefly discuss assumptions, scope, and delimitations, 
as well as limitations of specific aspects of the research that are critical to the 
meaningfulness of the study such as population’s boundaries, transferability, possible 
weaknesses, and biases of the study. Finalizing the chapter; I discuss the significance of 
the study section including potential contributions of the study to the individual, the 
community, society, as well as the public health practice. To close the chapter, I present 
the summary which highlights the main points covered in the chapter and provides a 
transition to the study’s next chapter. 
Background of the Study  
The term CLD describes a constellation of persistent symptoms in patients 
exposed to the bite of a tick infected with the bacterial spirochete Borrelia burgdorferi 
(Bb; Ali et al., 2014). The symptoms lasting more than six months range from fatigue, 
headache, back pain, myalgia, arthralgia, nausea, abdominal pain, and night sweats, to 
cardiac (arrhythmia) and neurological involvement; cognitive dysfunction, peripheral 
neuropathy and encephalomyelitis (Borgersmans et al., 2014). The Centers for Disease 
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Control and Prevention (CDC) recommend antibiotic therapy in the early stage of the 
disease, within 30 days of exposure, to hasten symptoms resolution and to prevent 
development of CLD (Horowitz, 2013; Hu, 2012). However, approximately 10 to 20% of 
patients treated with the recommended dose and duration of antibiotic therapy report 
persistent symptoms described as Post-Treatment Lyme Disease Syndrome (PTLDS), 
also referred to as CLD in this study (Adrion, Aucott, Lemke, & Weiner, 2015).  
Failure of standard antibiotic therapy for LD may be due to the complex genetic 
makeup of the causative organism with three times more plasmids than any other 
organism and the so-called stealth pathology. Stealth pathology refers to mechanisms 
used by Bb to evade immune response that include (a) immunosuppression; (b) genetic, 
phase and antigenic variation; (c) physical seclusion; and (d) secretion of factor to engage 
in autoresurrection becoming a dormant organism. These mechanisms suggest the need 
for prolonged use of antibiotics (Stricker, 2007). In addition, tick borne coinfections such 
as Babesia, Anaplasma, Ehrlichia, or Bartonella exacerbate LD symptoms and cause a 
low-grade infection that can increase the duration and severity of LD (Stricker, 2007). In 
a study conducted by Johnson, Wilcox, Mankoff, and Stricker (2014), using the CDC 
health-related quality of life (HRQoL) indicators to identify health needs, determine the 
burden of disease, and direct public health policy; patients with CLD compared to the 
general population reported a significant symptom disease burden, lower health quality 
status, more bad physical and mental days, and greater activity limitations. CLD patients 
also reported increased utilization of health care services, greater out of pocket expenses 
in medical cost, impairment in their productivity and ability to work, and limited 
recreation activities. The study findings also suggested that the CDC should include in 
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national population surveys questions regarding LD that will allow researchers to 
accurately characterize prevalence, annual incidence, and demographic distribution of the 
disease.  
 Adrion, Aucott, Lemke, and Weiner (2015) utilized retrospective data on medical 
claims from 547,993 LD diagnosed cases between 2006 and 2010 on persons ages 
ranging from 0 to 64-year-old enrolled in commercial health insurance plans to examine 
the impact of PTLDS on health care cost and utilization. Over a 12-month period those 
patients having one or more PTLDS-related diagnosis were associated with $3,798 higher 
total health care cost, 66% more outpatient and management visit, and 89% more 
emergency department visits than those with no PTLDS related diagnosis. The estimated 
cost for patients with neurological involvement associated with late stage LD was $6,007, 
while those with PTLDS uncomplicated or complicated cases estimated cost is $10,000. 
The study found patients with PTLDS to be 5.5 times more likely to suffer from 
debilitating and undue fatigue so severe as to affect the health-related quality of life. The 
researchers concluded that by extrapolating, the data there are approximately 240,000 to 
400,000 cases of LD annually in the United States with a LD and PTLDS total direct 
medical cost of $712 million to $1.3 billion each year. The implications of this study on 
public health policy are enormous as LD spreads to non-endemic areas such as Southern 
California. Increased awareness of the disease and the potential for complications from 
misdiagnosis, late diagnosis, or inappropriate treatment is crucial to provide cost-
effective and compassionate management of patients with CLD.  
The number of phenomenological approach studies conducted to understand 
patients’ diagnosis of CLD that explore the lived experiences of becoming diagnosed are 
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limited. Previous qualitative studies on CLD included purposive samples of 10 to 12 
participants diagnosed with the disease, face-to-face interviews were conducted and tape 
recorded, the interviews were transcribed and emerging themes and topics were 
categorized and analyzed. Drew and Hewitt (2006) found six themes that emerged from 
the interviews. Theme one, feelings of frustration on long process of diagnosis due to 
high rate of false-negative results, lack of “bull’s eye” rash erythema migrans (EM) 
presentation, and nature of the symptoms. Theme two, long road to diagnosis. Theme 
three, financial stress, patients have lost their jobs and medical expenses not covered by 
medical insurance. Theme four, self-advocacy, participants researched the internet, social 
support groups and other means to consider LD as differential diagnosis and educate 
others about the disease. Theme five, validation of their symptoms once diagnosed as 
relief and explanation of the multiple symptoms; and Theme six, sense of hopefulness 
once treatment began despite nature of the illness. Another study conducted by Ali et al. 
(2014) found four major themes. Theme one, changes in health status and social impact 
of CLD. Theme two, doubts about recovery and the future. Theme three, contrasting 
doctor-patient relationship in which participants characterized doctors as either uncaring 
and dismissive or exceptionally supportive. And theme four, unconventional therapies to 
treat CLD; besides receiving oral or intravenous antibiotic therapy for longer periods than 
the established guidelines with symptomatic relief while in the treatment, many patients 
in this study reported seeking out other health care providers such as neuropathic doctors 
or complementary and alternative medicine providers and therapies. According to Ali et 
al. (2014), there is a gap in the current literature when it comes to representing CLD 
clients from diverse ethical groupings with attention given to those in a higher socio-
6 
 
economic stratum, more education, and medical insurance coverage. This study will fill 
in the gap described by Ali et al. (2014).  This research was achieved by selecting a group 
of participants who were not just middle-aged whites with high a socioeconomic status, 
and who can afford full medical insurance coverage, but focused on a diverse ethnic, 
racial, educational, and socioeconomic group of participants. 
Problem Statement  
Lyme disease falls in the category of Emerging Infectious Diseases (EID), which 
comprises of a list of human pathogens that have emerged or remerged in the last three 
decades (Parks et al., 2005). The impact of EID on human society is enormous causing 
nearly 15 million deaths, suffering, and costing billions of dollars (Ostfeld, 2011). The 
annual incidence of LD has steadily increased more than 25-fold since 1982 when 
national surveillance began in the United States (Drew & Hewitt, 2006). Cases reported 
to the CDC in 2013 yielded a national incidence of 8.6 per 100,000 people (CDC, 2013). 
Extrapolations estimate annual cases to be from 240,000 to 440,000 cases (Gardner, 
2012). However, this number is underestimated due to inconsistency in reporting by 
physicians and laboratories, number of undiagnosed cases (Borgermans, et al., 2014) and 
lack of standard diagnostic practices in the states (Drew & Hewitt, 2006). LD is a 
multisystem zoonotic disease caused by Bb (Margos, et al., 2012). This bacterial 
organism has evolved by gene expression and adapted to various environments, the 
transmitting vector, and the mammalian host (Anguita, Hedrick, & Fikrig, 2003). LD is 
the most-prevalent arthropod-borne (tick) disease in North America and one of the fastest 
growing infectious diseases (Levi, Kilpatrick, Mangel, & Wilmers, 2012). The incidence 
has approximately doubled between 1991 and 2012 from 3.74 to 7.01 reported cases per 
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100,000 people (CDC, 2013). In some Eastern and Central states, the disease is more 
prevalent than in Western states (CDC, 2013). The general problem is that all the way to 
Southern California, both patients and practitioners fail to recognize the disease, resulting 
in misdiagnosis and delayed treatment (Hui 2008; Swei, Ostfeld, Lane, & Briggs, 2011). 
If diagnosis is missed or is treated inadequately the patient may go on to develop 
devastating long-term CLD or PTLSD consisting of many non-specific symptoms 
affecting various body systems (Drew & Hewitt, 2006; Stricker, 2007; Borgermans et al., 
2014). The annual burden of disease for CLD in the year 2000 was $17,580 per patient 
broken down into $1,380 direct medical, $389 indirect medical, $6,703 non-medical, and 
$9,108 loss of productivity (Adrion et al., 2015). Currently, the average annual cost of 
CLD exceeds $20,000 per patient (Adrion et al., 2015). Patients bear 88% of the cost, 
while insurers bear just 12% (Johnson, 2013; Horowitz, 2013). Total healthcare cost of 
CLD per patient is $3,798 higher for a 12-month-period relative to those who do not 
develop CLD (Adrion et al., 2015).  
The specific problem is that there exists a misconception that there is no LD and 
subsequently no CLD in Southern California (Hui, 2008). Therefore, primary care 
physicians and most individuals may not even be aware that the disease exists in their 
area (Sharlach, 2015). In California, the risk of encountering infected ticks is 
concentrated in national recreational parks and other wooded areas (Sharlach, 2015). In 
Los Angeles County, urban areas are located next to wilderness areas (Hollywood Bowl, 
Rose Bowl, and the Greek Theatre). Blacklegged ticks found throughout Hollywood 
Bowl (Hollywood Hills), Griffith Park, Angeles National Forest, Santa Monica 
Mountains, Los Padres National Forest, San Gabriel Mountains, Santa Monica 
8 
 
Mountains, Whittier Hills, La Puente Hills, and Palos Verdes (Woolford, 2015) 
constitutes a serious risk. The lack of early diagnosis, awareness, and prevention 
measures pose a great danger (Hui, 2008). Statistical figures indicate that from 1,561 LD 
total reported cases in a period of ten years from 1992 to 2001 there were 200 cases 
(13%) from Southern California mainly from San Diego, Los Angeles, and San 
Bernardino County (Hui, 2008; CDPH, 2014). The California Department of Public 
Health reported 120 cases of LD in 2013 of which 17 confirmed cases where from Los 
Angeles County (CDPH, 2014).  
According to Ali et al. (2014), there is a gap in the current literature when it 
comes to representing CLD clients from diverse ethical groupings with attention given to 
those in a higher socioeconomic stratum, more education, and medical insurance 
coverage. Little is known about CLD patient’s experiences and the impact on young 
adults’ health behaviors in the Los Angeles County, an ethnic, educational, and socio-
economic diverse population area (Hui, 2008; CDPH, 2013; California LD Association, 
2015). In his study, I addressed the gap found in Ali et al. (2014) by conducting a 
qualitative, descriptive study in which face to face semistructured interviews based on the 
health belief model (HBM) constructs of perceived susceptibility, severity, benefits, 
barriers, cues to action, and self -efficacy was conducted on an ethnically diverse group 
of young adults 18 to 40-year-old clinically diagnosed with CLD.  
Purpose of the Study  
The purpose of this phenomenological study was to explore the impact of chronic 
Lyme disease on the health-promoting behaviors of ethnically diverse, insured, young 
adults from similar educational and socioeconomic backgrounds based on their lived 
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experiences. The geographical focus of this study was restricted to Los Angeles County, 
California, because there is a general lack of awareness of LD and CLD on the West 
Coast of the United States (see Hui 2008; Swei, Ostfeld, Lane, & Briggs, 2011). The 
perspectives of this group of participants gave healthcare providers and the public a 
deeper insight into the affect CLD has on the personal and professional lives of affected 
clients and its impact on their decision-making processes.   
Research Questions  
RQ1: Qualitative: To what degree do different ethnic groups with average levels 
of socioeconomic status, education, and third-party coverage, perceive the likelihood of 
acquiring comorbidities related to CLD?  
RQ2: Qualitative: To what degree does the perceived severity of CLD impact the 
lives and decision-making processes of different ethnic groups with average levels of 
socio-economic status, education, and third-party coverage?  
RQ3: Qualitative: To what degree does the perceived benefits of treatment impact 
the lives and decision-making processes of different ethnic groups with average levels of 
socio-economic status, education, and third-party coverage?  
RQ4: Qualitative: To what degree do perceived barriers impact the lives and 
decision-making processes of different ethnic groups with average levels of socio-
economic status, education, and third-party coverage?  
RQ5: Qualitative: To what degree does the cues to action impact the lives and 
decision-making processes of different ethnic groups with average levels of socio-
economic status, education, and third-party coverage?  
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RQ6: Qualitative: To what degree does self-efficacy impact the lives and 
decision-making processes of different ethnic groups with average levels of socio-
economic status, education, and third-party coverage?  
Theoretical Framework  
  The HBM was used as the framework for the study to explain and predict health 
behaviors of CLD by focusing on the attitudes and beliefs of the individuals afflicted 
with the disease. The HBM has its origins in Lewin’s theory in 1947 which indicated that 
“behavior change is determined by how people value a particular outcome and the 
assumption that certain actions will facilitate that outcome” (Becker, Rosenstock, & 
Slack, 1974, p. 328). It is from Lewin’s hypotheses that social psychologists Hochbaum, 
Rosenstock, and Kegels in the 1950s popularized the HBM while working in the U.S. 
Public Health Services to better understand the widespread failure of people to participate 
in programs to diagnose or prevent disease (Crosby, DiClemente, & Salazar, 2006; 
Schiavo, 2007). The dimensions of the HBM constructs; perceived susceptibility, 
severity, benefits, barriers, cues to action, and self-efficacy (Crosby et al., 2006; Hayden, 
2013; Schiavo, 2007) aided to understand the illness presentations, health care choices, 
treatments options, and the individual’s beliefs and expectations of the disease (Ali et al., 
2014).  
The theoretical model explains individual perceptions in a disease being 
influenced by modifying factors such as age, sex, ethnicity, personality, insurance status, 
educational level, socio-economic, and knowledge which, in turn, influence the 
likelihood of action and perceived threat of disease modified by education, symptoms, 
and media information directly affecting likelihood of behavioral change which is 
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discussed in depth in chapter two (Crosby, DiClemente, & Salazar, 2006; Redding, Rossi, 
Velicer, & Prochaske, 2000). The HBM relates to this study approach and research 
questions in that it examined the impact that the experiences and perceptions of the Los 
Angeles County, California young adults diagnosed with CLD have on their health 
promoting behaviors; therefore, the HBM constructs (see Figure 1) provided the 
dimensions to focus on the perceptions and lived experiences of patients, including 
diagnostic methods, health benefits, perceived efficacy, and therapeutic regimens used. 
More details regarding the HBM and its value in framing the study design and execution 
are discussed in Chapter 2.  
 
    Individual Perceptions                     Modifying Factors       Likelihood Action 
 
      
      
                              
 
 
                             
                          
     
Figure 1. Conceptualizing the HBM. Adapted from Glams, K., Rimer, B. and Lewis, M. 
(2002). Health Behavior and Health Education: Theory, Research and Practice. Wiley 
and Sons, San Francisco. Copyright 2003 by The American Psychological Association. 
Perceived Susceptibility/ 
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Nature of the Study  
  I used a qualitative, hermeneutical phenomenology research design. Qualitative 
inquiry provided the means to examine the nature and scope of CLD through the lived 
experiences and perceptions of those afflicted by the disease in the natural setting (Baxter 
& Jack, 2008; Drew & Hewitt, 2006). Hermeneutical phenomenology, a descriptive style 
of qualitative research, provided the strategy of inquiry in which I identified and 
interpreted the essence of human experiences about CLD in language that was loyal to 
the lived experiences of the participants (Creswell, 2009; Rudestam & Newton, 2015). In 
addition, hermeneutical phenomenology research is a descriptive style of qualitative 
inquiry that permits the researcher to use introspective reflection as well as observation, 
listening, and empathetic alliance with the study participants (Drew & Hewitt, 2006; 
Rudestam & Newton, 2015). Qualitative inquiry and more precisely a phenomenological 
design was the most appropriate method since it allowed me to draw upon lived 
experiences of the participants to gain a deeper understanding and appreciation of how 
CLD impacts their lives and decision-making processes. This approach uniquely 
supported my goal to examine the experiences of an ethnically diverse, young adult 
segment of the Los Angeles County population afflicted with CLD. It also allowed me to 
gather insights about the impact of CLD on daily lives of the participants by exploring 
the full nature of the phenomenon and describing the human experience as it was lived 
(Drew & Hewitt, 2006; Rudestam & Newton, 2015).  
  I used semistructured interview questions for this qualitative study based on the 
HBM constructs focused on the experiences and perceptions of patients clinical 
diagnosed CLD as the main source of data. The purposive sample I used for this study 
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consisted of voluntary participants in the age range from 18 to 40 years old recruited 
from the social media (Facebook) group “Los Angeles County Chronic Lyme Disease 
Support and Discussion” as well as CLD patients known by the researcher. Participants 
continued to be recruited and interviewed until emerging patterns appeared and 
theoretical saturation was achieved indicated by well-characterized and differentiated 
categories (see Ali et al., 2014). Prior to the interview, approval from the Institutional 
Review Board was obtained as well as informed consent from the participants to collect 
demographic data such as age, sex, marital status, years of education, race/ethnicity, 
socio-economic and employment status, and health insurance coverage.  
The primary sources of data were demographic data from the study participants, 
transcripts of the tape-recorded interview sessions, and field notes taken during the 
interview sessions. Relevant documents were used a secondary source of data as needed 
to verify information gathered during the study (Creswell, 2009). Transcripts were 
analyzed using content analysis standard methods to determine emergent themes and 
categories assigned with codes by using the qualitative software QSR NVivo.  
Definitions  
Anaplasma: a genus of organisms transmitted by ticks that parasitize erythrocytes, 
thrombocytes, and leukocytes causing of human granulocytic anaplasmosis (HGA). The 
infection can be mild causing anemia, low white blood cell count, low platelet count, and 
elevated liver enzymes or severe causing respiratory insufficiency, kidney failure, and 
eventually death (Krakowetz, Dibernardo, Lindsay, & Chilton, 2014, CLDA, 2015).  
Babesia: protozoan parasite transmitted by ticks that infect the blood and cause a 
parasitic, hemolytic disease known as babesiosis presenting itself with fever and chills 
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then fatigue, headache, drenching sweats, muscle aches, chest pain, hip pain and 
shortness of breath as the disease progresses. Documentation in the literature of Babesia 
transmission cases from mother to unborn child or through a contaminated blood 
transfusion exist. Currently, most blood banks do not screen donated blood for Babesia 
(CDC, 2014).  
Bartonella: are bacteria that live primarily inside the lining of the blood vessels 
that can infect humans, mammals and a wide range of wild animals. The organism 
transmitted by fleas, ticks, animals, even spiders cause Bartonellosis. The infected patient 
may experience fever, fatigue, and loss of peripheral vision, bouts of muscle and joint, 
numbness of the hands, headaches, memory loss, and hallucinations (CLDA, 2015).  
Cognitive dysfunction: is the loss of intellectual functions such as remembering, 
thinking, and reasoning of sufficient severity to interfere with daily functioning. Also 
known as brain fog in which the patients have trouble with concentration, verbal recall, 
and basic arithmetic (Medalia & Revheim, 2012).  
Ehrlichia: bacterial organisms transmitted to humans by the bite of an infected 
tick. The lone star tick (Amblyomma americanum) is the primary vector in the United 
States. Symptoms of ehrlichiosis include fever, headache, fatigue, and muscle aches 
within one to two weeks following a tick bite (CDC, 2015).  
  Encephalopathy: a term for a diffuse disease of the brain that alters brain function 
or structure that may be caused by bacteria, virus, brain tumor, malnutrition, chronic 
progressive trauma, pressure in the skull, prolonged exposure to toxic chemicals, or lack 
of oxygen or blood flow to the brain. The condition results in altered mental state causing 
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lethargy, progressive loss of memory, inability to concentrate and subtle personality 
changes (NIH, 2010).  
Neuropathic: describes a problem with the nerves, mainly the peripheral nerves 
which can be sensory (numbness, tingling, increase or decrease ability to feel pain, heat 
or cold), motor (muscle weakness, twitching, crumps) or autonomic (dizziness, fainting, 
bloating, constipation, diarrhea, raising heart) caused by certain diseases, infection, 
vitamin B12/folate deficiency and drugs (Logigian & Steere, 2012).  
  Complementary and alternative medicine: abbreviated as CAM treatment of LD 
refers as a combination of different intravenous antibiotics therapy, herbal remedies 
administration, and nutritional supplements, to stimulate and enhance the immune 
system's ability to fight Bb an intracellular microorganism (Vojdani, Hebroni, Raphael, 
Erde & Raxlen, 2009).  
  Phenomenology: is the direct investigation and description of phenomena as 
consciously experienced, without theories about their causal explanations. In a 
phenomenological research design, the researcher attempts to understand the participant’s 
perspectives and perceptions and tries to answer questions such as; what is it like to 
experience CLD? then generalize from the insider’s perspective (Creswell, 2009).  
  Zoonotic disease: a disease transferred between animals and humans; caused, by 
viruses, bacteria, parasites, and fungi. Estimates indicate, “more than six out of every 10 
infectious diseases in humans are spread from animals” (CDC, 2013, p. 5).  
Assumptions  
I chose a qualitative research design for this study because the health promoting 
behaviors of young adults in the Los Angeles County afflicted with CLD needed to be 
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explored and their voices needed to be heard rather than to use predetermined 
information from the literature or relay on other studies. My first assumption was the 
paradigm assumption that patterns and theories can be explicated to develop a significant 
understanding of how young adults cope with CLD through the interview questions to get 
to the heart of the problem.  
The second philosophical assumption was that reality for the group of participants 
is the result of individual interactions in their social worlds; therefore, meaning is 
determined by their experiences, an assumption that was mediated through my own 
perception (Creswell, 2009). Lastly, the study relied on the responses the participants 
provided through interview questions, I assumed that the participants answered honestly 
and truthfully. In addition, given the fact that the study was a phenomenological study; 
the lived experiences of individuals were important to the study, the meaning of these 
experiences was best given by the people who experienced them, and one should not be 
preoccupied with method and the traditional concerns of reliability, generalization, or 
validity (Golafshani, 2003). For the study to progress, I provided reassurance to the 
participants by explaining how confidentiality will be preserved for the entire duration of 
the study and in the future. The participants were also informed that they might withdraw 
at any time without any ramifications.   
Scope and Delimitations  
Lyme disease (LD) is a controversial illness which has created battles for years 
between opposing views in the prevalence of the infection, the accuracy of diagnosis, 
effective modes of treatment, and the existence of a chronic form of the disease (Ostfeld, 
2011). On one side of the argument are physicians and researchers who state that chronic 
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Lyme disease (CLD) is difficult to contract, easy to diagnose, and effectively treated with 
conventional oral antibiotics (Horowitz, 2013). On the other side of the controversy, are 
groups of patients and health care practitioners who assert that LD is more severe and 
common than presented by the CDC’s statistics, unrecognized, undiagnosed, and if left 
untreated results in chronically infected patients (Horowitz, 2013).  
Failure to investigate and address the size of the problem by the public health 
community and health care providers has limited the development of sensitive diagnostic 
tools, modes of treatment, and effective disease management (Ostfeld, 2011). This study 
explored health promoting behaviors of male and female young adult’s ages 18-40 from 
diverse racial/ethnical background, various levels of education as well as socio-economic 
status, which did or did not have health care coverage. The participants were residents of 
the Los Angeles County who had been clinically diagnosed with CLD and had received 
or were receiving medical treatment or intervention including antibiotic therapy or 
complementary and alternative medicine treatment. The age group chosen for this study 
(18-40 years-old) was determined based on the level of activity, independence, and busy 
lifestyle often demonstrated by this age group under normal healthy circumstances. 
Persons excluded from the study included those who lacked medical diagnosis of CLD 
either by clinical disease definition or confirmatory laboratory diagnostic tests, self-
diagnosed, patients with diagnosed CLD who had received any treatment, and those 
outside the determined age group. Participants were recruited from social media groups; 
the Facebook page “Chronic Lyme Disease” and the “California Lyme Disease 
Association Los Angeles Chapter Support Group and Advocacy.”  
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The HBM was selected as the theoretical framework for this study after careful 
consideration was given to other theories and models frequently used in health promotion 
such as Stages of Change (Transtheoretical model) and the theory of reasoned action. 
Even though these models and theories relate to behavior change, they did not provide 
the dimensions this study focused on which included the perceptions and lived 
experiences of patients, including diagnostic methods, health benefits, perceived efficacy, 
and therapeutic regimens used (Redding, Rossi, Velicer & Prochaske, 2000). The results 
of this study may not produce transferability data to other CLD young adults in other 
counties in California or other communities in the nation.  
Limitations  
  Phenomenology, the nature of this qualitative research design, and data 
subjectivity leads to difficulties in the following areas: establishing reliability and 
validity, preventing or detecting researcher induced bias, interpreting data, and presenting 
the results in a manner that is usable to health care and public health practitioners 
(Shenton, 2004). In addition, there is no formula to determine sample size as in 
quantitative studies and phenomenology does not generate generalizable data (Patton, 
2002).  
Potential weaknesses in the study included: first, achieve adequate participants’ 
enrollment to obtain theoretical saturation. Theoretical saturation is defined as “the phase 
of qualitative data analysis in which the researcher has continued sampling and analyzing 
data until no new data appear and all concepts in the theory are well-developed” (Morse, 
2015). To achieve theoretical saturation, theoretical concepts were verified, conceptual 
borders were marked, verification of no further need for additional data was ensured, and 
19 
 
confirmation that the data analysis was data driven was performed. Second, introduction 
of the researcher’s induced bias. Introduction of my bias were considered as a method of 
dealing with them (see Rajendran, 2001). As the data “went through” my mind, I 
confronted opinions and prejudices using a flexible approach which entailed talking 
about myself, my choices, experiences, presuppositions, and actions during the research 
process allowing the reader to visualize the choices and decisions I experienced during 
the research inquiry (Ortlip, 2008).  
Third, establish credibility as means on internal validity. I strived to promote 
confidence, trust, and openness of the participants by developing early familiarity with 
the participant’s culture before the data collection took place. Open ended questions were 
posed during the interview process allowing the participants to articulate their 
experiences dealing with CLD. A form of triangulation was used which involved the use 
of a wide range of participants racial/ethnically, culturally, and financially diverse 
viewpoints and experiences verified against each other (Patton; 2002; Rajendran, 2001; 
Shenton, 2004).  
Participant’s checks were performed at various times during data collection. The 
participants had opportunities to read any transcripts of the dialogues and interviews they 
participated in to ensure the information captured was indeed their intended words (Guba 
1981; Patton, 2002). I used frequent debriefing sessions with the dissertation chair to 
discuss the study approach, identify flaws, develop ideas, and recognize bias (Shenton, 
2004) as well as peer scrutiny of the research by peers and colleagues.  
The fourth and last potential weakness of the study discussed here as with any 
qualitative research design is transferability or external validity. Since the findings of the 
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study were specific to a small group of individuals in a geographical area it is impossible 
to demonstrate applicability to other populations. The interpretation that the results of the 
research can be applied to a wider population like Los Angeles County study population 
affected by CLD are left up to the reader. My responsibility was to provide accurate 
description of the phenomenon and sufficient contextual information of health promoting 
behaviors of young adults with CLD, to enable the reader to make such a transfer 
(Shenton, 2004).  
Significance of the Study  
I uniquely addressed in this study the need for a deeper understanding of the 
impact of CLD on the health promoting behavior of ethnically diverse, young adults 
residing in Los Angeles County through a qualitative examination of their lived 
experiences. Results from this study may positively impact individuals, the community, 
and society by shedding light on the nature and scope of this disease from the perspective 
of those infected. I probed into the perceived effectiveness of conventional and 
nonconventional treatment modalities, which may lay the foundation for re-examining 
the care planning process. If treatment approaches are designed to meet the holistic needs 
of CLD clients, this may erode perceived barriers and foster health promoting and 
seeking behaviors.  
In addition, this study was intended to increase awareness of the scope and nature 
of CLD in a community with limited but growing infection rates (Hui, 2008; CDPH, 
2014), so that providers and the public can work collaboratively to retard the spread of 
this disease and safeguard the health and safety of society. This study may also serve as a 
positive catalyst for societal change by altering health promoting behaviors of the public 
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based, in part, of the lived experiences of the participants. Finally, it is the researcher’s 
sincerest desire to see this study lay the foundation for future qualitative inquiry in the 
nature and scope of CLD in the U.S. and abroad.  
Summary  
In this chapter, I provided a detailed description of the background of the study 
and the problem statement. The purpose statement, research questions, theoretical 
framework, and nature of the study were presented. Definitions of terms used were 
provided to clarify the meaning as the terms relate to CLD. Assumptions, scope and 
delimitations, as well as limitations of specific aspects of the research that were critical to 
the meaningfulness of the study such as population’s boundaries, transferability, possible 
weaknesses, and biases of the study were discussed. Significance of the study identified 
potential contributions to the individual, the community, society, and public health 
practice. The following chapter, the literature review, provides backing for the proposed 
study; the problem serving as the catalyst for the study; and finally, the theory that 
underpinned the study’s design and execution.  
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Chapter 2: Review of the Literature 
Introduction  
Lyme disease (LD), a globally emerging infectious disease caused by the 
spirochete bacteria Borrelia burgdorferi (Bb), is classified as the most common vector-
borne (tick) infectious disease in North America and Europe (Aucott, Rebman, Crowder, 
& Korte, 2013; Feng, Shi, Zhang, & Zhang, 2015) and one of the fastest growing 
infectious diseases (Levi, Kilpatrick, Mangel, & Wilmers, 2012). The LD burden to the 
individual and society remain high despite the knowledge and availability of prevention 
measures (Cameron, Johnson & Maloney, 2014).  
The incidence of LD ranges from 240,000 – 440,000 new cases a year (Gardner, 
2012; Adrion, Aucott, Lemke, & Weiner, 2015; CDC, 2013) making LD at least twice as 
common as breast cancer and six times more prevalent than HIV/AIDS (Stricker & 
Middelveen, 2015; The Lyme Times, 2015). However, this number is underestimated due 
to inconsistency in reporting by physicians and laboratories, number of undiagnosed 
cases (Whitmont, 2012; Borgermans et al., 2014), and lack of standard diagnostic 
practices in the states (Drew & Hewitt, 2006).  
In some Eastern and Central states, LD is more prevalent than in Western states 
(CDC, 2013). All the way to Southern California, both patients and practitioners fail to 
recognize the disease, resulting in misdiagnosis and delayed treatment (Hui 2008; Swei, 
Ostfeld, Lane, & Briggs, 2011). If diagnosis is missed or is treated inadequately the 
patient may go on to develop devastating long-term chronic Lyme disease (CLD) or Post-
Treatment Lyme Disease Syndrome (PTLDS) consisting of many non-specific symptoms 
affecting various body systems (Drew & Hewitt, 2006; Stricker, 2007; Borgermans et al., 
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2014). The purpose of this study was to explore the effect that CLD has on the health 
promoting behaviors of ethnically diverse, insured, young adults from similar educational 
and socio-economic backgrounds based on their lived experiences. The geographical 
focus of this study was restricted to Los Angeles County, California, because there is a 
general lack of awareness of LD and CLD on the West Coast of the United States (Hui 
2008; Swei, Ostfeld, Lane, & Briggs, 2011).  
In this chapter, I present a synthesis of the research literature relevant to LD and 
CLD, coinfections, treatments, and associated issues affecting health promoting 
behaviors of young adults with CLD. The specific literature search strategies and terms, 
library databases, and search engines are presented to facilitate finding articles for future 
reference and achieve reproducibility of the research. Previous and current application of 
the HBM are reviewed and the ways the model constructs support this research are 
discussed. Finally, the major themes elucidated in the literature review are summarized 
and the ways this study addressed gaps found in the body of literature are presented.   
Literature Search Strategy  
Literature research was conducted using various sources to retrieve information. 
Medline, PubMed, Google Scholar, Microsoft Academic Research, PLoS ONE, Bio One, 
and Science Direct were searched using Internet Explorer and Google Chrome as search 
engines. The Walden online library Health Sciences Research databases which included 
in addition to Medline, PubMed, and Scientific Direct; CINAHL Plus, ProQuest, 
PsycINFO, and evidence based and clinical resources such as Cochrane, Health 
Technology Assessments, and Annual Reviews (Walden, 2015). All databases were 
searched with the terms Lyme Disease, Chronic Lyme Disease, Lyme Disease in 
24 
 
California, or neuroborreliosis, in combination with case definition, statistics, diagnosis, 
treatment, prevention, climate change, ecology, epidemiology, prevention controversies, 
health promoting behaviors, young adults, or specific vector-borne infections associated 
with LD for reports published after January 2010. I conducted many searches. Inquiry 
using the words CLD in Google Chrome search engine produced an unbelievable 
7,540,000 results. Narrowing the inquiry with the words Lyme Disease in California 
produced 1,100,000 results that significantly decreased in articled to 330 when using 
Google Scholar search engine. When searching with much more specific words related to 
the topic of this study, health promoting behaviors in young adults with CLD I obtained 
594 results by using Google scholar engine of which only two articles were relevant to 
my topic of study. I obtained similar results when using the different databases available 
at Walden University Library.  
I conducted a review of the reference list of reports identified by the searches and 
selected articles as a strategy to locate additional relevant articles. Familiarity with CLD 
and the scientific literature was relied upon to search Lyme Disease Associations Journals 
available through memberships and Lyme Literate Medical Doctors’ offices. Non-peer-
reviewed publication, narratives, opinions, magazines, and newspaper articles provided 
lead to other sources that ultimately lead to systematic investigations, evidence based 
studies, and scientific data.  
I selected reports from the past 5 years, but I did not exclude older publications 
that were unique in its informational content and deemed useful. I selected books and 
reviews on LD, CLD treatments, ecology of LD, medicinal plants, and alternative and 
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complementary medicine chapters to be cited as additional and comprehensive sources of 
references.  
Selected articles and resources that I included in this study were full text, peer-
reviewed publications, evidence based scientific data, research, and information 
pertaining and affecting health promoting behaviors of young adults with CLD. Articles 
and literature resources focusing on the aforementioned LD and CLD themes affecting 
children under 18 years of age or over 40 years old, as well as those articles that 
concentrated on the East and Central states LD etiological agents and disease presentation 
were excluded. Exclusion took place to maintain the focus on research findings and 
disease presentation in California, which directly affect LD spreading to Southern 
California specifically to Los Angeles County’s active, young adult communities in the 
age group 18 to 40 years old.  
Articles, Master’s theses, or PhD dissertations relating directly with health 
promoting behaviors of young adults affected with CLD were limited. As I mentioned, a 
total of two closely related qualitative phenomenological studies using the HBM as 
theoretical framework were found and one PhD dissertation which focused mainly on the 
ecology of LD and the global pending epidemic to be acknowledged by the medical and 
public health community. I used databases and search engines since the preliminary 
stages of the study; from the initial drafting of the study prospectus and such practice 
continued to submission of the revised and final version of the study.  
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Theoretical Foundation  
The Health Belief Model  
The aim of public health practitioners is to achieve the mission of the 
multidisciplinary field of public health; prevent disease and death, promote a better 
quality of life, and create environmental conditions and interventions geared to healthy 
individuals, the community, and the society at large (Behavioral Change Models, 2012; 
Schiavo, 2007). For public health practitioners to achieve the public health mission, a set 
of skills and qualities as described in the following sentence are essential. In addition to 
possessing the skills to define and identify public health problems, assess causes of the 
problem, identify population at risk, implement interventions, and evaluate outcomes; the 
public health practitioner must know how to apply theories, basic principles, research 
findings, and methods to inform their efforts (Crosby, DiClemente & Salazar, 2006; 
Schiavo, 2007).  
The HBM mainly derived from social and behavioral sciences, as is the case with 
other behavioral change models, allows practitioners to assess public health problem 
fundamental causes and develop public health interventions to address those problems 
(Behavioral Change Models, 2012; Burke, 2013). The origin of the HBM dates to 1947 
with Kurt Lewin’s theory who stated, “Behavior change is determined by how people 
value a particular outcome and the assumption that certain actions will facilitate that 
outcome” (Becker, Rosenstock, & Slack, 1974, p. 328).  
According to his theory, perceptions of reality, not objective reality is what 
influences behavior; is the world of the perceiver that determines what an individual will 
and will not do (United States Department of Health and Human Services [DHHS], 
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2002). The developers of the HBM were United States Public Health Services research 
psychologist Godfrey Hochbaum, behavioral scientist Stephen Kegels, and psychologist 
Irwin Rosenstock greatly influenced by Kurt Lewin’s theory (DHHS, 2002). The purpose 
of the model was to explain and predict human behavior using a systematic method 
focused on the relationship of health behaviors, practices, and utilization of health 
services.  
Currently, scientist consider the HBM as the beginning of systematic, theory-
based research in health behavior and include general motivation to distinguish health 
behavior from illness and sick-role behavior (DHHS, 2002). The professional training 
and background of the HBM originators and the health settings of the 1950s, mainly 
disease prevention and not treatment or concern for symptoms and medical regimen’s 
compliance, were leading factors to the development of the HBM (DHHS, 2002; NICE 
2007). Hochbaum, Kegels, and Rosenstock popularized the HBM to better understand the 
widespread failure of people to participate in programs to diagnose or prevent disease 
(Crosby, DiClemente, & Salazar, 2006; NICE 2007; Schiavo, 2007).  
The Health Belief Model Brief Description 
  The hypothesis of the HBM states that health related action depends upon three 
different factors occurring simultaneously. First, general health values: sufficient health 
concern or motivation to make health issues relevant or salient. Second, specific health 
values about vulnerability to a health threat: belief of one’s susceptibility or vulnerability 
to a serious health problem, illness, condition or its sequelae (perceived threat). Third, 
beliefs about the consequences of the health problem: the belief that following a health 
recommendation at a subjectively accepted cost (perceived barrier) would reduce the 
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perceived threat (Behavioral Change Models, 2012; Rosenstock, Strecher, & Becker, 
1988).  
Motivation to undertake a specific health behavior would then be based on 
individual perceptions dealing with the importance of health to the individual, perceived 
susceptibility, perceived severity and modifying behaviors and demographic variables 
would influence perceived threat that directly influences likelihood of action (Behavioral 
Change Models, 2012). The conceptual model explains individual perceptions in a 
disease. It is influenced by modifying factors such as age, sex, ethnicity, personality, 
insurance status, educational level, socio-economic, and knowledge which, in turn, 
influence the likelihood of action and perceived threat of disease modified by education, 
symptoms, and media information directly affecting likelihood of behavioral change 
(Crosby et al., 2006; Redding, Rossi, Velicer, & Prochaske, 2000,).  
Dimensions of the Health Belief Model 
  The HBM consists of six constructs (NICE, 2007). The first four constructs are 
the original tenets developed by Hochbaum, Kegels, and Rosenstock. The last two 
constructs were added later as research on the HBM evolved (Behavioral Change 
Models, 2012; NIH, 2010).  
1. Perceived susceptibility: refers to the individual’s subjective perception of the 
risks involved in contracting a disease or condition (Janz & Becker, 1984; 
Rosenstock, 1974). This construct considers the individual’s vulnerability and 
wide variation in feelings regarding belief in the diagnosis, estimates of 
susceptibility to a disease or condition, and susceptibility to illness in general 
(Behavioral Change Models, 2012).  
29 
 
2. Perceived severity: refers to the individual’s feelings concerning the seriousness 
of contracting the disease, leaving the disease untreated, and clinical, medical, and 
social consequences of the choices made. This dimension includes how the illness 
affects family life, work, social relations, disability, pain, and death (Behavioral 
Change Models, 2012; Janz & Becker, 1984; Rosenstock, 1974). The 
combination of perceived susceptibility and perceived severity is termed 
perceived threat (Janz & Becker, 1984).  
3. Perceived benefits: this dimension refers to the individual perception of the 
effectiveness to reduce or cure the illness. When individual considers the 
available action to take based on the perceived susceptibility and severity. The 
threatened individual would be expected to accept the recommended health action 
when such action is perceived as efficacious and feasible (Behavioral Change 
Models, 2012; Janz & Becker, 1984).  
4. Perceived barriers: refers to the individual’s feelings on the obstacles present 
when performing a recommended health action (Behavioral Change Models, 
2012). Possible negative aspects considered by the individual regarding the 
recommended health action may include cost, dangerous side effects, unpleasant 
outcomes, painful, difficult, time consuming, and inconvenient (Janz & Becker, 
1984).  
5. Cues to action: refers to anything that triggers a decision to change 
behavior (Burke, 2013) the individual’s motivation to external or internal cues 
triggers action to take place regarding a recommended health action. Cues to 
action include physician’s advice, a change in health, wheezing, chest pains, death 
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of a friend, illness of family member, advice from others, newspaper article, and 
fleeting events elusive to record (Behavioral Change Models, 2012; Rosenstock, 
1974).   
6. Self-efficacy: Efficacy is directly affected by the level of the individual’s 
confidence in their ability to perform a behavior successfully (Behavioral Change 
Models, 2012). The most influential source of efficacy is performance 
accomplishment, followed by vicarious experience obtained through observation 
of other’s performance both successfully or unsuccessfully. Less powerful sources 
of efficacy include verbal persuasion or exhortation and physiological states of 
the individual (Rosenstock, Strecher, & Becker, 1994).   
Limitations of the Health Belief Model 
  The HBM being more descriptive than explanatory does not suggest specific 
strategies to produce change in health-related actions. Several limitations exist which 
limit the HBM’s utility in public health. The model does not consider the individual’s 
beliefs, attitudes, habitual behaviors, environmental, cultural factors, socioeconomic 
status, and previous experiences that promote or inhibit the recommended health action 
(Behavioral Change Models, 2012). The model also assumes that every person possesses 
the same amount of information on the disease, illness, or condition and that “health” 
action is the main goal in the individual’s decision-making process (Behavioral Change 
Models, 2012; DHHS, 2002). Even though the HBM may be useful to derive information 
leading to interventions designed to change health behaviors and health beliefs, the model 
fails to inform decision making how to best structure those interventions (NIH, 2007).  
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Applications of the Health Belief Model    
 The HBM since is development has been used as a conceptual formulation in 
predicting health behaviors to understand the reason individuals engage or do not engage 
in a wide variety of health-related actions; preventive health behaviors, sick role 
behaviors, and clinic utilization (Janz & Becker, 1984). A critical review of 46 HBM 
related studies carried by Janz and Becker (1984) consisting of preventive health 
behavior studies (influenza vaccine, genetic screening, risk factors), sick-role behavior 
(antihypertensive, diabetic, end-stage renal disease, mother’s compliance for child’s 
condition regimens, and physician visit for symptoms), and clinic utilization, provided 
substantial empirical support for the HBM.  
Across the study designs, both prospective and retrospective, the perceived 
susceptibility dimension was a strong contributor to understand preventive health 
behaviors than sick role behaviors. Perceived barriers proven the most powerful of the 
HBM dimensions, and perceived severity had the lowest overall significance ratio with a 
weak association with preventive health behaviors and strongly related to sick-role 
behaviors. On current studies, King, Vidourek, English, and Merianos (2014) obtained 
the same results when applying the HMB: “Vigorous physical activity among college 
students: using the HBM to assess involvement and social support.” In addition, in 
studies such as “Comparing Theory-Based Condom Interventions: HBM Versus Theory 
of Planned Behavior” (Montanaro & Bryan, 2014), or “An Empirical Study to explore the 
adoption of Telehealth: HBM Perspective” (Hsieh, & Tsai, 2013); the results have 
indicated that theory based interventions and research are superior to those not guided by 
theory.  
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Jones, Jones, and Katz, (1991) evaluated the HBM as a method to increase 
compliance among acute and chronic patients visiting the Emergency Department. The 
HBM suggests that a patient’s adherence to professional advice depends upon perceived 
susceptibility, perceived severity, benefits, and cost after evaluating an estimate of what 
barriers might be involved in undertaking the recommended health action (Behavioral 
Change Models, 2012). In chronic diseases in which an illness episode represents flare-
ups, compliance decreases with the treatment complexity and regimen’s duration. Jones, 
Jones, and Katz, (1991) found that positive treatment experience, demographic variables 
such as age, and knowledge of the illness affects a HBM intervention on compliance.  
Using the dimensions of the HBM, Ali, Vitulano, Lee, Weiss, and Colson (2014) 
conducted a qualitative, phenomenological study in 12 adult participants with CLD. The 
HBM dimensions provided insights into the health beliefs and lived experiences of CLD 
individuals in the health care system and their beliefs and expectations. By discussion 
with each study participant on the HBM dimensions which included their perceptions of 
susceptibility to CLD, severity of symptoms, benefits of treatment, barriers to treatment, 
cues to action, and self-efficacy; Ali, Vitulano, Lee, Weiss & Colson (2014) formulated 
emerging themes. Based on the participants perceptions and descriptions of their 
experiences four distinct themes emerged: changes in health status and social impact of 
CLD, doubts about recovery and the future, contrasting doctor-patient relationships, and 
unconventional therapies to treat CLD.   
Rationale for Using the Health Belief Model  
Review of the literature yielded applications of the HBM pertaining to studies on 
diseases, illnesses, both acute and chronic conditions, health promoting behaviors, and 
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implementation of interventions. The HBM provided theoretical constructs to carry this 
study on health promoting behaviors of young adults with CLD in a designated 
geographical area. In addition, the model supported the current study by providing a 
framework for the formulation of research questions and the questions for the semi-
structured interview based on each of the HBM dimensions. The model fit the study 
foundation to explain and predict health behaviors of CLD by focusing on the attitudes 
and beliefs of the individuals afflicted with the disease. Since the HBM is an 
intrapersonal theory used in health promotion to design intervention and prevention 
programs, the model aligned with the significance of the study to increase awareness, 
promulgate prevention, retard the spread of the disease, and safeguard the health and 
safety of society.  
Literature Review Related to Key Variables and/or Concepts  
A Brief History of Lyme Disease 
Lyme disease (LD), caused by the Borrelia burgdorferi sensu lato complex, is the 
most prevalent and reported tick-borne infection in the United States and Europe (Levi, 
Kilpatrick, Mangel, & Wilmers, 2012; Stene et al., 2011) with increasing public health 
importance (Aucott, Rebman, Crowder, & Kortte, 2013). The list of experiences, health 
beliefs, and concerns of patients identified with CLD is extensive including the basic 
validation of being sick, considerable limitation of daily life’s activities, decline in health 
status, long-term debilitation, severe and varied symptomology, and psychological stress 
(Ali, Vitulano, Lee, Weiss & Colson, 2014). In addition, apparent stigma and bias 
perception within the medical community attached to chronic Lyme disease have resulted 
in diagnosis and treatment delay (Aronowitz, 2011). Many patients see 15 to 20 
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physicians searching for answers for diagnosis and treatment before correct diagnosis is 
achieved (Horowitz, 2013). CLD patients’ negative experiences with physicians and 
insurance companies have led to mixed feelings and opinions on the health care system, 
public health practitioners, and health care policy makers (Ali, Vitulano, Lee, Weiss & 
Colson, 2014; Aronowitz, 2011; Horowitz, 2013). Some of those experiences include 
disallowance for longer antibiotic therapy than 30 days as standard of care for Lyme 
disease, ineffective treatments, fruitless testing, and unsatisfying explanations (Johnson, 
2013; Lantos, 2011). The following in depth literature review describes studies related to 
the methods consistent with the scope of the study and the research questions, explores 
basic case definition of CLD, history of the disease, epidemiology and ecology, 
transmission, symptoms and disease presentation, characteristics of the LD etiologic 
agent Bb, diagnosis, treatment, and prevention of LD.  
To understand the roots of the decline in health status associated with the disease 
impacting health promoting behaviors of young adults in California, what is controversial 
and what remains to be studied are also reviewed. Researchers in the field of 
epidemiology have just recently began involvement in studies to explore the lived 
experiences of those diagnosed with CLD as evidenced by the limited numbers of studies 
found in the literature. In a study conducted by Ali, Vitulano, Lee, Weiss & Colson, 
2014) the authors used a qualitative phenomenological study on 12 patients with CLD to 
gain insights on the participants experiences with the disease, perceptions of CLD 
burden, and changes in the health and social status using the dimensions of the HBM. 
Based on 60 – 90-minute semi-structured interviews the authors could recognize the 
emergence of four major themes from the participant’s perceptions and experiences with 
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CLD: “changes in health status and social impact of CLD,” “doubts about recovery and 
the future,” “contrasting doctor-patient relationships,” and “unconventional therapies to 
treat CLD.” Another qualitative approach to understanding patients diagnosed with CLD 
was carried by Drew & Hewitt (2006) on a sample of 10 participants diagnosed with 
CLD. Drew & Hewitt (2006) also used interviews to discover six emerging themes: 
frustration, long road to diagnosis, financial stress, self-advocacy, validation and 
explanation of symptoms, and sense of hopefulness. The strength found in these two 
studies approaches is the methodology used to obtain a deep understanding of the lived 
experiences of becoming diagnosed with CLD that will allow health care practitioners to 
develop new strategies and interventions as well as advocate for CLD patient’s policy 
development in the public health care environment.  
Ali, Vitulano, Lee, Weiss, and Colson (2014) and Drew and Hewitt (2006) 
qualitative studies on CLD were both conducted on Caucasian participants ranging from 
20 - 69 years old, a weakness in their approach and application of the study as it relates to 
the current racial/ethnic diversity and age of those affected with CLD in California. The 
severity of CLD compared to other chronic conditions quality of life survey carried by 
Johnson, Wilcox, Mankoff, and Stricker (2014) using the CDC health related quality of 
life (HRQoL) indicators (used to identify health needs, determine the burden of disease, 
and direct public health policy in the nation) found that CLD patients reported: increased 
utilization of health care services, impairment in their ability to work, lower health 
quality status, more bad physical and mental health days, greater activity limitations, 
significant burdens due to the disease symptoms, and more out of pocket medical 
expenses compared to the general population. Aucott, Rebman, Crowder, and Kortte 
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(2012) results of a prospective study of 63 participants with erythema migrans (EM) 
complements the results found in the survey carried by Johnson, Wilcox, Mankoff, and 
Stricker (2014). The authors found in the study that antibiotic treated EM patient’s signs 
and symptoms disappeared. In addition, new onset of symptoms increased after six 
months significantly lowering life functions compared to those who did not develop post 
treatment LD or CLD. Statistically significant differences found in CLD patients 
compared with non-CLD individuals included social functioning, vitality, and physical 
and emotional health (Aucott, Crowder, & Kortte, 2013).   
Diagnostic challenges and the lack of a concise case definition of CLD, essentials 
for satisfactory disease management due to the non-specific nature of many of CLD 
manifestations  
(Aucott, Crowder & Kortte, 2013; Stanek et al., 2010) are part of the problem with the 
disease. CLD diagnostic challenges stems from there being more than a dozen recognized 
genomic groups or Geno species of the Borrelia burgdorferi sensu lato complex (Center 
for Food Security and Public Health, 2011; Clark, Leydet & Threlkeld, 2014; Shapiro, 
2014). Each genomic group may cause a somewhat different syndrome with somewhat 
different clinical presentation depending of its geographical distribution, which in turn 
makes clinical and laboratory diagnosis a challenge (Buhner, 2005; Center for Food 
Security and Public Health, 2011). Genomic groups known to cause LD in humans 
include Borrelia burgdorferi sensu stricto (Bb), B. garinii, B. afzelii and the recently 
recognized species: B. lodestars, B. andersonii, B. japonica, B. spielmanii, B. bissettii, B. 
Lusitanian, B. miyamotoi, and B. valaisiana (Center for Food Security and Public Health, 
2011; Clark, Leydet & Threlkeld, 2014; Rizzoli, Hauffe, Carpi, Neteler, & Rosa, 2011; 
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Shapiro, 2014). The “Epidemiology and Ecology” section of this literature review 
discusses more details on the geographical distribution of Bb. Case definitions are of 
critical value in clinical management for collection and analysis of laboratory data as 
supporting or confirmatory evidence of the disease and a requisite for reliable 
epidemiological studies (Stanek et al., 2011). The CDC (2011) uses case definition of LD 
for reporting surveillance purposes only. The case definition not intended for diagnostic 
purposes is described by the CDC (2011) as “a systemic, tick borne disease with protean 
manifestations, including dermatologic, rheumatologic, neurologic, and cardiac 
abnormalities.” The most common marker for the disease is EM, the initial skin lesion 
that occurs in 60% - 80% of patients (CDC, 2011; EID, 2013). Laboratory criteria 
established by the CDC (2011) for diagnosis for surveillance purposes only are:  
• Positive culture for Bb, or  
• Two-tier testing adhering to established criteria where Positive Immunoglobulin 
M (IgM) is sufficient only when ≤ 30 days from symptom onset or Positive IgG is 
sufficient at any point during illness 
• Positive Single tier IgG immunoblot  
• CSF antibody positive for Bb by Enzyme Immunoassay (EIA) or 
Immunofluorescence Assay (IFA), when the titer is higher than it was in serum 
The CDC criteria classify LD cases as suspected, probable, and confirmed (CDC, 2011). 
On the other hand, the case definition of CLD is non-existing at the CDC website. 
Instead, the CDC has given the term PTLDS to those cases that after four to six weeks of 
antibiotic treatment have symptoms of fatigue lasting more than six months (CDC, 2015; 
Ljostad & Mygland, 2013). The Infectious Disease Society of America (2011) case 
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definition of PTLDS includes a documented episode of early or late LD, with resolution 
of objective symptoms of LD, with subsequent onset of symptoms. Such symptoms 
include of fatigue, musculoskeletal pain, and cognitive complaints severe enough to 
affect the individual’s functional ability in daily life persisting more than six months after 
treatment (Perrone, 2015; Rissenberg & Chambers 1998). However, in long-term 
duration untreated LD patients whether in early or late phases of LD, experience the same 
symptoms: fatigue, musculoskeletal pain, and cognitive dysfunction persisting for years 
affecting quality of life of the individuals both physically and socially (Aucott, Crowder, 
& Kortte, 2013). One may ask then what CLD is.  
CLD is “considered a constellation of persistent symptoms in patients with or 
without evidence of Bb infection” (Borgermans et al., 2014). The clinical definition of 
CLD refers to the continuation of such symptoms such as fatigue, arthralgia, myalgia, 
headache, and memory loss after antibiotic therapy for LD (Fallon, Petkova, Keilp, & 
Britton, 2012; Hu, 2012). Fatigue is not uncommon after antibiotic treatment of LD that 
persists for several months; however, CLD patients experience polarized symptoms like 
those seen in chronic fatigue syndrome and fibromyalgia (Buhner, 2005; Horowitz, 2013; 
Hu, 2012). There are currently no serological tests or specific biomarkers to define CLD 
as antibiotic treatment may prevent seroconversion of seronegative early LD cases 
(Aucott, Crowder, & Kortte, 2013). Therefore, PTLDS and CLD seem to be synonymous 
even though the legitimate clinical entity of CLD, definition, and diagnosis has become 
highly controversial (Ali, Vitulano, Lee, Weiss & Colson, 2014; Aronowitz, 2011; 
Horowitz, 2013; Hu, 2012). As stated by Aronowitz (2011), although the definition of a 
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disease is limited by biological processes, what counts as a new disease often depends on 
values, interests, and contingent historical events.   
  Spirochetes (the causative agent of LD) are some of the most ancient bacteria on 
Earth; they have been around billions of years and have evolved to develop separate 
DNA strands or plasmids just for humans (Buhner, 2005). Ticks, the vector of Lyme 
disease, are resilient, persistent in the environment, inhabit almost every continent with 
over 850 species, and fossil evidence suggest that they originated 65 – 146 million years 
ago (IOM, 2013). The earliest human case of LD was designated as Lyme borreliosis 
(LB) and was found on a 5,300-year-old Copper age individual known as the Tyrolean 
Iceman discovered by two hikers in the Tisenjoch Pass in the Alps (Italy) in 1991 (Keller 
et al., 2012). The Bb genome was 60% characterized in this mummy by whole genome 
sequencing indicative of LB (Keller et al., 2011). Scientist use as evidence of transfer 
across Siberia into Alaska between 30,000 BCE and 10,000 BCE by the genomic variety, 
presence, and complexity of the LB species in northern Asia (Ostfeld, 2011). In addition, 
unique genome alterations of the American Bb in Europe suggest spread of the organism 
by heavy European contact after 1492 (Ostfeld, 2011). In Europe, as early as 1910 
clinicians recognized that following a tick bite a rash they called erythema chronicum 
migrans (now referred to as erythema migrans) was connected to most likely a bacterium 
probably a Rickettsia associated with meningitis (Aronowitz, 2011). In the United States, 
the first reported case of erythema migrans (EM) occurred in 1970 in Wisconsin and the 
first cluster of EM cases was in Groton, Connecticut in 1976 reported in the Journal of 
the American Medical Association by a physician of the naval base in Groton 
(Aronowitz, 2011). Around the same time, a Yale rheumatologist investigated a 
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significant number of children and adults in the closely located communities of Lyme, 
Old Lyme, and East Haddam, Connecticut. The practitioner found patients afflicted by an 
undiagnosed illness consisting of swollen joints and other problems including a rash in 
25% of the patients regarded as juvenile arthritis (Aronowitz, 2011; Buhner, 2005; 
Ostfeld, 2011; Randolf, Caimano, Stenson, & Hu, 2012). While looking for rickettsia in 
ticks from Shelter Island, New York, Willy Burgdorfer—a native from Switzerland 
working at Rocky Mountain Laboratory in Montana—discovered the spirochete that 
causes Lyme in 1981(Buhner, 2005; Mervine, 2015; Ostfeld, 2011). While dissecting 
ticks, Burgdorfer noticed a nematode in the hemolymph or blood of two female ticks and 
decided to check the digestive system for more worms. He made smears of the tick’s 
midgut and discovered poorly stained, coiled, bacteria that he confirmed as spirochetes 
by dark field microscopy (Mervine, 2015). The spirochetes reacted with the serum of 
those individuals in Lyme, Connecticut afflicted with the undiagnosed illness (Ostfeld, 
2011). The disease was renamed Lyme disease and the spirochete Borrelia burgdorferi in 
honor of Willy Burgdorfer (Buhner, 2005; Ostfeld, 2011; Randolf, Caimano, Stenson, & 
Hu, 2012). Borrelia burgdorferi sensu lato has been infecting humans for a very long 
time, yet it was not until just recently that, the spirochete could be seen under a 
microscope, isolated, and grown in laboratory specialized media (Randolf, Caimano, 
Stenson, & Hu, 2012).   
Ecology, Epidemiology and Transmission of Lyme Disease  
Lyme disease (LD) is an emerging vector-borne disease of global importance 
creating new challenges for public health (Kilpatrick & Randolph, 2012). The ecology of 
LD is based on the interactions of Bb (the pathogenic agent), Ixodes ticks (the vector), 
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and the vertebrate reservoir hosts (Rizzoli, Hauffe, Carpi, Neteler, & Rosa, 2011). LD 
etiological agent Borrelia burgdorferi (Bb) is an exotic pathogen that has increased 
incidence in endemic regions, causes serious impact when introduced to new regions 
infecting local populations for the first time, and has increased number of infected people 
each year (Ostfeld, 2011). The emergence of LD in the 20th century is believed to have 
underpinnings to the reforestation in the northeastern region of North America which 
caused recolonization by deer, a range-wide decline of the red fox, expansion of coyote 
population, and subsequently multiplication of ticks effectively predicting the spatial 
distribution of LD (Kilpatrick & Randolph, 2012; Levi, Kilpatrick, Mangel & Wilmers, 
2012). Even though deer are an incompetent host of LD they supply good feeding for 
adult ticks (Kilpatrick & Randolph, 2012) and are important in the maintenance of the 
Ixodes tick population because the adult ticks mate on them (Randolf, Caimano, Stenson, 
& Hu, 2012). Forest fragmentation and changes in predator communities have influenced 
increased abundance of small mammals such as white-footed mice, shrews, and eastern 
chipmunks that are the main transmission hosts of Bb in the eastern states (Ostfeld, 
2011). The increase of available host’s results in increased numbers of Bb infected 
nymphal ticks which the main biting vector stage infecting humans (Ostfeld, 2011). In 
addition to change in geographic range, other factors that determine the expansion of 
ticks and Bb population to expand and drive invasion include temperature and rainfall 
affecting the climate, habitat, host species range and density and the presence/adaptation 
of competent vector species (Anguita, Hedrick, & Fikrig, 2013; Ogden, Mechai & 
Margos, 2013). Ticks spend majority of their life living free in the environment off hosts, 
subject to weather and climatic conditions (Brunner, Killilea & Ostfeld, 2012). Direct 
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regulation in abundance of transmitting vectors occurs by climate changes including 
desiccation, overheating, and freezing while indirect regulation examples include climate 
altering vegetation structure and type (Kessing et al., 2009; Medlock & Leach, 2015). 
Ecological conditions must be just right to support this zoonotic illness (Kessing et al., 
2009; Shapiro, 2015). Loss of biodiversity affects the transmission of Bb by changing the 
abundance of the vector or host; the loss of a species from an ecological community has 
the potential to increase disease transmission (Devevey & Brisson, 2012). In the case of 
LD in the eastern States the white-footed mouse (an ecological resilient host) is the most 
abundant, most competent, and the highest quality host for immature ticks infecting high 
proportion of ticks (Kessing et al, 2010; Ostfeld, 2012). The opossums, in contrast, are 
poor hosts for Bb since it kills most of the ticks that try to feed on them; therefore, ticks 
are absent from degraded forests and low diversity forest fragments (Ostfeld, 2011). As 
biodiversity is lost the opossum disappears (strong buffering effect) and the mouse 
remains (strong amplifying effect) (Bouchard et al., 2013; Kessing et al., 2010; Ostfeld, 
2011).  
Reports of LD and CLD have been documented in North America, Europe, Asia, 
and Australia with recent acknowledgement of the disease in Mexico, Colombia, and 
Brazil (Center for Food Security and Public Health, 2011). Scientists have reported that 
Borrelia burgdorferi sensu stricto is the main cause of LD and the only genospecies 
responsible for human disease in the United States. However, a novel Borrelia 
burgdorferi sensu lato complex strain Borrelia carolinensis sp. has been isolated from 
rodents and ticks in the southeastern states (Rudenko, Golovchenco, Grubhoffer & 
Oliver, 2011). Borrelia kurtenbachii is widely distributed in North America (Margos, 
43 
 
Piesman, Lane, Ogden, Sing, Straubinger, and Fingerle, 2014) and Borrelia americana 
strains are isolated in California (Rudenko, Golovchenko, Tao Lin, Grubhoffer & Oliver, 
2009) like B. bissettii which has been identified as causing human disease (Clark, Leydet 
& Threlkeld, 2014). In a study conducted by Ogden et al. (2011), ticks infected with Bb 
also carry Borrelia miyamotoi with no diagnostic methods available. The advancement in 
bioinformatics and recent development of Next Generation Sequencing (NGS) methods 
have made great advances in research epidemiology and proven to have enormous 
potential to detect and survey Borrelia genotypes in vectors and various localities 
(Vayssier-Taussat et al., 2013). Borrelia burgdorferi sensu stricto is endemic in 
northeastern and mid-Atlantic states, northeastern U.S., and the Pacific coast (Center for 
Food Security and Public Health, 2011) documented in 47 out of 50 states (McKechnie, 
2016). B. burgdorferi sensu lato complex comprises over 20 genospecies (genotypes) of 
which B. afzelii, B. garinii, B. burgdorferi sensu stricto, B. bavariensis, and B. spielmanii 
(associated with skin disease) are pathogenic in Europe (Makhani, Morris, Page, Brophy, 
Lindsay & Banwell, 2011; Stanek & Reiter, 2011). They are mainly transmitted by the 
tick Ixodes ricinus, where B. afzelii and B. garinii are found to be the most common of 
the genospecies (Rizzoli, Hauffe, Carpi, Voutch, Neteler, & Rosa, 2011; Randolf, 
Caimano, Stenson, & Hu, 2012). Studies have reported B. afzelii, B. burgdorferi sensu 
stricto, B. lusitaniae, B. spielmanii, and B. valaisiana in Russia. B. afzelii and B. 
burgdorferi sensu stricto have been detected in Taiwan; while B. bissettii, B. valaisiana, 
B. lusitaniae, and B, miyamotoi have also been found in Asian countries (Center for Food 
Security and Public Health, 2011; Perrone, 2014; Randolf, Caimano, Stenson, & Hu, 
2012). See Appendix A for a list of bacteria responsible for LD, Lyme like diseases, other 
44 
 
Borrelia burgdorferi sensu lato complexes, and other tick-borne microorganisms isolated 
in humans.  
Europe considered endemic for LB has an incidence ranging from several to more 
than 100 confirmed cases per 100,000 inhabitants (Lewandowska, Kruba & Filip, 2013). 
In the United States, the total incidence is 7.9, with some states such as Maine, 
Massachusetts, Connecticut, New Hampshire, Pennsylvania, and Rhode Island’s 
incidence ranging from 50 to 89 confirmed cases per 100,000 population (CDC, 2015). 
The average incidence rate in California of reported confirmed cases is 0.23 per 100,000 
Californians (CDPH, 2011). Scientist attribute the geographical variation in LB incidence 
to environmental factors that affect abundance, occurrence, activity of hosts and tick 
vectors, regional variation of genotypes, the efficiency of transmission cycles, and /or the 
behavior of humans (Margos et al., 2012).  
B. burgdorferi sensu stricto is transmitted in North America primarily by the 
blacklegged tick Ixodes scapularis east of the Rocky Mountains and by Ixodes pacificus 
in the far Western states (Ostfeld, 2011; Margos et al., 2012). Bb has also been isolated in 
mites (Russia), biting flies (Germany and Connecticut), fleas, and biting mosquitoes 
(Ostfeld, 2011). Although Bb is thought not to be transmitted via the environment or 
body fluids once an individual is infected, the spirochete can be found in breast milk, 
blood, urine, tears, and semen (Buhner, 2005; CDC, 2014; Center for Food Security and 
Public Health, 2011). Studies have also shown that babies contracted the infection in the 
womb (Horovitz, 2013). Bb can survive up to 48 days in human blood processed for 
transfusion and stored at 4°C (Center for Food Security and Public Health, 2011). 
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Seventy percent ethanol and by 1% sodium hypochloride inactivate the organism (Center 
for Food Security and Public Health, 2011).  
Ixodes pacificus in California is known to infest more than 100 species of lizards, 
birds, squirrels, and mammals including dogs, cats, horses, cows, goats, pigs, and sheep 
(Hasle, 2013; Newman et al., 2015; Ostfeld, 2011). Reservoirs hosts are animals that can 
carry a significant number of infected ticks without getting sick themselves (Center for 
Food Security and Public Health, 2011). B. burgdorferi sensu lato primary reservoir hosts 
in California are the dusky-footed woodrat, the western gray squirrel, and birds (Newman 
et al., 2015). Salkeld, Leonhard, Girard, Hahn, Padgett & Lane (2008) investigated the 
role of the western gray squirrel (Sciurus griseus) as a reservoir host for Bb by surveying 
222 western gray squirrels in California showing an overall prevalence of Bb infection of 
30% to 50% by polymerase chain reaction (PCR). Birds, because of the long distance 
they travel, are an important host of the spirochete (Ostfeld, 2011; Sahagun, 2014). Birds 
can easily cross barriers like fences, oceans, mountains, glaciers, and desserts that stops 
mammals; birds are also much faster at transporting infected ticks and possibly serve as 
hosts for Bb transfer through co-feeding between ticks (Hasle, 2013; Nanoka, Ebel, & 
Wearing, 2010). Co-feeding must occur in close spatial and temporal proximity as 
illustrated in the diagram below; Figure 2 (A) illustrates infected nymph to larva co-
feeding transmission of Borrelia spirochetes in a mouse reservoir host in which “larva 1” 
acquires spirochetes, but “larva 2” does not as it is too distant from the infected lymph. 
Figure 2 (B) illustrates systemic transmission in which larva can acquire spirochetes 
anywhere they bite the infected mouse (Voordouw, 2015). Co- feeding transmission may 
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facilitate contact between isolated Borrelia species, allow genetic exchange between 
Borrelia, and contribute to mixed infections (Voordouw, 2015).  
  
Figure 2. Co-feeding and Systemic Transmission of Borrelia. Voordouw, M. J. (2015). 
Co-feeding transmission in LD pathogens. Parasitology 142, 290-302. Copyright 2014 
Cambridge University Press. 
  The relapsing fever spirochete Borrelia miyamotoi transmitted by nymphal I. 
pacificus tick causes an illness like Lyme disease and was identified by Chowdri et al. 
(2013) by reversing the traditional approach to disease discover (Branda & Rosenberg, 
2013). B. miyamotoi was first isolated in Japan. Scientist have detected the organism in 
blacked legged ixodid ticks in Russia and North America (Branda & Rosenberg, 2013). 
Chowdri et al. (2013) first identified the infectious agent by PCR in the vector then 
searched for human disease correlation. This accelerated the discovery of the Borrelia 
miyamotoi human infection that overlaps neurological symptoms experienced by chronic 
Lyme disease patients (Branda & Rosenberg, 2013). Scientist added B. miyamotoi to the 
California statewide tick-testing program to enhance understanding of this novel 
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pathogen ecology, geographic range, and prevalence in California as well as its relation 
to coinfections in CLD (Padgett et al., 2014).  
Risk behaviors associated with exposure to nymphal stage of Ixodes pacificus 
ticks in California in descending rank are: sitting on logs in deciduous hardwood forest, 
gathering wood, sitting against trees, contact with leaf litter either by stirring, walking or 
sitting on leaf litter (Lane, Steinlein, & Mun, 2014). The western fence lizards play a 
unique role in LD ecology in California serving for blood meal hosts to larval and 
nymphal ixodid ticks rather than mammals, but are non-competent host for reservoir of 
Bb (Swei, Ostfeld, Lane & Briggs, 2011). The western fence lizard has a protein in their 
blood that kills Bb; as a result, few adult ticks carry the organism (Klein, 2013). In a 
study conducted by Swei, Ostfeld, Lane & Briggs (2011) it was found that an 
incompetent host reservoir for Bb, such as the western fence lizard, may in fact increase 
risk by maintaining a higher vector density and subsequently a high density of infected 
vectors. Ticks are not insects; they belong to the phylum Arthropoda and the class 
Arachnida. They do not fly; do not have a head, a thorax, or an abdomen (IOM, 2013). 
Ticks can attach to any part of the body especially in hard to see places such as the scalp, 
armpit, or groin area. It must remain attached feeding for 36 to 48 hours or more for 
transmission of Lyme disease causing spirochetes to humans (CDC, 2014).  
The Ixodes tick enzootic cycle depicted in Figure 3 consists of three stages of 
growth: larva, nymph, and adult and feed only one blood meal per stage (Nonaka, Ebel & 
Wearing, 2010; Randolf, Caimano, Stenson, & Hu, 2012). Once engorged the ticks drop 
off the host and either molt in to the next stage or if adult, lay eggs for a new generation 
(Ostfeld, 2011; Whitmont, 2012). The adult tick lays eggs that hatch into larvae in about 
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a month when the temperature is warm. Borrelia infects only a small portion of the eggs. 
Scientists use the term transovarian transmission when the eggs are lay already infected 
with the Borrelia organism (Nonaka, Ebel & Wearing, 2010; Ostfeld, 2011). 
Transovarian transmission occurs in about one percent of the larvae (Ostfeld, 2011). 
Larval ticks are very small about the size of a period at the end of a sentence feeding right 
after hatching on infected reservoir animal hosts such as mice, squirrels, and birds. 
Scientists use the term trans-stadially transmission to larval ticks retaining the Borrelia 
bacterium to subsequent stages nymph and adult (Randolf, Caimano, Stenson, & Hu, 
2012). Transovarian transmission occurs in about one percent of the larvae (Ostfeld, 
2011). 
  
Figure 3. Enzootic Cycle Borrelia burgdorferi. Radolf, J. D., Caimano, M. J., Stevenson, 
B., and Hu, L.T. (2012). Of ticks, mice and men: understanding the dual-host lifestyle of 
LD spirochetes. National Review of Microbiology, 10, 2, 87-99.  
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Larval ticks are very small about the size of a period at the end of a sentence 
feeding right after hatching on infected reservoir animal hosts such as mice, squirrels, and 
birds. Scientists use the term trans-stadially transmission to larval ticks retaining the 
Borrelia bacterium to subsequent stages nymph and adult (Randolf, Caimano, Stenson, & 
Hu, 2012). Once the larval tick attaches and bites into the skin a substance of similar 
composition of collagen and keratin in vertebrate skin from tick saliva cements its 
attachment and prevents leakage of blood or tick saliva (Buhner, 2005). The tick saliva 
containing hundreds of biochemical counteract host-immune defenses such as hemostasis 
which includes blood coagulation, platelet aggregation/vasoconstriction, inflammation, 
and immunity both innate (complement system) and acquired (immunoglobulins) 
(Buhner, 2005; Lane, Moss, Nonaka, Ebel & Wearing, 2010; Wei, Mesirow, & Kuo, 
1999). Once uninfected larval ticks start feeding on the reservoir host, spirochetes flow 
through the blood stream into the tick larva and colonize the tick’s gut mediated by 
receptors for the spirochete’s outer surface protein A (OspA) and spreading to the tick’s 
salivary glands, ovaries, and connective tissue (Buhner, 2005; Ostfeld 2011). Larval ticks 
are about the size of a poppy seed (CDC, 2014) and feed for about 72 hours before falling 
off the host and molting into nymphs; a process that takes about 35 days (Buhner, 2005). 
The Borrelia infection rate in larval ticks range from three percent to 100 percent 
(Buhner, 2005). Nymphs feed about four to five days and when engorged fall off the host 
and molt into adult ticks which are about the size of a sesame seed (CDC, 2014; Randolf, 
Caimano, Stenson, & Hu 2012). When an infected larvae or nymph bites the animal or 
human host, the changes in temperature and pH cause the spirochetes to leave the tick 
and enter the host (Buhner, 2005). Transmission of infected humans to feeding larvae is 
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not known and humans are considered incidental hosts and not part of the enzootic cycle 
(Center for Food Security and Public Health, 2011; Randolf, Caimano, Stenson, & Hu 
2012). Even though wild carnivores and dogs not considered reservoir hosts, they may 
transmit Borrelia burgdorferi sensu lato to ticks. Domesticated animals such as dogs, 
cats, horses, and cattle may develop LD confirmed by serological tests and with 
symptoms ranging from the initial EM or “bull’s eye” rash to lameness, stiffness, chronic 
weight loss, arthritis, Lyme nephritis, hypertension, and neurological signs (Center for 
Food Security and Public Health, 2011; Halperin, 2014). However, there is little or no 
evidence that under natural conditions Bb is communicable from domesticated animals to 
other animals or humans (Center for Food Security and Public Health, 2011).  
Lyme Disease in California  
In California, the most incidences of reported Lyme disease (LD) ranges from 
April to August coinciding with the tick nymphal peak activity rather than adult tick 
activity from October through April (Eisen, Lane, Fritz & Eisen, 2006). LD accounts for 
97% of the vector borne diseases in California (Hui, 2008). In a global imaging system 
(GIS) approach study conducted by Eisen, Lane, Fritz & Eisen (2006) it was found that 
LD and acarologic (tick) risk of tick exposure in Southern California depends on the zip 
code of residence with elevated risk in zip codes adjacent to public lands. California 
variety of geographic areas including the moist and cool redwood forest in the west, the 
coniferous forest in the northeast, and the dry and hot woodlands or chaparral in the 
southeast allows human population to cluster in public lands for various recreational 
activities increasing the risk for exposure to tick vectors (Woolford, 2015). The 
California Department of Health Services started surveillance for LD in California in 
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1983 (Lane et al., 1999) and reported the presence of Bb in other ticks other than I. 
pacificus known to bite humans include Dermacentor occidentalis—found in shrubs, 
chaparral, and among trails—and D. variabilis—known as the American dog tick or 
wood tick (CDPH, 2014). Diagnostic issues in California include; only 20 percent of 
individuals recall a tick bite, only 56% have EM, 41% exposed outside the county of 
residence, and 22% exposed outside the state. In addition, bloodsucking flies have also 
been associated with Bb seropositivity (Diers, 2005; Lane et al., 1999). Even though 56 
out of 58 counties in California have reported ticks infected with Bb, many health care 
practitioners are unaware of the existence of LD in the area they serve (Kuykendall, 
2013). The13 million people population of Los Angeles County share urban and 
recreational areas next to wilderness. Such areas include: Griffith Park, Los Angeles 
National Forest, Santa Monica Mountains, Los Padres National Forest, San Gabriel 
Mountains, Whittier Hills, La Puente Hills, Palos Verde, Rose Bowl, and the Greek 
theater, where black-legged ticks are found throughout (Healy & Lowery, 2013; Hui, 
2008; Woolford, 2015).  
Symptoms and Disease Presentation 
Following the tick bite there is an incubation period that is usually seven to 14 
days, but can be up to 36 days and no more than three months. The first sign is the 
characteristic skin lesion erythema migrans (EM) and only appears in 60 to 80 percent of 
infected people after incubation (Biesiada, Czepiel, Lesniak, Garlicki, & Mach, 2012; 
Ljostad & Mygland, 2013). EM first takes the form of a painless but mildly itchy bull’s-
eye with a central clearing frequently in the lower extremities (approximately 54%) or the 
trunk (approximately 29%) averaging 15 centimeters in diameter or larger (Center for 
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Food Security and Public Health, 2011; McKechnie, 2016). The typical EM starts as a 
macula or papule that widens and develops into a red or bluish rash lasting for a few days 
and may disappear even without treatment (Berghoff, 2012; Emerging Infectious 
Diseases, 2013). In about 50% of untreated patients after a few days, multiple secondary 
lesions may appear which are smaller without central induration anywhere in the body 
except the palms and soles (McKechnie, 2016). EM may go unrecognized and confused 
with an allergic rash or an insect bite (Perrone, 2014). Weeks or months later symptoms 
may slowly appear and develop into a syndrome, which varies on the individual 
depending on the genospecies of the Borrelia and the geographic locations that causes 
different clinical presentations (Ljostad & Mygland, 2013; Shapiro, 2015). Three distinct 
stages have been determined based on presenting symptoms:  
 Stage I (Primary Stage or Early Localized Stage): In addition to EM described 
above, flu-like symptoms may develop, followed by fatigue, myalgia, polyarthralgia, 
stiff neck, headache, fever, sore throat, lymphadenopathy, and chills. A small 
percentage of patients, approximately 10% will develop nausea, vomiting, abdominal 
pain, conjunctivitis, and urticarial (McKechnie, 2016; Miklossy; 2012). Properly 
diagnosed and treated LD at this stage causes mild or no persistent symptoms occur 
(Horowitz, 2013).  
 Stage II (Secondary Stage or Early Disseminated Stage): Neurological 
manifestations and cerebrospinal fluid (CSF) inflammation occurs in about 10 to 15 
percent of the cases and is the hallmark of this stage. It is evident about six months 
after the EM has faded, (McKechnie, 2016; Miklossy; 2012). In addition, headache, 
stiff neck, fever, fatigue, vomiting, myalgia, arthritis, and photophobia may be 
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present (Miklossy; 2012). The neurological manifestations may occur in the absence 
of Stage I of the disease (McKechnie, 2016). Patients with Lyme encephalopathy are 
afflicted with problems of concentration, memory, thinking, and confusion referred as 
“mental fogginess” (Halperin, 2010). Some of the neurological manifestations are:  
o Lymphocytic meningitis (manifested with frontal or occipital headache, 
eye pain, photophobia, and low-grade fever). 
o  Cerebral symptoms, accompanied by emotional liability, somnolence, 
hallucinations, confusion, paranoid psychosis, agitation, irritability, 
disorientation, tremors, coma/seizures, myelitis symptoms, (which include 
loss of superficial reflexes, Babinski signs, urine retention, and 
bowel/bladder incontinence). 
o  Cranial neuropathies (which develop on about 60% of LD patients with 
involvement of the facial nerve and differentiated from Bell’s palsy by 
summer onset, bilateral involvement, and history of tick bite or EM) and 
o  Radiculopathy or spinal pain, resistant to analgesics and worse at night 
(McKechnie, 2016). The pain is severe and described as stabbing, burning, 
shock-like, persistent, and debilitating involving the trunk or a limb 
(Halperin, 2010). 
 Stage III (Tertiary Stage or Late Chronic Disease Stage): This stage is 
characterized by arthritis, that may develop weeks or years after initial onset of the 
disease manifested with joint pain and swelling, and neuropsychiatric manifestations 
(McKechnie, 2016; Miklossy; 2012). Lyme arthritis will develop in 50 to 80 percent 
of untreated LD patients (Horowitz, 2013). Untreated patients are those patients who 
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do not receive antibiotic therapy at the onset of the disease or presentation of EM 
(McKechnie, 2016). Since on average only 37% of people present EM, considering 
that about 240,000 – 440,000 cases of annually infected and 50% a year do not 
receive antibiotics, approximately 120,000 – 220,000 people will develop Lyme 
arthritis (Buhner, 2005; Horowitz, 2013; McKechnie, 2016). Bramwell, Teuscher 
&Weis (2014) studied forward genetics; a genetic approach to determine a heritable 
trait allele responsible for variability using genetic mapping. This study may soon 
elucidate regulators of Lyme arthritis severity and develop approaches to counteract 
heritable genetic risk factors. Some of the most common symptoms of tertiary stage 
LD include: profound fatigue, sweats/skin flashes, sleep disturbances, severe 
headaches, numbing/tingling sensation, language difficulties, impaired memory, 
problems of concentration, thinking, mental fogginess (Bransfield, 2012; Halperin, 
2010), and nervous system involvement referred to as neuroborreliosis or Lyme 
encephalopathy with predominance of psychiatric symptoms (Holtore, 2015; 
Logigian & Steere, 2012). Bb breaks down the blood-brain barriers that sequester the 
brain for the periphery and activate immune cells; neutrophils attracted by 
chemokines into the central nervous system (CNS) contributes to neuroborreliosis 
early inflammatory associated events and neuronal damage (Aucott, Seifter & 
Rebman, 2012; Brissette, Kees, Burke, Gaultney, Floden, & Watt, 2013).  
  When LD evaluation has not been conducted properly, key symptoms may be 
overlooked and patients may be diagnosed with an array of conditions including chronic 
fatigue syndrome, multiple sclerosis, Epstein-Barr virus, fibromyalgia, lupus, and 
psychiatric conditions (Bransfield, 2012; Holtore, 2015; Horowitz, 2013). Anyone would 
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consider CLD patients at this stage as “crazy” and “hypochondriac” driving the patients 
to depression and anxiety from alienation of family, friends, and the health care system 
(Bransfield, 2012; Ljostad & Mygland, 2013). Patients with CLD cognitive complaints 
experience a significant and measurable decline in intellectual acuity interfering with all 
aspects of normal living and functioning. Aspects affected include, but are not limited to 
home life, marriage, family, employment, emotional well-being, and social interactions 
(Bransfield, 2012; Medalia & Revhein, 2012). Lyme neuroborreliosis can mimic 
psychiatric disorders and type of encephalopathies analogous to neurosyphilis (Holtorf, 
2015; MacDonald, 2014). Bb can evade the host’s immune system and persist in tissue 
maintaining a chronic inflammation and the infection has been isolated from tertiary 
lesions in the brain and the CSF (Miklossy, 2012). Commonalities of neuroborreliosis 
and neurosyphilis include caused by a spirochete, involving multiple systems, and 
affecting neurological functions leading to cognitive symptoms and psychiatric illness 
(Fallon & Nields, 2013; Holtorf, 2015). Stricker & Middelveen (2015) examined the 
ability of the organism through enzymes to form cysts, round bodies, and L-form 
structures, which can hide in biofilms, persist in hostile environments, resist antibiotic 
treatment, and reach privileged areas such as the synovial fluid, the eye, and the brain 
suggesting the infection can be harbored in the genital tract as well. The marked 
propensity of antibiotic failure in treatment of CLD in sexually active couples speculated 
to be the result of reinfection occurring by person- to person intimate contact. Bb is 
known to be neurotropic, leaving the CSF and adhering to glial cells and other brain 
tissue forming a membranous material (blebs) during growth that bind Bb-specific IgM 
antibody enabling Borrelia to escape immune surveillance (Fallon & Nields, 2013). In 
56 
 
many neuroborreliosis patients brain Magnetic Resonance Image (MRI) scans are 
normal, but the use of CSF examination (microscopic, chemical, and serological), single 
proton emission computed tomography (SPECT), and positron emission tomography 
(PET) scans provide evidence to support the clinical diagnosis of neuroborreliosis 
(Donta, Noto & Vento, 2012; Halperin, 2010; Perrone 2014). Neuroborreliosis in 
children is manifested by difficulty in concentration, memory, learning, efficiency and 
speed processing information, language expression, auditory response, and multitasking 
significantly affecting learning, and school performance directly impacting self-esteem, 
self-confidence, and quality of life (Rhee & Cameron 2012; Shea & Leventhal, 2015). 
Psychiatric sequelae in the form of depression may occur in children and adults ranging 
from 25 to 65 percent as well as panic attacks and panic disorders with 5.3% prevalence 
with periods of hopelessness or suicidal thoughts lasting for months to years after 
diagnosis and treatment of CLD (Bransfield, 2015; Garakani & Mitton, 2015). The 
magnitude of the effects of Bb in the brain and central nervous system are still unknown. 
In a study conducted by MacDonald (2014) of Alzheimer’s autopsy brain specimens, 
“touch preparations” stained with silver stains and Barbour’s Borrelia-specific antibodies 
confirmed the presence of Borrelia. Scientific organizations need to conduct further 
studies and investigation to demonstrate the possible association of Alzheimer’s dementia 
and CLD (The Lyme Times, 2015).  
CLD patients are often co-infected with other tick-borne organisms and infections 
that may increase the severity of the symptoms (Horowitz, 2013) and make diagnosis and 
treatment more challenging (Hersh et al., 2014; Horowitz, 2013). Co-infections clinically 
relevant in alphabetical order include Anaplasma, Babesia, Bartonella species, 
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Chlamydia pneumoniae, Ehrlichia, Mycoplasma pneumoniae, Rickettsia, Yersinia 
enterocolitica, and tick-borne encephalitis virus (Berghoff, 2015; Borgermans et al., 
2014; Horowitz, 2013; Perrone, 2015). Additionally, Morgellons disease or “fiber’ 
disease” associated with CLD and emerging skin syndrome characterized by skin lesions 
with dermal filaments of different colors fluorescent under ultraviolet light (Wood’s 
lamp) and specks or dots referred to as granules on or in the skin coming out from the 
lesion with itchy or crawling feelings under the skin (Horowitz, 2013). Scientists have 
detected Bb spirochetes in the dermatological specimens of patients with Morgellons 
disease (Borgermans et al., 2014). Bb shares the same vector, the black legged tick with 
Anaplasma phagocytophilum explaining the incidence increase of human granulocytic 
anaplasmosis (HGA) (IOM, 2013; Berghoff, 2015). Borrelia miyamotoi a novel species 
has been implicated also in HGA (CDPH, 2014; Chowdri, Berardi, Goethert, Molloy, 
Sterling & Telford, 2013; Platonov et al., 2011). A. phagocytophilum causes anemia, low 
white blood cell count, low platelet count, and elevated liver enzymes or it may have a 
severe presentation causing respiratory insufficiency, kidney failure, and eventually death 
by parasitizing the host’s blood formed elements such as red blood cells, white blood 
cells, and platelets (CDPH, 2014; CLDA, 2015; Krakowetz, Dibernardo, Lindsay, & 
Chilton, 2014).  
Babesia is a protozoan parasite transmitted by ticks that infect the red blood cells 
and cause a parasitic hemolytic disease known as babesiosis (CDC, 2014; Berghoff, 
2015). Babesia and Bb share the same enzootic cycle; therefore, babesiosis is spreading 
just like LD (CDC, 2013; Horowitz, 2013) but geographically slightly lagging due to a 
lower efficiency of transmission between the mice reservoir hosts and ticks (Dunn et al., 
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2014). Babesia microti and Babesia duncani both found in United States are transmitted 
by the nymphal stage of the tick. They can cause more persistent and severe symptoms in 
CLD patients (CDC, 2014; Hersh et al., 2014). Babesia is one of the most dangerous and 
tenacious coinfections exacerbating the symptoms of LD such as increase in fatigue, 
headache, joint pain, and cognitive dysfunction, with malarial symptoms of fever, 
shaking chills, weakness and sweating with unexplained cough and shortness of breath 
(air hunger) that may lead into acute respiratory distress syndrome (Berghoff, 2015; 
CDC, 2014; Horowitz, 2013). Babesiosis standard treatment is a combination of 
antibiotics and antimalarial drug quinine proven very effective for CLD patients 
(Berghoff, 2015; Horowitz, 2013). Babesia testing by microscopic exam is difficult to 
find especially if the amount of parasite in the blood is less than five percent. Accurate 
detection requires the use of more expensive tests and laboratory techniques such as 
immunofluorescent antibody titers (IFA), PCR, fluorescent in situ hybridization (FISH), 
and RNA testing performed only in highly specialized laboratories such as the CDC 
laboratories and IGeneX in California (Horowitz, 2013). Mode of transmission of 
Babesia include from mother to the fetus in the womb, from person to person, or through 
contaminated blood transfusion (CDC, 2014). Bartonella on the other hand, a bacterium 
difficult to grow in laboratory media, is relatively easy to diagnose by serological 
methods (Berghoff, 2015; Horowitz, 2013; Maritsi, Zarganis, Metaxa, Papaioannou, & 
Vartzelis, 2013). Bartonella bacteria live primarily inside the lining of the blood vessels, 
and can infect humans, mammals and a wide range of wild animals. Fleas, ticks, animals, 
even spiders, can transmit the bacteria. The infected patient may experience fever, 
fatigue, lost their peripheral vision, bouts of muscle and joint pain, numbness of the 
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hands, headaches, memory loss, and hallucinations (CLDA, 2015). Bartonella henselae is 
common in children and responsible for a low-grade fever and subacute regional 
lymphadenitis known as cat scratch disease (CDC, 2013; Maritsi, Zarganis, Metaxa, 
Papaioannou, & Vartzelis, 2013). Cat scratch disease is self-limited and usually resolves 
without antibiotics (Horowitz, 2013. However, when B. henselae accompanies LD in a 
patient by unusual severe neurological manifestations occur including seizures and 
ophthalmic problems (CDPH, 2014; Berghoff, 2012; Horowitz, 2013). One unusual 
presentation of Bartonella in patients with LD is stretch marks found in the thighs, breast, 
abdomen, and upper shoulders due to burrowing of Borrelia and Bartonella through the 
subcutaneous fat, which are often confused with stretch marks due to weight loss 
(Horowitz, 2013). Bartonella can also be transmitted to the fetus during pregnancy 
(CLDA, 2015; Horowitz, 2013). Borrelia carrying ticks may also carry Mycoplasma 
pneumoniae, Mycoplasma genitaliun, and Mycoplasma fermentans detected in some 
cases of CLD by indirect fluorescent assay (IFA) or serial PCR (CDPH, 2014; Horowitz, 
2013). Mycoplasma species may cause overstimulation of plasma cells and B cells 
promoting autoimmune reactions and rheumatoid disease (Horowitz, 2013). Despite long 
term treatment (about a year) of Mycoplasma with tetracycline, quinolones, and 
macrolides antibiotics this intracellular organism persists in CLD patients evidenced by 
joint pain, headaches, and cognitive difficulties (CLDA, 2015; Berghoff, 2015). 
Chlamydia like Mycoplasma (not transmitted by ticks) is an intracellular organism 
associated with arthritis in multiple joints (poly arthritis) can cause exacerbation of LD 
symptoms (Berghoff, 2012; CDPH, 2014; Horowitz, 2013). Chlamydia pneumoniae 
causes respiratory infections. LD can activate this organism when dormant (Berghoff, 
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2015; Horowitz, 2013). Rickettsia like both Anaplasma and Mycoplasma live inside the 
host cells (CDC, 2015; Berghoff, 2015). Rickettsia infections commonly found in CLD 
patients are Rocky Mountain spotted fever and Q fever. Rocky Mountain spotted fever 
caused by R. rickettsii. Various species of ticks such as Amblyomma americanum (lone 
star tick), Dermatocentor andersoni (wood tick), and Dermatocentor variabilis (dog tick) 
can transmit the organism. Coxiella burnetti is the organism that causes Q fever and 
presents itself as a myriad of non-acute symptoms consisting of severe headache, fever, 
sweats, and muscle pains which may affect CLD patient severely (Horowitz, 2013). Q 
fever diagnosis consists of serological tests and treatment consists of a tetracycline 
antibiotic regimen such as doxycycline (CDC, 2015; Berghoff, 2015). Ehrlichia 
chaffeensis is also transmitted by ticks (such as the lone star tick Amblyomma 
americanum) and causes ehrlichiosis with symptoms of fever, headache, fatigue, and 
muscle aches within 1 – 2 weeks following a tick bite (CDC, 2015; Clark, Leydet & 
Hartman. 2013). Ehrlichiosis diagnosis in the same way as anaplasmosis through a 
combination of blood tests for cell blood count, liver function, and antibody titers (Levin 
& Fish, 2000; Horowitz, 2013). Microscopic examination of Ehrlichia infected white 
blood cells in blood, bone marrow, and CSF show intracellular colonies arranged in 
clusters called “morulae” indicative of the infection (Horowitz, 2013; CDC, 2015). The 
basis on the importance of Yersinia enterocolitica as an LD coinfection is on the 
manifestation of reactive arthritis, gastroenteritis, urethritis, uveitis, thyroid involvement, 
and autoimmune processes such in the case of Chlamydia experienced by CLD patients 
with seropositivity for Yersinia (Berghoff, 2015). In addition to the parasitic and bacterial 
infections that can affect CLD patients, there are vector-borne viral infections such as tick 
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borne viral encephalitis and non-tick borne viral infections such as Epstein-Barr virus, 
human herpes virus 6 (HHV-6), cytomegalovirus, and West Nile that can be reactivated 
from previous infections responsible for significant fatigue, fibromyalgia, and 
neurological symptoms (Horowitz, 2013). Chronic viral as well as parasitic infections 
may explain some of the antibiotic resistant symptomology seen in CLD patients 
(Berghoff, 2015; Horowitz, 2013). Lastly, candida and other fungal infections may be 
encouraged to overgrow in CLD patients taking antibiotics for bacterial coinfections and 
can cause chronic symptoms of fatigue, joint, and muscle pain, brain fog, headache, and 
gastrointestinal complaints that can be confused with antibiotic resistant LD (CDC, 2013; 
Horowitz, 2013).  
Unique Biological Characteristics of the Organism 
Borrelia burgdorferi (Bb) may be considered a postmodern organism given the 
facts that the illness it causes varies in presentation, is likely to have a variable treatment 
response, and the organism does not have a predictable incubation period (Stanek & 
Reiter, 2011). Borrelia, a spirochete, belongs in a group of phylogenetically distinct 
bacteria with motility by means of endoflagella, or axial filaments, within the periplasmic 
space between a semi-rigid peptidoglycan helix and a flexible outer membrane (Charon et 
al., 2012; Todar, 2015). Figure 4 depicts the longitudinal and the cross-section diagram of 
Bb and its component parts. The corkscrew fashion motility of the organism is due to the 
filaments rotation in this space, a movement developed by adaptation to viscous 
environments such as biofilms, mucosal tissue, and intestinal tracts of animals allowing 
the organism to hide the flagella from the immune defenses of the host (Charon, et al., 
2012; Todar, 2015). The corkscrew shape of the spirochete allows the organism to “drill’ 
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through tissue and embed itself in brain, CNS, heart, spleen, liver, and joints resulting in 
a plethora of symptoms ranging from dizziness and fatigue to paralysis (Kingston, 2014). 
Motility plays an important role in the organism’s chemotaxis (movement toward or 
away from a chemical stimulus) (Motaleb & Wolgemuth, 2012). The infection process, 
starting form survival in nature, completion of the host-vector cycle, transmission, 
dissemination through the skin, migration to the target tissues such as joints and the 
brain, persistence, and evasion to the host’s immune response (Charon et al., 2012). 
Unlike the spirochete responsible for syphilis, the Lyme spirochete Borrelia has been 
successfully grown in laboratory culture media called Barbour-Stoenner-Kelly (BSK) 
medium. BSK is enriched with nutrients such as bovine serum, albumin, and other 
ingredients dissolved in a rabbit serum base incubated in a microaerophilic environment 
at least 32°C for 24 – 72 hours (Clark, Leydet & Hartman. 2013; Todar, 2015; Wang et 
al., 2004).  
 
Figure 4. Typical Spirochete. Charon, N.W., et al (2012). The unique paradigm of 
spirochete motility and chemotaxis. Annual Review of Microbiology, 66, 349-370.  
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Borrelia’s size is 20 – 30 µm length by 0.2 – 0.3 µm width (Todar, 2015). It 
cannot be visualized using the conventional light microscope due to its width being 
below the resolving power; therefore, to visualize the spirochete dark-field microscopy 
must be used (Todar, 2015). New methodologies such as the cryoelectron microscopy 
have allowed Bb optimal analysis (Charon et al., 2012). Bb is not classified as a Gram 
negative or positive organism even though it stains Gram positive, its chemical 
composition is of Gram negative organisms with an outermost lipid bilayer cell 
membrane, inner membrane, and a periplasmic space with a layer of peptidoglycan 
(Todar, 2015) lacking lipopolysaccharides, but containing cholesterol lipids unusual in 
bacteria (Charon et al., 2012). The outer membrane of Bb is composed of various unique 
outer surface proteins denominated OspA through OsPF, decorin binding protein (Dbp) 
A and DbpB, and Borrelial persistence in ticks (Bpt) A are lipid modified (Todar, 2015) 
and play a role in the Bb’s virulence, tropism, dissemination, and immune evasion 
(Kennedy, Lenhart & Akins, 2012; Todar, 2015). Besides being the most abundant, OspA 
and OspB along with OsPC found exclusively on the surface of the organism, also found 
in the periplasm of the organism contribute to virulence by adaptation of the organism to 
the tick or animal host environment as needed (Kennedy, Lenhart & Akins, 2012). OspA 
mediates the attachment of Bb to the tick midgut, OspA and OspB downregulate to 
produce OsPC mediated by temperature changes to bind a tick salivary protein playing a 
role in transmission and survival during host colonization. OspE recruits complement 
regulator factors to the Bb cell membrane to evade complement-mediated cell lysis of the 
animal host immune response (Bhattacharjee et al., 2013). DbpA and DbpB bind to 
decorin a proteoglycan that interacts with collagen fibers and connective tissue (Kennedy, 
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Lenhart & Akins, 2012). OsPC genotypes were exclusively associated with Bb 
dissemination in blood and CSF (Wormser et al., 2008) and OspF enables the Bb 
spirochete to maintain chronic infection by evading the immune system (Vojdani, 
Hebroni, Raphael, Erde & Raxlen, 2009). OspA surface protein of Bb was used to 
develop a vaccine composed of three doses combined with an adjuvant (Steere et al., 
1998) which was approved and used for several years but discontinued production in 
2002 and is no longer in use due to complaints of individuals getting the disease and 
eventually developing CLD symptoms (Kennedy, Lenhart & Akins, 2012). The genome 
of Bb is small requiring complex nutritional requirements. The genome consists of a very 
stable linear chromosome of 950 kb with more than 1,500 gene sequences in at least 132 
functioning genes (Stricker, 2007). The genome exhibits little variation among isolates 
and a variable number of 7 – 21 linear and circular plasmids comprise one third of the 
organism’s total genetic material (Munderloh, 2013; Todar, 2015) essential for survival 
in ticks in the reservoir hosts as well as rearrangement on different genotypes (Schutzer et 
al., 2011). In addition to the genetic diversity of Bb that provides the organism with 
adaptive processes to evade the host defense mechanisms and achieve persistence 
(Schutzer et al., 2011) Bb possess large and diverse adhesive surface proteins to promote 
dissemination (Coburn, Leong & Chaconas, 2013), immunosuppression, mutation, 
antigenic variation, and recombination (Perrone, 2015). In addition to mechanisms to 
change antigenic structure, the LD spirochete borrows a practical coat from the saliva of 
its tick vector introduced during attachment and feeding into the animal and human hosts 
(Buhner, 2006; Vojdani, Hebroni, Raphael, Erde & Raxlen, 2007). Borrelia can survive 
both extracellularly and intracellularly in a dormant state by formation of cysts that under 
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favorable conditions convert into free new Borrelia spirochetes in tissues (Stricker & 
Johnson, 2011; Perrone, 2015). In a study conducted by Wormser et al., (2008) based on 
restriction fragment polymorphisms (RFLP) of the 16s and 23S rRNA, Bb was classified 
in three distinct genotypes called ribosomal spacer type (RST) 1, RST2, and RST3. Each 
genotypic strain is responsible for differential pathogenicity demonstrating that certain 
Bb genotypes are more invasive resulting in different disease presentation and the need 
for various detecting mechanisms and treatment modalities.   
Laboratory Diagnosis of Lyme Borreliosis 
LD is diagnosed based on clinical presentation, mainly EM considered to be 
pathognomonic of the disease, epidemiology, and laboratory testing (Perrone, 2014; 
Shapiro, 2014). The only standardized test approved by the US Food and Drug 
administration (FDA) to support the diagnosis of LD in the USA is serology (Ang, 
Notermans, Hommes, Simmons-Smit & Herremans, 2011; Johnson, 2011). The 
serological tests available in the market detect IgM and IgG antibodies to Borrelia 
burgdorferi sensu stricto that develop after a few weeks of infection (Lee, Vigliotti, Jones 
& Shearer, 2014). Different test exists to detect Bb directly such as cultures; only 
available in limited number of diagnostic laboratories, and Polymerase Chain Reaction 
(PCR). PCR is used for detection of the organism genetic material in blood, synovial 
fluid, urine, CSF, and skin that may confirm the clinical diagnosis in seronegative 
patients, but are not sensitive enough and not available for routine testing (Lee, Vigliotti, 
Jones & Shearer, 2014; Perrone, 2014). There are also tests not supported by the CDC or 
not approved by the FDA for routine testing including antigen capture assays in urine, 
lymphocyte transformations tests, immunofluorescent staining for cysts forms of Bb, 
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quantitative CD57, and reverse Western blots assays to name a few (Johnson, 2011). 
Figure 5 schematic illustrates the current two-tiered serology test used in North America 
for surveillance and individual patient evaluation. This is the recommended protocol for 
LD diagnosis by the FDA, the National Institute of Health, the Association of Public 
Health Laboratories, the Council of State and Territorial epidemiologists, and The 
Clinical Laboratory Standards Institute (Johnson, 2011: Perrone, 2014). First-tier testing 
consists of enzyme immunoassays (EIA) such as enzyme-linked immunosorbent assay 
(ELISA), or immunofluorescent assays (IFA). These tests use whole cell sonicate of the 
tick derived in vitro culture strain of Bb designated B31 (Perrone, 2014; Vojdani, 
Hebroni, Raphael, Erde & Raxlen, 2007), which if negative no more testing is needed, 
but if positive or indeterminate (equivocal or borderline) would prompt tier-2 testing 
(Ang, Notermans, Hommes, Simmons-Smit & Herremans, 2011; Johnsons, 2011). The 
second tier consists of immunoblotting with purified antigens known as Western blot. 
When the Western blot test is positive it is diagnostic of LD. LD is positive only if both 
the EIA or IFA and the immunoblots, results are positive. A positive IgG result with 
clinical history may be indicative of LD. A single positive IgM is not diagnostic since 
IgM antibody levels may remain positive even after effective treatment (Johnson, 2011; 
Lee, Vigliotti, Jones & Shearer, 2014).  
The CDC criteria for Western blot positive results for IgG are five of 10 antigenic 
bands measured in kilodalton (kDa) for molecular weight designation. The antigenic 
bands are:18 kDa, 23 – 25 kDa (OsPC), 28 kDa, 30 kDa, 39 kDa, 41 kDa, 45 kDa, 58 
kDa, 66 kDa, and/or 83 – 93 kDa (Johnson, 2011; Clark, Leydet & Hartman, 2013; Lee, 
Vigliotti, Jones & Shearer, 2014). The criteria for a positive result using protocol from 
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IGeneX Lyme specialty laboratory in California is an IgG Western blot is two of the 
following six bands: 23 – 25 kDa, 31 kDa (OspA), the 34 kDa (OspB), 39 kDa, 41 kDa 
and/or the 83 – 93 kDa. 31kDa and 34 kDa antigens are included to the criteria due to 
their importance in the recurrent and/or persistent disease period (Haley, 2011; IGeneX, 
2015; Schutzer, et al., 2013). For IgM, the CDC positive criteria are two of the three 
bands 41 kDa, 39 kDa, and 23kDa with intensity equal or greater than the calibration 
control (Johnson, 2011).  
 
Either Blot Positive 
Tier 1: IgG or IgM EIAs (combined or 
separate) 
Positive or 
Indeterminate 
Negative 
Tier 2: IgG and/or IgM immunoblots 
(separate) 
Reported as Negative 
Negative 
Reported as Negative IgG Positive IgM Positive 
Reported as 
Positive 
Reported as Positive but only 
clinically relevant if disease 
duration is less than one month 
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Figure 5. Two-tiered Serology for Lyme Disease. Adapted from Johnson, J. B. (2011). 
Laboratory Diagnostic Testing for Borrelia burgdorferi Infection. Manual of Molecular 
and Clinical Laboratory Immunology, 7th edition. ASM Press, Washington, DC.  
Figure 6 below is an example of Western Blot tests showing significant Lyme 
disease antibodies (IGeneX, 2013; Johnson, 2011; Vojdani, Hebroni, Raphael, Erde & 
Raxlen, 2007). The two-tiered serology test CDC diagnostic guidelines for IgM is two of 
three bands and IgG is five out of 10 bands.  The test may be negative a few weeks after 
EM presentation. It may also be negative or non-diagnostic in up to 75% of clinically 
suspected cases of early LD, but in cases of disseminated neurologic or cardiac disease 
caused by B. burgdorferi sensu stricto it is reasonably sensitive more than 87% and 
specific up to 99% in diagnostic testing (Hinckley et al., 2014; Lee, Vigliotti, Jones & 
Shearer, 2014; Lee, Shapiro, 2014).  
 
 
Figure 6. Examples of IgM and IgG Immunoblots. Courtesy of IGenex Inc. Retrieved 
from https//www.google.com 
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Limitations of the two-tiered test include high specificity and sensitivity only after 
two weeks of Bb infection, insensitive during EM presentation and during early 
neuroborreliosis, it is technically demanding, expensive, and it can be difficult to 
determine disease onset for IgM testing (Johnson, 2011). In addition, the immunoblots 
scoring criteria applies only to Borrelia burgdorferi sensu stricto and no other Borrelia 
genotypes (Dattwyler & Arnaboldi, 2014; Johnson, 2011). It is possible that some 
equivocal or negative EIA or Western blot test results interpreted by the current CDC 
guidelines may not be not accurate. These interpretations are due to Borrelia burgdorferi 
sensu lato strains, a problematic issue with those afflicted with CLD symptoms and 
negative EIA, IgM, and IgG Western blot current serological test available that are falling 
by the wayside (Clark, Leydet & Hartman, 2013; Johnson, 2011; Perrone, 2014; The 
Lyme Times, 2015). The distribution of Borrelia burgdorferi sensu lato complex is 
worldwide, yet the organism is not tested routinely; neither is Borrelia miyamotoi that 
causes a disease like Lyme and does not cross react with Bb (Perrone, 2014). Failure to 
diagnose neuroborreliosis by a clinician unaware of the difficulty in diagnosing CLD may 
implicate the labeling of patients with erroneous diagnosis such as idiopathic, viral, 
degenerative, autoimmune, psychosomatic or inflammatory (Auwaerter, 2015; Perrone, 
2014) and delay in appropriate treatment leading to chronic neurologic problem and even 
death (Perrone, 2014). Therefore, the situation demands the development of new 
diagnostic methods. The methods may include immunoblot tests containing specific 
epitopes of Borrelia strains that can improve specificity and sensitivity (Dattwyler & 
Arnaboldi, 2014). Also, new PCR methods, new genomic techniques such as high 
throughput sequencing, and most importantly closer collaboration between 
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microbiologists, epidemiologists, geneticians, immunologists, entomologists, 
veterinarians, environmental scientists, and health care practitioners in a multidirectional 
approach to determine strain pathogenicity diagnosis (Perrone, 2014). Horowitz (2013) in 
his book Why Can’t I Get Better: Solving the Mystery of Lyme & Chronic Disease 
discusses how the health care system is not primed for chronic diseases affecting 
humanity in the 21st century such as CLD and primed mainly for acute diseases such as 
urinary tract infections and heart attack. Horowitz (2013) blames the disease postulate 
one germ, one disease known as the “Pasteur postulate” thought in medical school. 
Horowitz (2013) also addresses in his book the need for a “paradigm shift” in his 
proposed 16-point differential diagnostic map which is an assessment of the various 
contributors to chronic illness as well as a new term for the syndrome with infectious 
involvement following a tick bite: “multiple systemic infectious disease syndrome” or 
MSIDS.  
Treatment of Lyme Disease 
  Borrelia burgdorferi’s complex background concerning its biology, diagnostic 
problems, and testing difficulties continues with reported failures when attempting to 
treat LD (Stricker, 2007). The standard recommended antibiotic regimen for LD 
presentation of EM in early localized or early disseminated in the absence of specific 
neurologic manifestations or cardiac involvement is doxycycline (100 mg twice per day 
for 10-21 days), amoxicillin (500 mg 3 times per day for 14- 21 days), or cefuroxime 
acetyl (500 mg twice per day for 14 to 21 days) (Klempner et al., 2013; Wormser et al., 
2006). For late neurologic LD in adult patients the recommended treatment is intravenous 
ceftriaxone for 2 to 4 weeks, or as an alternative cefotaxime or penicillin G administered 
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intravenously (Klempner et al., 2013; Ljostad & Mygland, 2013; Wormser et al., 2006). 
Prophylactic treatment with a single dose of doxycycline in an endemic area after a tick 
bite to prevent LD was effective in a study conducted by Warshafsky, Lee, Francois, 
Nowakowsky, Nadelman & Wormser (2010). About 10 to 20 percent of the patients 
treated with the recommended monotherapy of doxycycline, amoxicillin, or cefuroxime 
report persisting symptoms such as fatigue, muscular pain, and neurological afflictions 
even after six months following treatment where Bb can be detected in serological tests, 
but it cannot be cultured in laboratory media (Feng, Shi, Zhang & Zhang, 2015). A 
frequent event during beginning or prolonged antibiotic treatment is the acute 
exacerbation of symptoms known as the Jarish-Herxheimer (JH) reaction (Perrone, 
2015). JH is a temporary worsening of LD symptoms that occur as a combination of the 
killed Borrelia spirochete and the body’s own immune defenses response by the 
production of inflammatory molecules (CDC, 2013; CDPH, 2013; Horowitz, 2013). JH 
reaction creates the treatment with antibiotics a difficult situation since the antibiotics are 
working to kill the bacteria, but they temporarily making the patient feel worse 
(Horowitz, 2013). Bb persisters were demonstrated in vitro after treatment with 
antibiotics by Hodzic, Imai, Feng, and Barthold (2014) and by xenodiagnoses method 
using non-infected ticks to feed in antibiotic treated mice with successful recovery of Bb, 
a method that may be one day applicable to humans to confirm diagnosis of LD 
(Maloney, 2014). Evidence from CLD trials followed by Fallon, Petkova, Keilp, & 
Britton (2012) demonstrated that the effectiveness of the use of repeated or long-term 
antibiotic treatment cannot be proven or disproven, and antibiotic regimens are not 
robustly effective. Nevertheless, approximately 60% of patients with persistent fatigue 
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symptoms after antibiotic treatment in the trials experienced minor clinical improvement 
after retreatment. The work of Feng, Wang, Zhang, Shi & Zhang (2014) using an 
optimized SYBR Green Iodide dye assay for antibiotic susceptibility testing of Bb in a 
high throughput drug screen format, showed to be a rapid, sensitive, convenient, and 
powerful method for identifying drugs against Bb persisters in biofilms that can be used 
as a rapid antibiotic susceptibility test. Currently, there are no guidelines for antibiotic 
treatment of CLD (Wormser et al., 2006). Despite the increased number of LD reported 
nationwide, pharmaceutical companies have not taken the interest to develop new 
treatment regimens; therefore, evidence based treatments are conflicting, sparse, and 
emerging (Cameron, Johnson & Maloney, 2014).    
  Considering the current antibiotics side effects, length of treatment, and lack of 
guidelines for treating CLD a novel approach used by Vojdani, Hebroni, Raphael, Erde & 
Raxlen (2007) utilizing in vivo induced antigen technology (IVIAT) and ELISA that may 
provide the data needed to justify CAM treatment of CLD. IVIAT’s technique identifies 
Borrelia antigenic gene products and antibodies expressed in the patient during infection 
(Bb lysate, OspA, OspC, OspE, C2 peptide, C6 peptide, complement regulator protein -1, 
and decorin binding protein of Bb); cross reactive micro-organisms (T. pallidum, B. 
microti, Ehrlichia, Bartonella, Y. enterocolitica, Mycoplasma, salmonella, Shigella, 
Chlamydia, etc.); and the target tissue antigens in blood (thyroid stimulating hormone 
receptor, plasmin, plasminogen, collagen, arthritis related protein glutathione, myelin, 
ganglioside, etc.) before presentation of CLD symptoms (Vojdani, Hebroni, Raphael, 
Erde & Raxlen, 2007). 
73 
 
 
 
Figure 7. Complementary and Alternative Medicine Treatment and its Actions.   
Vojdani, A., Hebroni, F., Raphael, Y., Erde, J., and Raxlen, B. (2009). Novel Diagnosis 
of Lyme  disease: Potential for CAM Intervention. Evidence Based Complementary 
Alternative Medicine 6(3), 283-295.  
CAM provides a different intervention strategy for health care and includes a 
combination of antibiotics, herbal, and nutritional supplements summarized in Appendix 
B. These herbs and supplements utilized by CAM work at different levels. Levels include 
attachment of the ticks, inhibition of the inflammatory process, and reduction of bacterial 
load; resulting in elimination of Bb from the cells and tissues while diminishing cross-
reactive antibodies in the blood leading to the repair of the blood brain barrier damage 
caused by LB (Buhner, 2006; Vojdani, Hebroni, Raphael, Erde & Raxlen, 2007; 
Weintraub, 2013). Figure 7 schematically depicts the different levels of CAM action. 
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According to Gardner (2015), Zerbe (2015), and Whitmont (2012) there is 
evidence to suggest that additional natural LD treatments help heal the body by getting 
rid of the infection, reducing inflammation, and restoring the injured immune system. 
Those additional natural ways to deal with Lyme include:  
 Acupuncture to help reduce or eliminate pain, homeopathy by individualized 
disease disturbances removal (Whitmont, 2012).  
 Treatment with green tea with curcumin (a compound of turmeric) to reduce 
oxidative stress and aid in antibiotic treatment (Whitmont, 2012). 
 Probiotics use to help replenish beneficial bacteria damaged by long-term use of 
antibiotics and prevent yeast overgrowth (Harte, 2011). 
 Exercise to improve oxygen intake to help destroy the organism in the body 
(Harte, 2011) and  
 The use of inflammation annihilators such as a low-glycemic-index healthy diet 
(Harte, 2011).   
Prevention 
  Education is the best prevention against LD and development of CLD (CDC, 
2011; CDPH, 2014). Education on tick avoidance includes staying away of brush and 
grassy areas when hiking, staying in the middle of trails, and dressing appropriately for 
tick in habited areas.  Appropriate dress includes wearing long pants, tucking those pants 
into boots, as well as to pulling socks over pants, tucking the shirt into the pants, utilizing 
a hat, and wearing light colored clothes so ticks are easily spotted (CDPH, 2014; CDPH-
LA Vector Management, 2015). Application of 0.5% Permethrin on clothing to repel the 
ticks, insect repellants that contain up to 25% of DEET in adults and 10% in children, or 
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lemon eucalyptus oil is effective (CDC, 2013). Recommendations of environmental 
precautions to decrease the risk of tick are; mow grass along trails, buildings, and 
camping areas; remove brush in recreational areas and trails, check pets, children, and 
yourself for ticks, shower immediately after outdoors activities where ticks may be 
present, and learning how to remove a tick properly (Britain, 2015; CDC, 2013). The 
procedure on how to remove an attached tick include:  
1. Firmly pull the tick.  
2. No jerking or unscrewing the tick. 
3. Do not attempt to remove the tick by cigarette or match burning or applying 
Vaseline      or other product. 
4. Wash the hands and bite site with soap and water applying antiseptic to the 
area. 
5. Save the tick in a container or bag for identification. 
6. Contact the health department to submit tick for identification of LD 
infectivity.  
7. Consult your physician if the tick cannot be removed or any part remains 
inside the bite site or if after 30 days of the bite flu symptoms develop 
(Britain, 2015).    
The Chronic Lyme Disease Controversy  
As if the plethora of CLD associated symptoms was not already enough to deal 
with, diagnosis of CLD brings along a handful of controversies for the affected 
individuals to face (Borgersmans, Goderis, Vandevoorde & Devroey, 2014). Due to 
absence of accurate data on annually diagnosed patients, solid cause, a clear case 
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definition, diagnostic criteria, biological complexity of Borrelia, and treatment options; 
CLD continues to be a poorly understood disease (Borgermans, et al., 2014). In addition 
to the confusion, data on gender was compiled in a cross-sectional study by Wormser, 
Eugene & Shapiro (2009) based on a systematic review of antibiotic treated patients with 
CLD and it was found that patients with CLD were 69% female suggesting that illnesses 
with female preponderance such as chronic fatigue syndrome, depression, and 
fibromyalgia may be misdiagnosed. Patients who seek care for CLD have diverse 
backgrounds, medical literacy, and perspectives, but soon become aware of concepts 
about LD that are controversial and deemed inaccurate by opposed scientific views 
(Lantos, 2011). On one side of the controversy are the claims of some scientific groups 
who believe Lyme activists and Lyme literate doctors (LLMD) through political lobbying 
and public appeal have managed to divert attention from evidence-based medicine to 
redefine LD and its antibiotic therapy regimens (Auwaerter et al., 2011). The Infectious 
Disease Society of America (IDSA) has been challenged and threatened with antitrust 
litigation after the release of updated LD guidelines claiming the guidelines were “rife 
with conflict of interest” resulting in the convening of an independent scientific panel to 
review the appropriateness of the IDSA antibiotic guidelines (Auwaerter et al., 2011). On 
the other side of the controversy are physicians represented by the International Lyme 
and Associated Disease Society (ILADS) and patient advocate organizations such as the 
Lyme Disease Association in New Jersey and the California Lyme Disease Association. 
In addition, agencies that claim unjust sanctions of Lyme literate medical doctors by state 
medical licensing boards in state and federal agencies about ethics and medical credibility 
by using certain diagnostic laboratories and conflict of interest continue litigation 
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(Auwaerter et al., 2011; Lantos et al., 2010). The heavy burden of illness associated with 
CLD patients demands an end to the ongoing controversy associated with the disease. 
Such controversy resolution can be accomplished by broader use of clinical diagnosis 
tools available; development of new methodology with increased accuracy, specificity, 
and sensitivity; novel treatment approaches; and an integrative multidisciplinary 
approach needed to prevent and treat the disease effectively (Borgermans, et al., 2014; 
Johnson, Aylward & Stricker, 2011). Patient-powered research approaches developed and 
run by patients such as “MyLymeData”; a patient-powered research project developed by 
CLD patients currently sick or who have recovered from the disease; tracks patients over 
time using computer technology to privately pool diagnosis and treatment experiences. 
MyLymeData (MLD) allows patients to learn from each other and provide data for 
research and insights into the disease process and treatment effectiveness (The Lyme 
Times, 2015). The MLD registry will allow researchers soon to gather and analyze large 
amounts of health information on CLD patients to study LD providing a new tool in the 
researcher’s toolbox.  
Summary  
The current literature on CLD provides extensive evidence to show that persistent 
symptoms of LD are due to chronic infection with Bb spirochete, in conjunction with 
other bacterial, parasitic, and viral tick-borne coinfections (Berghoff, 2015). Persister 
forms of the bacterial organism, cysts, and biofilms enhanced by unique infection 
mechanisms maintain the chronic status of the disease and exacerbate symptomology 
leading to considerable decline in health status and debilitation despite extended use of 
antibiotics (IOM, 2013) leading the CLD patient to search for CAM, private LLMD, and 
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other modalities of treatment (Buhner, 2006; McKechnie, 2016; Vojdani, Hebroni, 
Raphael, Erde & Raxlen, 2009). Use of qualitative studies to gather insights into the 
health beliefs and lived experiences of young adults diagnosed with CLD provided an 
opportunity to heighten understanding and sensitivity of the complexity and difficulty of 
living with CLD (Ali, Vitulano, Lee, Weiss & Colson, 2014).  
  Few studies on CLD have focused on the perceptions of disease burden and lived 
experiences of young adults diagnosed with CLD using the dimensions of the HBM. 
Previous studies did not take into consideration other racial and ethnic backgrounds 
besides Caucasians in a wide age range (Drew & Hewitt, 2006; Ali, Vitulano, Lee, Weiss 
& Colson, 2014). In California, and specifically in the Los Angeles County where 
recreational places are within urban settings the risk for Borrelia carrying ticks, is an 
emerging public health problem (CDPH, 2014). Awareness of public health practitioners, 
health care providers, and the population of the problem through education and a 
multidisciplinary approach (Stricker & Johnson, 2011) is imperative. Guided by the 
research questions, the focus of this qualitative study was to examine the impact CLD has 
on the health promoting behaviors of ethnically diverse, insured, young adults from 
similar educational and socioeconomic backgrounds based on their lived experiences in 
the Los Angeles County, California. Using semi-structured interview questions based on 
the dimensions of the HBM participants provided lived experiences insights of CLD life 
after diagnosis of this mysterious disease and the impact on their personal, professional, 
and decision-making processes.  
In the following chapter, the methodology, I define and explain the role of the 
researcher, provides detailed information on the study population, sampling strategy, 
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participant selection, number of participants, identification, and recruitment rationale that 
take into consideration other racial and ethnic backgrounds besides Caucasians in a wide 
age range identified as a gap in the literature. In addition, in the following chapter, data 
collection instruments and source of each data are identified, issues of trustworthiness 
such as content validity, transferability, and dependability are established, and ethical 
procedures such as the Institutional Review Board documentation and treatment of data 
description are provided.  
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Chapter 3: Research Method 
Introduction  
The purpose of this phenomenological study was to explore the impact chronic 
Lyme disease (CLD) has on the health promoting behaviors of ethnically diverse, 
insured, young adults from similar educational and socioeconomic backgrounds based on 
their lived experiences. The geographical focus of this study was restricted to Los 
Angeles County, California, because there is a general lack of awareness of Lyme disease 
(LD) and CLD on the West Coast of the United States (Hui 2008; Ostfeld, 2011; Swei, 
Ostfeld, Lane, & Briggs, 2011). The perspectives of this group of participants’ gives 
healthcare providers and the public a deeper insight into the impact CLD has on the 
personal and professional lives of affected patients and its impact on their decision-
making processes.  
This chapter discusses the study design and rationale highlighting the research 
questions and methodology, including the role of the researcher regarding personal and 
professional relationships with the study participants. Any bias resulting from this 
relationship and how it was handled are explained as well as any ethical issues. 
Description of the study population, recruitment procedures, U.S. federal regulations and 
measures followed to protect human subjects, processes to safeguard participant’s 
information and maintain anonymity, data collection instruments, and data organization 
plan are presented. The software used for data analysis is identified, method of data 
analysis is presented, and approaches to the study’s rigor such as credibility, 
transferability, dependability, and confirmability are discussed.  
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Research Design and Rationale  
  The following research questions guided this study:  
RQ1: Qualitative: To what degree do different ethnic groups with average levels 
of socioeconomic status, education, and third-party coverage, perceive the likelihood of 
acquiring comorbidities related to CLD?  
RQ2: Qualitative: To what degree does the perceived severity of CLD impact the 
lives and decision-making processes of different ethnic groups with average levels of 
socio-economic status, education, and third-party coverage?  
RQ3: Qualitative: To what degree does the perceived benefits of treatment impact 
the lives and decision-making processes of different ethnic groups with average levels of 
socio-economic status, education, and third-party coverage?  
RQ4: Qualitative: To what degree do perceived barriers impact the lives and 
decision-making processes of different ethnic groups with average levels of socio-
economic status, education, and third-party coverage?  
RQ5: Qualitative: To what degree does the cues to action impact the lives and 
decision-making processes of different ethnic groups with average levels of socio-
economic status, education, and third-party coverage?  
RQ6: Qualitative: To what degree does self-efficacy impact the lives and 
decision-making processes of different ethnic groups with average levels of socio-
economic status, education, and third-party coverage?  
  The qualitative research design, which investigates the why and how of the 
process of a developed phenomenon (Sanjari et al., 2014), in this case health promoting 
behaviors of young adults with CLD, was selected as the research method. The 
82 
 
naturalistic approach of the qualitative research design is in real world settings where the 
phenomenon of interest unfolds naturally, and the researcher does not attempt to 
manipulate the phenomenon (Victor & Barnard, 2016; Sanjari et al., 2014). The 
naturalistic approach was the most efficient and appropriate way to investigate the 
research questions in this study.  
Little is known about health promoting behaviors of young adults diagnosed with 
CLD (Ali, Vitulano, Lee, Weiss, & Colson, 2014). In this study, the qualitative research 
design provided me the means to help understand this situation that otherwise is 
mysterious, enigmatic, or confusing (see Katz, 2015). The qualitative approach provides 
a robust research method to use when little information exists about a subject (Creswell, 
2012; Malagon-Maldonado, 2014)— this the case of young adults living with CLD. The 
qualitative research approach is useful in the early stages of knowledge development 
(Katz, 2015), as is in this case, with the aim to understand the participants’ perspective 
and interpretations of the environment in which they live, work, or receive care (see 
Creswell, 2012).  
  I chose the traditional phenomenological approach to achieve an understanding of 
the everyday experience of young adults living with CLD and their health promoting 
behaviors by exploring the human condition to gain a deep insight into the lifeworld and 
lived experience of the participants (Creswell, 2012; Malagon-Maldonado, 2014). 
Phenomenological research is a strategy of inquiry in which the researcher identifies the 
essence of human experiences about a phenomenon as described by participants 
(Creswell, 2012). The emphasis was on understanding the ways in which young adults 
with CLD construct their realities or to reveal what perspective they hold and how they 
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interpret events that happen (Crosby, DiClemente, & Salazar, 2006). A hermeneutic 
approach to this phenomenological inquiry was carried out in which I brought to the 
study; personal experience, insights, discoveries, and reflections because of mutual effort 
with the participants to elucidate the nature, meaning, and essence (Victor & Barnard, 
2016) of health promoting behaviors of young adults living with CLD.  
Role of the Researcher  
  I was an integral part of the study process and I was directly involved in all stages 
of the study from seeking participants, conducting interviews, participating in 
transcription, performing analysis, carrying out verification, and reporting concepts and 
themes found. I relate to young adults with CLD and hold membership to the Lyme 
Disease Association of Los Angeles County Chapter, with no supervisory or instructor 
relationships involving power over the prospective participants. I obtained informed 
consent from the study participants and followed all the federal regulations and 
requirements (DHHS, 2009). I also provided many opportunities to the participants to 
consider participation to minimize undue influence (DHHS, 2009).  
In the phenomenological qualitative method, the main task of the researcher is 
transformation of data to the lived experiences (Sanjari et al., 2014). I used interpersonal 
skills to make an appropriate human instrument that is of major importance in natural 
settings and qualitative research study processes (Sanjari et al., 2014). The established 
relationship between the participants and me during the inquiry in this qualitative study 
can raise a range of ethical concerns such as respect for privacy, establishment of honest 
and open interactions, and misinterpretations (Creswell, 2009). I managed ethically 
challenging situations by preserving the participants’ confidentiality, minimizing the 
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possibility of intrusion, and thoroughly explaining informed consent issues such as the 
nature and objectives of the study, identity of the researcher, participant’s role, and how 
the results were to be used and published (Patton, 2002; Sanjari et al., 2014).  
Methodology  
Population Sampling Method, Size, and Contingencies 
Purposeful sampling was the most appropriate method for this study because it 
enabled me to select in a nonrandom manner a sample of elements representative of the 
target population based on the purpose of the study (Suri, 2011); a population consisting 
of young adults living with CLD. I used stratified purposeful sampling (Suri, 2011) to 
capture major variations in the manifestation of the phenomenon. The stratified 
purposeful sampling provided the sampling methods to capture varied key factor 
associated with CLD, as well as enabled me to identify distinct strata and clusters of key 
health promoting behaviors within each stratum (Suri, 2011). Sampling was conducted 
until theoretical saturation was obtained, that is when further evidence collection 
provided little or no new insights, perspectives, or concepts in well characterized and 
differentiated categories (Ali, Vitulano, Lee, Weiss, & Colson, 2014; Suri, 2011). 
Purposeful sampling provided a higher likelihood of reaching data saturation (Suri, 
2011).  
As typically anticipated in phenomenological studies, a sample size consisting of 
eight to 10 participants is sufficient to achieve saturation (Suri, 2011). I anticipated a 
similar sample size (eight to 10 participants) for this study to achieve saturation, but I 
also considered the possibility for a larger sample. Since the required sample size seemed 
relatively small, it was possible that a larger sample might have been required. I pursued 
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support and agreement from the Los Angeles Lyme Disease organization members that 
attend social gatherings and that post on the online website to participate in the study. In 
addition, as stated in the recruitment section below, I used social media as a recruitment 
contingency.  
Inclusion/exclusion Criteria  
Participants’ inclusion criteria included being 18 to 40 years old, residing in the 
Los Angeles County, signing the Internal Review Board (IRB) approved consent 
document (Appendix C), being clinically diagnosed with CLD, and having received or 
currently receiving medical treatment or intervention including antibiotic therapy and or 
complementary and alternative medicine treatment (CAM). The age group I chose for 
this study was determined based on the level of activity, independence, and busy lifestyle 
often demonstrated by this age group under normal healthy circumstances. Persons 
excluded from the study included those who did not reside in the Los Angeles County 
area, persons who lacked medical diagnosis of CLD either by clinical disease definition 
or confirmatory laboratory diagnostic tests, self-diagnosed patients, patients with 
diagnosed CLD who had not received any treatment, and those outside the determined 
age group (18-40 years old). I did not allow participation in the study by individuals who 
did not meet the inclusion criteria. 
Recruitment  
I distributed an electronic recruitment flyer using the Facebook Los Angles Lyme 
group site and personally handed a hard copy recruitment flyer (see Appendix D) 
soliciting participants that fit the studies’ population criteria willing to complete an in-
person one-hour interview at the Los Angeles County Lyme Disease Association’s social 
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gathering. I secured explicit written permission from the organization for recruiting of 
participants and distribution of the recruitment flyer (see Appendix E). In case not 
enough participants were recruited from the L.A. County Lyme Disease group, I posted 
an invitation to participate in the study on the social media sites Facebook and LinkedIn 
(see Appendix F). Basic descriptive information in the recruitment flyers included: study 
title, purpose of the study, basic eligibility criteria, study location, and my name and 
contact phone number for providing further information if needed (UDHHS, 2005). Once 
the respondents contacted me, a short on the phone interview documented in the 
“Respondent Screening Form” (see Appendix G) was given to the respondents consisting 
of basic screening questions and authorization to be recorded during the study interview 
to ensure the sample criteria was met.  
Screening  
As mentioned above, when the respondent contacted me by email, the  
“Respondent Screening Form” (see Appendix G) was completed by self-report as I 
prompted the subjects for the information contained within the form. Inclusion and 
exclusion criteria were contained in the form to determine eligibility to participate in the 
study. Acceptance to the study granted the participants a permanent record number 
(PRN). The PRN had no personal information linking to the participant. The PRN 
consisted of six digits indicating date of acceptance and sequential order of recruitment. 
For example, for the first participant accepted February 27, 2017; the PRN was 022701. 
The PRN followed the participant in all the phases of the study: interview(s), 
transcription, data analysis, results reporting, and publishing, thus providing 
confidentiality of personal identifiers in all the records. I am the only person who has 
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access to the participant’s identification data matched with the PRN and stored in a 
locked drawer at my desk. I notified the respondents determined to be ineligible by email 
thanking them for the interest to participate on the study and reminding them the 
importance of the eligibility requirements on the outcome of the study.  
Informed Consent  
Eligible participants received the informed consent form (Appendix C) from me 
via email as well as the interview core questions (Appendix H). Providing the interview 
core questions enhanced the informed consent process and prepared the respondents for a 
successful interview. The informed consent form met all the general requirements as 
determined by the DHHS (2009) which include: a statement that the study involves 
research, purpose of the research, expected duration of the informant’s participation, 
description of any benefits from the research to the participant or others, description of 
the extent of time confidentiality of records, identification of the participant will be 
maintained, the researcher’s contact information to answer pertinent questions about the 
research and participant’s rights, and a statement that participation is voluntary and 
withdraw from the study may be done at any time without any penalty.  
In addition, I provided sufficient opportunity to consider whether to participate in 
the study to minimize any possibility of coercion or undue influence. Once the qualified 
participant had read and agreed upon the consent form’s contents and to be interviewed, 
the words “I Consent” were e-mailed to my email address listed on the informed consent 
(patricia.bolivar@waldenu.edu) by eligible participants. The “Respondent Screening 
Form” (Appendix G) and the Informed Consent Participant Log (see Appendix I) 
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containing the participant demographic information and eligibility criteria, the only 
records linking the participant to the research, are maintained in my custody (DHHS, 
2009); locked in a desk drawer designated “research study records” and kept for five 
years after completion of the study, upon which time all records will be destroyed by 
shredding. I conducted all the interviews. Interviews took place at a private place such as 
the local library individual study rooms reserved prior to the interview. Upon the 
participants’ request, few interviews took place at the privacy of the participant’s home.  
Instrumentation  
  Data collection instruments consisted of a semistructured interview using a series 
of open-ended questions asked to all participants in a pre-determined order (Crosby, 
DiClemente, & Salazar, 2006; Patton, 2002; Turner, 2010). Open-ended questions 
allowed the participants to elaborate and contribute as much additional details on their 
experiences as desired (Giacomini & Cook, 2000; Turner, 2010). The core interview 
questionnaire consisted of 35 directive questions (see Appendix H) used to ascertain the 
research questions based on the Health Belief Model (HBM) constructs (Delgado-Rico, 
Carretero-Dios, & Ruch, 2012). I read the questions exactly as they were worded to avoid 
changing the intent of the question, in addition I was prepared to ask follow-up questions 
to ensure optimal responses from the participants (Heckemann et al., 2016; Turner, 
2010). A semistructured interview format allowed me to engage in dialogue with the 
participant whereby modification of the initial question took place in the light of the 
participant’s responses (Smith & Osborn, 2013). Although I was encouraged to use 
probes, the probes were as neutral as possible to avoid introducing bias into the process 
(Crosby et al., 2006; Denzin & Lincoln, 2008). Prior to scheduling the participants for the 
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interview process, I confirmed that informed consent response with the words “I 
Consent” was on file by reviewing the Informed Consent Participant Log (see Appendix 
I). The existence of the informed consent on file was also documented in the interview 
sheet notes, and my study journal. I kept a study journal to document how the study 
progressed from initial forays of the research to the conclusion’s arrival (Bazeley & 
Jackson, 2014). All interviews as previously authorized by the participants were recorded 
using an Olympus WS-321M digital voice recorder.  
Instrument Content Validity  
Content validity has been defined as “the degree to which an instrument has an 
appropriate sample of items for the construct being measure” (Polit & Tatano Beck, 
2006). To establish the content validity of the core questions (Carretero-Dios, & Ruch, 
2012; Delgado-Rico), I assembled a content validity panel. Four professionals with 
expertise in a variety of areas including study design, qualitative research, public health, 
human behavior, education, research ethics, and microbiology, were assembled (See 
Appendix J). I contacted these professionals by phone and asked about their willingness 
to participate. All four individuals agreed to serve on the content validity panel. I sent 
everyone by email the 35 interview questions and the Survey/Interview Validation Rubric 
for Expert Panel - VREP© (Simon & White, 2016) to grade the questionnaire (Appendix 
K). I did not need explicit permission directly from the author to use the 
Survey/Interview Validation Rubric. A statement of permission by the authors to use this 
survey and include it for dissertation manuscripts was given to the public as stated in the 
Internet (Simon & White, 2016). The Survey/Interview Validation Rubric provides a 
Likert scale at the top of the page and instructs to rate the interview questions for clarity, 
90 
 
wordiness, negative wording, overlapping responses, balance, use of jargon, 
appropriateness, use of technical language, application to praxis, and relationship to 
problem as well as relevance of the questions to the underlying construct as follow. The 
grades are as follows: 1= not acceptable (major modifications needed), 2= below 
expectations (some modifications needed), 3= meets expectations (no modification 
needed, but could be improved with minor changes), and 4= exceeds expectations (no 
modification needed).  
Once the panel members graded the questions and returned them to me (Appendix 
L) I calculated the average congruency percentage (ACP). The ACP indicates whether 
each item on a scale is congruent or relevant to the construct (Polit & Tatano Beck, 
2006). I computed then the percentage of items rated by each expert, and calculated the 
average of the percentages across experts. An ACP percentage of 90 percent or higher is 
considered acceptable (Polit & Tatano Beck, 2006). The ACP I calculated from the 
content validity panel’s grading of the interview questionnaire for this study was 93.84% 
(Appendix M).    
The Survey/Interview Validation Rubric for Expert Panel - VREP© is designed to 
measure face validity, construct validity, and content validity (Simon & White, 2016). 
Face validity refers as how reasonable the questions are to gain the information the 
researcher is attempting to obtain (Moores, Jones, & Radley, 2012). Construct validity 
requires agreement between definitions and concepts and the measuring device for all 
constructs being measured (Sackett, 2012), and content validity determines if an 
instrument measures the specific domain of content (Sackett, 2012).  
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Calculation of the content validity ratio (CVR) described by Lawshe (1975) as 
CVR= n – N/2 ÷ N/2; where n represents the number of panelists that rated the questions 
3 or 4 and N is the total number of panel members; this readily demonstrates whether the 
level of agreement among panel members was greater than 50% (Polit & Beck, 2006; 
Ayre & Scally, 2014). The entire panel gave a score of 3 or 4 to all the questions giving a 
CVR of 1.0 indicating perfect agreement in a one-tailed test (α = 0.05) based on exact 
binomial probabilities at which concurrence of the panel would not be considered to have 
occurred by chance (Ayre & Scally, 2014). Therefore, agreement of the two validity 
methods was demonstrated concluding inclusion of all the questions with minor 
modifications.  
The interview questions recommended for review by the content validity panel 
(see Appendix L) were Questions 22, 25, 27, and 35. Original interview core questions 
are included in appendix N. In Question 22, I explained to clarify the word literate and 
what a Literate Lyme disease doctor entails, in Question 25 I changed the word failure 
for inadequacy, and reworded Question 27 from What will it take for you to overcome 
CLD? to What tactics do you think will be most beneficial to you to overcome CLD? and 
in Question 35 I explained the word community to include what the community 
encompass; neighbors, church, businesses, health care practitioners, etc.   
After I implemented questions based on the validity review panel’s comments and 
recommended revisions I carried a practice interview session with a colleague on April 
27, 2016. The interview duration was one hour. Participants were reminded upon 
eligibility of the length of the interview and the possible need to schedule additional 
follow up interviews if clarification of the questions remained. Participants were 
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informed when the entire interview process had been completed and encouraged to ask 
questions to inquire of the study progress via a telephone call. I hired a professional 
dissertation transcriber to transcribe the recordings of the interview within 48 to 72 hours 
of finalizing the interview process. The PRN assigned upon confirmed eligibility was the 
only identifier provided to the transcriber. The entire interview was transcribed to the 
semantic level, including the interview questions, all words spoken, significant pauses, 
and other features leaving a left-hand margin wide enough to make analytical comments 
pin two separate columns (Smith and Osborn, 2007). I gave the participants the 
opportunity to review the transcription of their interview, ask questions, and make 
comments before data analysis and documented the activity in the “Participants Activity 
Log” (Appendix O). The study protocol (Appendix P) summarizes all the central 
elements involved in the study participants’ recruitment and interview process (WHO, 
2016) as described above.   
A small pilot study consisting of 10 to 20 percent of the sample size is 
recommended to pretest or try out the research instrument (Simon, 2011). I used one 
participants to conduct a pilot study as a trial run to address several logistic issues in the 
research instrument, transcription, and documentation. This small pilot study provided an 
opportunity to make sure the instructions were comprehensible, the wording was 
adequate, validity and reliability were met, and to assure efficacy is achieved.  
Data Analysis Plan  
  The process of data analysis began with the process of data collection discovering 
the when, what, and where of experiences (Sandelowski, 2000) of young adults living 
with CLD and their health promoting behaviors during the interviewing process and data 
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documentation (Kim, Ju, & Khatun, 2015). Documentation of the data analysis process 
was carefully and thoroughly executed to enhance the ability of subsequent investigators 
to verify the findings and to follow the researcher’s decisions (Shenton, 2004). The 
analytic strategy consisted of utilizing the concepts of content analysis such as latent 
content, labels, meaning units, codes, themes, and unit of analysis (Graneheim & 
Lundam, 2004). I utilized these tools to proceed with the analysis following a detailed 
review of the transcripts as the process to recognize important themes, create a coding 
system to identify those themes, and finally, to interpret the data (Ulin, Robinson, & 
Tolley, 2005). To achieve this task, I immersed myself into the data by reading and 
rereading the transcripts and becoming familiar with the content (Ulin, Robinson, & 
Tolley, 2005). During the process, I sat aside preconceptions, pre-existing personal 
experiences, attitudes, and beliefs to view and understand the phenomenon in a pure and 
clear form (Drew & Hewitt, 2006) and became familiar with the responses (Creswell, 
2012).  
I followed the process by organization and characterization of the data into a list 
of significant statements grouped into “meaning units” or themes condensed into 
categories and codes to finally arrive to the interpretation of the phenomenon (Creswell, 
2012). The data analysis process that I followed is summarized in Table 1. The aim of 
analyzing the data is to try to understand or make sense of the content and the complexity 
of those meanings instead of the mere measuring of their frequency (Creswell, 2009; 
Sanjari et al., 2014). The study protocol (Appendix P) describes a summary of the steps 
to follow in data analysis and data interpretation.  
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Table 1 
Data Analysis in Phenomenology  
Data Management Create and organize files for data 
Reading Read through text, make margin notes 
Describing Describe the essence of the phenomenon 
Classifying Develop significant statements, group statements into meaning units, codes 
Interpreting Develop a description of the “essence” experience 
Representing Present narration of the experience in discussion 
 
I requested that the transcripts of the interview were written in such a way as to 
provide sufficient space to contain two columns. The first column of the transcript was 
used for commentary and to note significant and/or interesting details of what the 
participant said and the second margin column to document emerging theme titles in the 
form of concise phrases through the interpretative process (Snelgrove, 2014). I continued 
this process for the entirety of the first transcript. A theme captures the experience 
meaning and brings identity, intensity, and depth to the participant’s recurrent 
experiences (Drew & Hewitt, 2006). I listed the emergent themes first chronologically in 
a separate data sheet where I looked for connections between the emerging themes in 
order to arrange them in a more analytical and theoretical order making connections 
between the emerging themes (Denzin & Lincoln, 2008). Some of the themes clustered 
together, while others emerged as subordinate concepts (Smith & Osborn, 2007). I 
created then a table of the themes and arranged them in a coherent order as well as the 
subordinate cluster themes, documenting the page number of where in the transcript each 
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of them were found. I put aside the theme table from the first participant’s transcription 
and worked on the next transcript from scratch. I used the theme tables to identify 
repeating patters as well as new issues emerging respecting divergences and 
convergences in the data acknowledging which participant’s accounts was similar but 
also different (Smith & Osborn, 2007; Denzin & Lincoln, 2008). After analysis of all the 
transcripts in the described fashion and revision of the emergent themes tables multiple 
times, I constructed a table of superordinate themes or categories (Smith & Osborn, 
2007). I assigned codes to the specific categories in each transcript. Then, I identified 
codes as marked sections of the data and assigned labels towards the development of 
themes, subthemes, categories, or major constructs (Denzin & Lincoln, 2008; Malagon-
Maldonado, 2014). Next, I condensed themes and codes into categories. I accomplished 
condensation of similar coded text by utilizing a coding sort (Ali, Vitulano, Lee, Weiss, 
& Colson, 2014). The qualitative data analysis software package NVivo from QSR 
International set of tools assisted me in analyzing, managing, and shaping the data 
(Bazeley & Jackson, 2014; Creswell, 2012). NVivo software also provided security by 
sorting the database in a single file and enhanced rigor to the research by providing a 
comprehensive “trail” of decisions made during data collection and analysis (Creswell, 
2012; Houghton, Casey, Shaw, & Murphy, 2013). Upon completion of all the data 
collection and the coding process, I performed data reduction followed by data synthesis, 
and finally, interpretation of the data which explained how all the different themes and 
subthemes fit together and the overall meaning of the responses given by the participants 
(Ulin, Robinson, & Tolley, 2005).  
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I obtained verbal commitment of independent qualitative researchers analyzing 
the data and interpreting the results to produce dependable results which allowed for 
percentage of agreement comparisons. The verification panel consisted of the San 
Bernardino County Public Health Laboratory Director Linda Ward, a scientific research 
writer and analyst; and Alexander Del Rosario, a graduate student. Once the independent 
researchers had concluded the analysis, then I was ready to engage in the iterative process 
to control some of the bias that are naturally inherent when only one researcher examines 
data.   
Issues of Trustworthiness  
  One of the most critical aspects of qualitative research is achieving and 
maintaining rigor during the study (Loh, 2013; Thomas & Magilvy, 2011). Rigor is 
defined by the Oxford dictionary (2007) as the quality of being extremely thorough, 
accurate, or exhaustive. In other terms, rigor refers to various ways of establishing trust 
or confidence by providing details to replicate the results and findings of a research study 
with a different research sample (Thomas & Magilvy, 2011). Lincoln and Guba (1985) 
naturalistic investigators in their classic work proposed a model of how to build trust in a 
qualitative research or a model of trustworthiness. The authors explained the basic 
question of qualitative rigor, “How can an inquirer persuade his or her audiences 
(including self) that the finding of an inquiry are worth paying attention to, worth taking 
account of?” (Lincoln & Guba, 1985, p. 297). Positivist investigators on the other hand, 
often question the trustworthiness of qualitative researchers, perhaps because their 
concepts of reliability and validity cannot be addressed in the same way in naturalistic 
work (Shenton, 2004). Lincoln and Guba’s work addressed similar issues in four 
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constructs corresponding to the positivists investigators criteria as follow: credibility (in 
preference of internal validity); transferability (in preference to external 
validity/generalizability); dependability (in preference to reliability); and confirmability 
(in preference to objectivity) (Loh, 2013; Malterud, 2001; Shenton, 2004; Whittemore, 
Chase, & Mandle, 2001). I used the strategies to determine rigor based on the four criteria 
proposed by Lincoln and Guba (1985) for ensuring rigor and determining trustworthiness 
in this qualitative research are described in more detail as follows.  
Credibility (Internal Validity)  
I ensured the study measured what was intended by remaining sensitive to the 
relationship between the emerging data, the research questions, and the theoretical 
framework; therefore, maintaining methodological coherence (Kramer-Kile, 2012; 
Morse, Barret, Mayan, Olson, & Spiers, 2002; Shenton, 2004). I promoted confidence 
that health promoting behaviors of young adults living with CLD were accurately 
recorded by adhering to the following provisions. First, prolonged engagement between 
myself and the participants to gain a full understanding of the phenomena: health 
promoting behaviors of young adults living with CLD, and to establish a relationship of 
trust (Shenton, 2004). Second, I practiced persistent observation by spending sufficient 
time and prolonged engagement in the field until there was lack of any new emerging 
data as evidence that saturation had been achieved (Creswell & Miller, 2000; Houghton, 
Casey, Shaw, & Murphy, 2013; Simon, 2011). Third, triangulation across data provided 
by the participants in the interviews and my detailed observations and documentation to 
confirm data and to ensure data were complete (Houghton, Casey, Shaw, & Murphy, 
2013; Kim, Ju, & Khatun, 2015). I searched for convergence among the participant’s 
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information to form themes or categories in the study eliminating overlapping areas 
(Creswell & Miller, 2000).  
Fourth, review of the data and the research process by the dissertation committee 
members, peer review by the verification panel and debriefing (Shenton, 2004; Simon, 
2011). The verification panel as stated previously consisted of two members: a scientific 
research writer and analyst, and a graduate student. The interview transcripts and my 
interpretations were reviewed and put under scrutiny for accuracy of the methods and the 
interpretations (Simon, 2011) by the verification panel. Finally, described by Lincoln and 
Guba (1985) as “the most critical technique for establishing credibility” is member 
checking. I took the data and its interpretations back to the study participants so that they 
could confirm the credibility of the findings and had an opportunity to react to both the 
data and its interpretation (Creswell & Miller, 2000; Morse, Barret, Mayan, Olson, & 
Spiers, 2002). I documented this activity in the “Participants Activity Log” (Appendix 
O).  
Transferability (External Validity)  
Transferability, defined by Malterud (2001, p. 484), is “the range and limitations 
for applications of the study findings, beyond the context in which the study was done”. 
It is understood that no study can provide information in its findings that are universally 
transferable, regardless of the method used (Malterud, 2001). The aim of the researcher is 
to produce enough information that could be shared and applied beyond the study settings 
(Sharma, 2016). Since the findings of this study are specific to a small group of young 
adults living with CLD in Los Angeles County, it will be impossible to demonstrate that 
the findings and conclusions will be applicable to other populations and environments 
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(Shenton, 2004). I provided thick, rich description and detail of the setting, the 
participants’ accounts, perceptions, ideas, events, situations, and the themes in order to 
create verisimilitude; defined by the Oxford Advanced Learner Dictionary (2005) as “the 
quality of seeming to be true or real,” transporting the readers into the world of young 
adults living with LD and enabling them to make decisions about applicability and 
transferability of the findings to similar contexts or other settings (Creswell & Miller, 
2000; Houghton, Casey, Shaw, & Murphy, 2013; Log, 2013; Malagon-Maldonado, 2014; 
Noble & Smith, 2015; Sharma, 2016; Shenton, 2004).  
Dependability (Reliability)  
To achieve dependability of the study, I reported in detail the processes within the 
study and provided an in-depth coverage of the research practices enabling future 
researchers to be able to repeat the work and allow readers to gain a thorough 
understanding of the methods and their effectiveness (Shenton, 2004). I established an 
audit trail by keeping a research log of clear and comprehensive documentation of 
activities, chronology of data collection, data contextual background, and methodological 
decisions (Creswell & Miller, 2000; Houghton, Casey, Shaw, & Murphy, 2013). In 
addition, the audit trail I included: a) Description of the specific purpose of the study, b) 
Discussion of how and why the participants were selected, c) Description of how the data 
were collected and how long the data collection lasted, d) Explanation of how the data 
were transformed or reduced for analysis, e) Discussion of the interpretation and 
presentation of research findings, and f) Communication of the specific techniques used 
to determine the credibility of the data (Thomas & Magilvy, 2011). NVivo query tools in 
conjunction with the researcher’s reflective diary was used to keep a comprehensive trail 
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of decisions made during data collection and data analysis. I used NVivo tools to search 
for specific words in the interview transcripts and observational field notes for important 
terms, codes, and themes for analysis to ensure findings were not the perception of one 
person, but of several participants sharing the same perception or experience (Bazeley & 
Jackson, 2014; Houghton, Casey, Shaw, & Murphy, 2013). I ensured reflexivity by self-
disclosing personal beliefs, values, assumptions, and biases that may shape the research 
inquiry as well as reflecting on social, historical, and cultural forces affecting personal 
contributions that shape the interpretations (Creswell & Miller, 2000).  
I elicited the support of at least one qualitative researcher to examine the raw data 
and interpret its findings to establish inter rater reliability. The qualitative independent 
researcher used the protocols I had previously established which outline the data collection 
process, data analysis process, and the process used to interpret the findings (Appendix P). 
The independent qualitative researcher used the established protocols to theme and code 
the data and come up with interpretations. I then determined the percentage of agreement 
where the higher the percentage of agreement, the greater the interrater reliability.  
Confirmability (Objectivity)  
Once I had established credibility, transferability, and dependability, confirmability then 
took place (Thomas & Magilvy, 2011). In addition to triangulation and admission of my 
beliefs and assumptions, I took the following steps to ensure as far as possible that the 
study findings were the results of the participants’ ideas and experiences rather than my 
preferences and characteristics. After I interviewed every participant, I wrote personal 
feelings, insights, and biases; I made a conscious effort to follow rather than lead; and I 
created an audit trail represented using data oriented diagrams. The diagrams showing 
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how data led to the formation of recommendations and how it was processed during the 
study’s course allowed the readers to trace the course of the research step by step of the 
procedures I followed and decisions I made (Shenton, 2004; Thomas & Magilvy, 2011). 
The in-depth methodological description allowed integrity of the results to be scrutinized 
(Thomas & Magilvy, 2011). Table 2 below summarizes the strategies I followed to 
establish rigor to the study.  
Table 2  
Summary of Strategies to Determine Rigor 
Approaches to Rigor Strategies 
Credibility Prolonged engagement and persistent observation  
Triangulation  
Peer debriefing  
Member checking  
Transferability Thick description  
Dependability Audit trail  
Reflexivity  
Inter rater reliability  
Confirmability Audit trail  
Reflexivity  
  
Ethical Procedures  
  I did not begin the study until all the comments, guidance, and approvals were 
received from the research ethics committee (USDHHS, 2005). I followed all the laws 
and regulations that establish the principles of ethical conduct: do not harm, protect the 
privacy and anonymity of the participants, and maintain confidentiality of information. I 
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obtained informed consent of participants, assured that participation was voluntary 
providing ample opportunity to withdraw from the research, avoided any inappropriate 
behavior, and interpreted data honestly without distortion (Creswell, 2009; Patton, 2002; 
USDHHS, 2005; World Medical Association; 2005). I obtained approval of the research 
plan and all research materials from the Walden University IRB. Approval was obtained 
on 02/17/2017 11:34:47 -06’00’. The IRB is responsible for ensuring that all research 
conducted by Walden University’s students complies with the university’s ethical 
standards as well as U.S. federal regulations and any applicable international guidelines 
(Walden, 2016). The following documents were submitted to the IRB for review and 
approval: the research plan or dissertation proposal (Chapter 1, 2 and 3), Informed 
Consent Form (see Appendix C), Recruitment Flyer (see Appendix D), Approval letter to 
recruit participants from the Los Angeles County Lyme Disease Association (see 
Appendix E), Social Media Invitation to Study Participation to Facebook and LinkedIn 
Chronic Lyme Disease Study Invitation (see Appendix F), Respondent Screening Form 
(see Appendix G), Interview Core Questions (see Appendix H), Informed Consent 
Participant Log (see Appendix I), Content Validity panel (see Appendix J), 
Survey/Interview Validation Rubric for Expert Panel - VREP© (see Appendix K), 
Completed VRP by Validation Panel (see Appendix L), Content Validity Panel and 
Results (see Appendix M), Original Core Interview Questions Sent to Validation Panel 
for Review (see Appendix N), Participants Activity Log (see Appendix O), Study 
Protocol (see Appendix P), and proof of recent human subjects protection training (see 
Appendix Q). The IRB approval period for conducting the study, guidelines, established 
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policies and procedures, reporting of any deviation from the procedures, and submission 
of continuing review approval applications was respected and strictly followed as 
required.   
Summary  
This chapter included a discussion of the research design and rationale 
highlighting the research questions and methodology. My role as the researcher was 
clearly defined and explained. Detailed information of the study population, sampling 
strategy, recruitment procedures, participant selection, data collection instruments, and 
the process of validating the semistructured interview questions that validated the 
research questions were presented. The data analysis plan was elucidated, including a 
brief description of NVivo (the software that was used to enhance the process). Measures 
to protect human subjects following U.S. federal regulations, processes to safeguard 
participant’s information and maintain anonymity, and issues of trustworthiness such as 
credibility, transferability, dependability, and confirmability were established. Finally, 
ethical procedures such as the IRB documentation and treatment of data description were 
also provided. The following chapter includes a description of the results of the study by 
addressing each research question, presenting data to support findings, and illustrating 
results as appropriate.  
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Chapter 4: Results 
Introduction 
The lack of qualitative phenomenological research studies on the impact that 
chronic Lyme disease (CLD) has on the health promoting behaviors of ethnically diverse 
groups has been affirmed by Ali et al., (2014). I explored this gap in the literature by 
selecting a group of participants who were not just middle-aged whites with high 
socioeconomic status, and who can carry full medical insurance coverage. The purpose of 
this study was to explore the impact chronic Lyme disease (CLD) has on the health 
promoting behaviors of ethnically diverse, insured, young adults from similar educational 
and socio-economic backgrounds based on their lived experiences. The 
phenomenological research design was used in this study to elicit CLD affected 
participants to share their day to day experiences living with the disease.  
This study was guided by a series of closely related questions (Simon, 2011) 
based on the Health Belief Model constructs (Rosenstock, Strecher, & Becker, 1988; 
Behavioral Change Models, 2012) that helped me to avoid being distracted by interesting, 
but irrelevant digressions and to stay on target (Simon, 2011). The research questions 
were as follow: 
RQ1: Qualitative: To what degree do different ethnic groups with average levels 
of socioeconomic status, education, and third-party coverage, perceive the likelihood of 
acquiring comorbidities related to CLD?  
RQ2: Qualitative: To what degree does the perceived severity of CLD impact the 
lives and decision-making processes of different ethnic groups with average levels of 
socio-economic status, education, and third-party coverage?  
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RQ3: Qualitative: To what degree does the perceived benefits of treatment impact 
the lives and decision-making processes of different ethnic groups with average levels of 
socio-economic status, education, and third-party coverage?  
RQ4: Qualitative: To what degree do perceived barriers impact the lives and 
decision-making processes of different ethnic groups with average levels of socio-
economic status, education, and third-party coverage?  
RQ5: Qualitative: To what degree does the cues to action impact the lives and 
decision-making processes of different ethnic groups with average levels of socio-
economic status, education, and third-party coverage?  
RQ6: Qualitative: To what degree does self-efficacy impact the lives and 
decision-making processes of different ethnic groups with average levels of socio-
economic status, education, and third-party coverage?  
 In this chapter, I describe the conduct of the pilot study, report any impact of the 
pilot study on the main study, describe the setting and how the proposed plan was 
performed, and present the study’s purposive sample population demographics and 
characteristics relevant to the study. I describe in detail all the processes of data 
collection including where the participants were interviewed and how the data was 
transcribed and analyzed. The data analysis process is explained describing the specific 
codes, categories, and themes that emerged from the data using quotations as needed to 
emphasize its importance.  
I also discuss how I used the NVivo from QSR International set of tools program 
in analyzing, managing, and shaping the data. Measures used to establish evidence of 
trustworthiness are also described. Finally, I present the data to support each finding by 
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addressing each research question with the actual candid and rich descriptions of CLD 
affected individuals’ experiences to demonstrate the relationship of thematic patterns and 
the research questions. 
Pilot Study 
A small pilot study consisting of one individual as recommended by Simon 
(2011) was recruited to try out the research instrument. I used a pilot study as a trial run 
to address several logistic issues in the research instrument, transcription, and 
documentation. This small pilot study provided an opportunity to make sure the 
instructions were comprehensible, the wording was adequate, validity and reliability were 
met, and to assure efficacy was achieved (Simon, 2011). The participant was recruited as 
described in the methodology section, where informed consent was obtained for the 
interview process and a permanent record number (PRN) was issued to indicate that 
inclusion criteria was met and that confidentiality was maintained during the transcribing 
and the data analysis processes.  
The pilot interview took place March 6, 2017 at the public library in Pasadena, 
California; duration 32 minutes. The transcriber received the interview 3 days later, and 
returned its transcript back to me 4 days after submission. The process of data analysis 
started immediately after I received the transcript. The process consisted of immersion 
into the data by reading and re-reading the data and becoming familiar with the content 
(Ulin, Robinson, & Tolley, 2005). Next, a column to the right in each of the pages of the 
transcript was made to note significant and interesting details, to document emerging 
titles in the form of concise phrases through the interpretive process (Snelgrove, 2014), 
and to ensure sufficient data were obtained to address the research questions.  
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The coding process began with identification of meaning units documented in my 
interview journal. A total of 77 meaning units or themes were found which were 
condensed into 36 categories/codes related to the research questions and documented in a 
matrix chart for easy visualization which allowed me later with the study interviews to go 
through each topic to pick out concepts and themes (see Denzin & Lincoln, 2008). The 
transcript was also imported to the qualitative research software NVivo 11 for Windows 
by QSR International and nodes were created based on the data entry on the manually 
created chart to methodically find meaning units in the transcript. Data from the interview 
was exported to the created nodes as the transcript was read to answer the research 
questions. A detail description of the data analysis process carried for the study is 
provided in the Data Analysis section of this chapter. 
Lessons learned from the pilot study which affected the main study and were 
implemented during the interviews’ process were: 
1. To make sure the location for the interview was secured such as confirmation 
in person at the library at least an hour earlier of the scheduled time. Even 
though phone pre-arrangements are made, just the reservation without prior 
confirmation does not guarantee the room. 
2. To verify ahead of time that the place where the interview is scheduled is 
indeed quiet and private. 
3. To become familiarized with the recorder and its functions such as making 
sure a pause during the interview does not start a new file, as well as having 
extra batteries, and testing the recorder before each interview.  
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4. To prepare with a list of additional questions to ensure the core questions are 
answered completely.  
5. To develop a strategy to bring the participant back to the core question when 
digression takes place.   
6. To remember that the program that enables transferring data from the recorder 
to the computer must be downloaded to all the computers used for that 
function. 
7. To keep in mind that the NVivo license allows data import to be performed 
only in my personal laptop computer. 
8. To consider that the transcriber make take from 72 hours to 5 days to get the 
interview transcripts back to my email so checking daily is a must. 
9. To reassure that the data analysis process (reading of the transcript, coding, 
synthesis, compression of the data into the data matrix, and importing the data 
to NVivo) must take place immediately after receiving each interview 
transcript to ensure observations are well documented. 
Setting 
There were no personal or organizational conditions that influenced participants 
or their experience at the time this study was conducted and the interpretation of the 
study results. All the participants I recruited in this study, including the pilot study, 
participants were recruited using the methods approved by the Walden University 
Internal Review Board (IRB). All the participants were enrolled in the study from the 
pre-approved IRB research sites: Los Angeles County Lyme disease group, L.A. Lyme 
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social media website and word of mouth referrals. All the participants met the inclusion 
criteria and voluntarily participated in the interview. 
Demographics 
The sampling method I chose, stratified purposeful sampling, was the method that 
best enabled insights into the research questions of this study (see Ali, Vitulano, Lee, 
Weiss, & Colson, 2014; Drew & Hewitt, 2006; Suri, 2011). The purposive sample 
consisted of voluntary participants recruited from Los Angeles Lyme group (Facebook); 
a chronic Lyme disease (CLD) support and discussion website, CLD patients who I met 
at the L.A. Lyme group social gatherings, and participants that were referred for the study 
in the age range from 18 to 40 years old. Additional eligible criteria included both men 
and women who reside in the Los Angeles County, had been diagnosed with chronic 
Lyme disease by either clinical disease diagnosis (medical case definition criteria) or by 
confirmatory laboratory diagnostic tests, and had received or were currently receiving 
treatment for the disease.  
The sample was 67% females (n = 6) and 33 percent males (n = 3). Males were 
mainly white, while the female population consisted of a mixed race/ethnical 
background. Participants’ age average was 33 years old. Education level ranged from 
high school to graduate school. The interviews took place at the location chosen by the 
participants. Locations included the local library as planned to ensure privacy located 
near the participants place of residence, their home, and one interview was carried at my 
place of residence as requested by the participant.  Duration of the interviews varied from 
as short as 32 minutes to as long as to 84 minutes (one hour and 24 minutes). The average 
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length of interviews was 55 minutes. A summary of the participant demographics 
relevant to the study is illustrated in Table 3.   
Table 3 
 Participants Demographics 
Participant  PRN Gender Age Race/ethnicity Education  Interview 
location 
Interview 
duration 
(minutes) 
1 022701 F 27 Mixed (White 
Hispanic/Pacific 
Islander/Asian) 
AS degree in 
Nutrition 
Library 32 
2 022702 F 34 Asian BS in 
Business 
Participant’s 
home 
84 
3 031903 F 27 White Hispanic Some college Participant’s 
home 
75 
4 030704 M 27 White BS 
Accounting 
Library 48 
5 031605 M 32 White Hispanic High School Library 60 
6 031906 M 35 White Some college Researcher’s 
home 
40 
7 050207 F  36 Mixed (American 
Black, White, 
American Indian) 
MS Speech 
Pathology 
Participant’s 
home 
42 
8 050708 F 40 Mixed (White, Asian) Registered 
Nurse 
Library 60 
9 060409 F 39 Mixed (White, 
American Indian) 
Mental 
Health 
Counselor 
Library 54 
 
Data Collection 
 The data collection phase of the study started with the pilot interview on March 6, 
2017 and ended on June 5, 2017, a total of 14 weeks. Final IRB approval was received on 
February 17, 2017, and soon after, the IRB approved recruiting flyers were posted on the 
L.A. Lyme website on Facebook and the LinkedIn social media website (see Appendices 
D & F). Exactly 10 days after the IRB approval, the first participant was recruited 
(February 27, 2017). Participants were continuously recruited and immediately scheduled 
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for interview after eligibility was confirmed. Sampling and analyzing continued until no 
new data appeared; theoretical saturation had apparently been reached. Overall 
recruitment proceeded as expected. Initially response was fast. Five out of nine 
participants were recruited and interviewed in the month of March. Recruiting then 
slowed down. The recruitment flyer (see Appendix F) was then re-posted in the L.A. 
Lyme website. This resulted in additional participants to enroll. In April one participant 
was interviewed, followed by two in May and the last interview took place in June when 
saturation was confirmed. No response was received from recruiting flyer posted in 
LinkedIn social media website (see Appendix D).  
Prospective participants contacted me by email whom I contacted back by phone 
and completed the Respondent Screening Form (see Appendix G) to determine eligibility 
to participate in the study. All the eligible individuals (n = 9) were sent via email the 
Inform Consent form (see Appendix C). Once I received the words I Consent from the 
participant by email the participant was assigned a Permanent Record Number (PRN) 
consisting of six digits indicating date of acceptance and sequential order of recruitment. 
For example, the pilot interview individual was qualified eligible to participate in the 
study on February 27, 2017; therefore, the PRN created was 022701. The PRN followed 
the participant in all the phases of the study: interview, transcription, data analysis, results 
reporting, and will follow publishing, thus providing confidentiality of personal 
identifiers in all the records. Only I have access to the participant’s identification data 
matched with the PRN currently stored in a locked drawer at my desk. Two of the 
respondents to the recruitment flyer did not meet the eligibility geographical location 
requirement. 
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All interviews were face-to-face, in depth, open ended questions (see Appendix 
H). I made a conscious effort to follow rather than lead for every interview. Out of a total 
sampling group of nine interviews, five were conducted at the local library, three 
interviews took place inside the participants’ home as requested by the participants who 
for reasons of the disease stage where unable to meet at the local library, and one 
participant was interviewed at my home due to the participant’s available time to conduct 
the interview (only after 7:00 p.m.) and absence of a permanent place of residence (see 
Table 3). The proposed sample size was from 8 to 10 participants to achieve saturation 
(Suri, 2011). Saturation in the study was achieved with participant number eight and one 
more participant was interviewed to confirm saturation; where no new information was 
obtained. Each interview was audio recorded using the Olympus WS-321M digital voice 
recorder. Duration of the interviews varied as illustrated in Table 3 above from as short as 
32 minutes participant 1 (PRN 022701); a young lady who was on the road to recovery 
from the disease to as long as to 84 minutes from participant 2 (PRN 022702) who was a 
very sick patient; bedridden for almost two years and wanted to share her experiences 
dealing with the disease. The average length of interviews was 55 minutes. Participants 
were excited and happy to have someone hear their CLD stories and look forward for the 
information provided to be shared with numerous readers through this study. The 
qualitative design interview of open ended questions (Crosby, DiClemente & Salazar, 
2006; Patton, 2002; Turner, 2010) provided the means to express the participant’s 
experiences with CLD without interruption, in a transparent and introspective manner 
addressing each of the research questions. Immediately after each individual interview, 
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field notes were taken documenting the participant’s nonverbal reactions, my personal 
feelings, insights, biases, and overall perceptions.  
Recordings were reviewed for clarity and completeness before they were sent to 
the transcriber. All nine transcriptions were performed by Weloty Academic 
Transcription Services. The company provided a Non-Disclosure Agreement for 
Transcription Services (see Appendix R) reassuring confidentiality of the recordings and 
deletion of the interview contents upon completion on the study transcription services. 
The cost of the transcription services was $0.75 per minute. The total interview time was 
495 minutes for the grand total of $372.00.   
 Neither variations nor deviations of the data collection plan or the study protocol 
occurred with any of the nine interviews conducted. Early discontinuation of participation 
did not take place. Two of the participants requested the interview to be paused; 
participant 2 (PRN 022702) to take scheduled medicines and participant 3 (PRN 031903) 
to use the restroom.   
Data Analysis 
Data analysis was a continuous and evolving process beginning from personal 
notes taken at the interview and continuing immediately after receiving the transcripts of 
the recordings. The first step in analyzing the data was by reading and rereading the 
transcripts. I read each transcript at least three times, put aside preconceptions, 
preexisting personal experiences, attitudes, and beliefs to view and understand the 
phenomenon in a pure and clear form (see Drew & Hewitt, 2006) and became familiar 
with the responses (see Creswell, 2012).  
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Reading the transcripts many times ensured sufficient data was obtained 
addressing the research questions. I requested the transcripts of the interview to be 
written in such a way as to provide sufficient space to contain two columns. The page 
was laid out in portrait orientation to insert the columns. The first column of the 
transcript was used for commentary and to note significant and/or interesting details of 
what the participant said. The second margin column was used to begin the coding.  
The coding was performed by documenting patterns within the data searching for 
similarities and differences in the responses and formulating meaning unit’s titles in the 
form of concise phrases through the interpretative process (Snelgrove, 2014) using words 
related to the research questions. This process was continued for the entirety of each of 
the transcripts. A code matrix was then created using Windows Excel spreadsheet with 36 
codes corresponding to the answers given to the interview core questions in relation to 
the six research questions. Simultaneously, each transcript was also imported to the 
qualitative research software NVivo 11 for Windows by QSR International the data 
obtained from each interview was exported to the individual nodes designed to match the 
manually created code matrix to methodically find meaning units. The qualitative data 
analysis software package NVivo from QSR International set of tools assisted the 
researcher in coding, analyzing, managing, and shaping the data (Bazeley & Jackson, 
2014; Creswell, 2012).  
NVivo software also provided security by sorting the database in a single file and 
enhanced rigor to the research by providing a comprehensive trail of decisions made 
during data collection and analysis (Creswell, 2012; Houghton, Casey, Shaw, & Murphy, 
2013). Upon completion of all the data collection and the coding process completed, the 
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data reduction took place followed by data synthesis, and finally, interpretation of the 
data (Ulin, Robinson, & Tolley, 2005).  
  Manual analysis of the transcripts and use of the NVivo tools facilitated the 
creation of five categories: a) Vulnerability/Prevention, b) Diagnosis/Personal Story; c) 
Impact of the Disease; d) Management/Treatment; and e) Influences on Care; which 
evolved from primary and secondary themes discussed in the results section of this 
chapter. Codes and nodes were developed using words related to the research questions to 
name a few; route of transmission, health before CLD, prevention of CLD, symptoms, 
diagnosis, treatment, support, and recovery. For example, Participant 6 (P 031906) 
described his experience with CLD as follow: 
So, when I was in college, I actually I had got some weird strange symptoms one 
day, kind of out of the blue. And I do not remember a tick bite, I never had bulls-
eye rash either, nothing like that that I remember. And it just kind of appeared. 
And then it went away. I never knew what it was, all the symptoms went away. I 
was fine. Actually, I was fine for about 8 years and everything kind of dissipated. 
And then about over 4 years ago, all of my symptoms came back, kind of had a 
lot going on in my life and it brought everything to ahead. I was diagnosed by 
luck, I mean I actually went to a doctor who knew how to diagnose for Lyme, she 
had dealt with Lyme herself, so she knew what test to order and the test came 
back positive. 
The first part of his response was coded as route of transmission under the 
category Vulnerability/ Prevention and the theme Acquiring CLD. The route of 
transmission code captured the essence of experience acquiring the disease (Radolf, 
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Caimano, Stevenson, & Hu, 2012). Another coding resulting from his response was his 
experience being diagnosed coded under the category Diagnosis/Personal History under 
the theme Diagnosis illustrated in Table 4 in the Results section of this chapter. There 
were no discrepant cases to be factored into the analysis of this study. Participants shared 
their CLD stories in a transparent and straight forward manner.   
Evidence of Trustworthiness 
Credibility 
 To demonstrate the congruency of my findings with reality, the following 
provisions were made to promote confidence that health promoting behaviors of different 
ethnic groups with average levels of socioeconomic status, education and third-party 
coverage dealing with Chronic Lyme disease had been recorded under scrutiny: 
1. Establishment of a relationship of trust was ensured during the recruitment and 
the interview process by spending sufficient time with the participants to gain a 
full understanding of the phenomena (Shenton, 2004).  
2. Continuous recruitment and engagement in the field was maintained until no new 
themes emerged or categories evolved as evidence that saturation has been 
achieved (Creswell & Miller, 2000; Houghton, Casey, Shaw, & Murphy, 2013; 
Simon, 2011).  
3. Triangulation was maintained by examining the data multiple times to verify 
interpretations, documenting in a journal detailed observation, and confirming 
completeness of the data making sure overlapping areas did not exist when 
formulating categories and themes (Creswell & Miller, 2000).  
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4. The verification panel composed of three members was established. Each 
member was given the interview transcripts and a spreadsheet matrix with my 
interpretation of the responses to the interview questions. Each of the panel 
members reviewed the data and put it under scrutiny for accuracy and 
completeness of its contents. No discrepancies were found. One of the members 
added a few words to the pilot interview I had omitted on my interpretation to 
clarify the responses to three of the core questions. The other member agreed 
100% with the matrix contents.  
5. Finally, as described by Lincoln and Guba (1985) “the most critical technique for 
establishing credibility” is member checking. Each of the members was emailed 
his/her corresponding matrix of synthesized responses to each interview question 
given an opportunity to review the data.  None of the participants had a negative 
reaction to the data synthesis and its interpretations.  
Transferability 
 As indicated previously, according to Malterud (2000) no study can provide 
information in its findings that are universally transferable regardless of the methods 
used. The aim of the study was to produce enough information that can be shared and 
applied beyond the study settings (Sharma, 2016). Transferability determination to 
similar contexts or settings by the readers is facilitated by thick rich descriptions and 
details of the setting, the participants’ accounts, perceptions, ideas, events, situations, and 
the themes. 
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Dependability  
To establish dependability in these research findings I adhered to the proposed 
methods with no deviations from the protocol and interview guide. I reported in detail the 
processes within the study enabling future researchers to repeat the work and the readers 
to gain a thorough understanding of the methods and their effectiveness (Shenton, 2004). 
The following measures were taken to establish trust in this study findings: an audit trail 
was established by keeping a research log of clear documentation of activities such as 
participant eligibility based on meeting inclusion criteria, screening date, consent 
agreement, interview date, duration of the recorded interview, date of transcript, and 
interpretation of interview responses. NVivo query tools in conjunction with the 
researcher’s reflective diary was used to keep a comprehensive trail of decisions made 
during data collection and data analysis. I used NVivo tools to search for specific words 
in all the participants’ interview transcripts for important terms, codes, and themes for 
analysis ensuring that the findings were not the perception of one person, but of all the 
participants sharing the same perception or experience as illustrated in the results section 
of this chapter (Bazeley & Jackson, 2014; Houghton, Casey, Shaw, & Murphy, 2013).  
In addition, I elicited the support of one qualitative researcher to examine the raw 
data and interpret its findings to establish inter rater reliability. The qualitative 
independent researcher used the protocols previously established outlining the data 
collection process, data analysis process, and the process used to interpret the findings 
(Appendix P). The independent qualitative researcher used the established protocols to 
code the data. The percentage of agreement reliability was calculated after several 
periods of debriefing and two meetings to compare our individual findings. In our first 
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meeting, we discussed the method used to code the pilot interview. After review of the 
pilot interview I had 77 manual codes and the inter rater had 70 codes obtaining a 91% 
agreement. For our second meeting, we discussed the task being too cumbersome since 
many codes overlapped. The codes were then reduced based on the interview questions as 
they relate to the research questions and NVivo coding. After coding 2 more interview 
transcripts, the inter-rater coded 36 codes and I had 35 codes giving an agreement 
percentage of 97%. All the transcripts were then coded using 36 codes and a matrix 
consisting of 36 codes belonging to all the nine participants’ interview responses was 
created to help visualize the responses and document emerging themes, subthemes, and 
eventually categories related to the research questions.  The same 36 codes were used to 
perform the creation of nodes using the NVivo from QSR International set of tools which 
helped to manage and shape the data as illustrated in figure 8 below comparing two 
transcripts depicting the 36 codes agreed with the inter rater to be used in this study 
coding. 
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Figure 8. NVivo 36 codes used for transcripts coding.  
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Confirmability  
To ensure confirmability of the study I used the following steps so that the study 
findings are the results of the participants’ ideas and experiences rather than the 
researcher’s preferences and characteristics. After each individual interview my personal 
feelings, insights, and biases were documented; during the interview, I made a conscious 
effort to follow rather than lead; and an audit trail was documented in my research 
journal as well as in NVivo.  
The in-depth methodological measures taken in the processes of credibility, 
transferability, dependability, and confirmability described above allows the integrity of 
the results to be scrutinized (Thomas & Magilvy, 2011).    
Results 
Table 4 summarizes the categories, primary themes, and secondary that emerged 
from the data analysis.  
Table 4 
Emerging Categories and Themes 
Categories Primary Themes Secondary Themes 
Vulnerability/Prevention Health Status Change Acquiring CLD 
Preventing CLD 
Advise on prevention 
 
Diagnosis/Personal Story Diagnosis  Issues getting diagnosed 
Reaction to disease diagnosis 
Symptoms 
Impact of CLD Challenges of having CLD Physical Health 
Family/close relationships 
Social Issues 
Emotional Issues 
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Management/Treatment Recovery from CLD Treatments received 
Effectiveness of treatment 
Acquiring CLD treatment information 
Challenges obtaining treatment 
Beneficial activities combating CLD  
Motivation 
Influences on Care Support Family and friends 
Community 
Health care providers 
Public Health  
 
The emergent themes were listed first chronologically in a separate data sheet 
where I looked for connections between the emerging themes or primary themes and 
subthemes or secondary themes to arrange them in a more analytical and theoretical order 
making connections between the emerging themes (Denzin & Lincoln, 2008). Some of 
the themes clustered together, while others emerged as subordinate concepts (Smith & 
Osborn, 2007). A table of primary themes was then created and arranged in a coherent 
order as well as the secondary themes (Smith & Osborn, 2007; Denzin & Lincoln, 2008). 
After analysis of all the transcripts in the described fashion and revision of the emergent 
themes in a table format multiple times; Table 4 above was developed discussed herein as 
they relate to the six research questions. 
I discussed with each study participant guided by 35 core interview questions 
their perceptions of susceptibility to chronic Lyme disease (CLD), severity of symptoms 
affecting physical, family, social, and emotional life, treatments and benefits of 
treatments, barriers in obtaining treatment, and recovery of the disease using the Health 
Belief Model. I also queried the participants on cues to action and self-efficacy in terms 
of internal and external triggers such as motivation, support from family, friends, the 
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community, and health care practitioners in the health care system including public health 
agencies. 
Research Question 1 
RQ1 stated, to what degree do different ethnic groups with average levels of 
socioeconomic status, education, and third-party coverage, perceive the likelihood of 
acquiring comorbidities related to CLD? 
Data collected from open-ended questions 1-7 of the interview guide (Appendix 
H) answered this research question. Study participants indicated that the likelihood of 
acquiring comorbidities related to CLD does not depend on any degree on being healthy 
or identifying how they got the disease, but on awareness of the existence of the disease 
in the Los Angeles County and timely diagnosis.  
Vulnerability/Prevention: Health Status Change. Seven of the nine participants 
noted that they were productive and involved in an active daily life style before CLD and 
described themselves as “excellent health, not tired, normal”, “extremely active, weight 
lifting, martial arts, very active”, “exercised a lot, yoga, ate healthy, lived an active and 
healthy life”, “amazing health, active, and a hiker”. The other two participants 
(Participants 3 & 9) had been sickly since childhood; participant 3 expressed her 
declining health:  
I had health issues throughout my childhood I was always sick. I think the biggest 
time where I noticed something I was in college. On my sophomore year at 
college, it was just like every system was kind of failing. Then, I would get better 
for a little while, and then they would just be bouts throughout my life. It wasn’t 
124 
 
until I was in my early thirties, at post-partum after my second daughter was born, 
that I was just completely knocked out.  
And participant 9 expressed her sickly teenage years as: 
I had no problems before the age of 13, then I kind of got recurrent ear and nasal 
infections, I had all kinds of chronic tonsil infections all the time and I was put on 
all kinds of varying antibiotics, a million times over. Then when I was developing 
as a teenager I had pneumonia, and I almost died I remember it was horrible when 
I was 16. By 19 I couldn’t get up early in the morning anymore, I was tired, since 
age 13 I had horrific joint pain, where I had trouble walking. 
Acquiring CLD. Six out of the nine participants did not know how they acquired 
the disease:  
Participant 1: “Not exactly known.” 
Participant 2: “I’ve no idea how I was infected, but I started to see the symptoms 
that we now know that are associated with Lyme disease when I was 7 or 8 at 
least so that was at least 25 years ago really don’t know how I got Lyme. I’d 
never seen a tick, we never lived in the woods.”  
Participant 6: “It’s unknown, it’s speculated it may be in the family because of 
symptoms my family has and my sister has, but it’s unknown.”  
One of the three participants who knew the route of transmission explained: 
I found the tick, but I did not get it properly diagnosed or treated. Then for about 
maybe a week or later I got sick for just kind of felt like a cold running, run down, 
like feverish a little bit. I figured I just had a flu or cold. Then about 6 to 8 months 
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later I started dealing with more very severely ongoing fatigue, and other 
cognitive issues with my brain and short-term memory. Nothing too significant to 
make myself not have like a daily living struggle. But it made things more 
difficult and I felt like I was really exhausted, and kind of a in a mental fog and 
didn’t really know why. To a certain point where I kind of had a crash of my 
health, and I actually had I went to several hospitals to get you looked at. Because 
they knew that there was something going on, and my body becoming weaker and 
I couldn’t walk long distances. Eventually my legs would get really tired and this 
kind of like nerve, feeling in my nervous system that is hard to describe. But 
going through proper testing, through different labs and hospitals. Nobody really 
knew what it was and they just prescribed me stuff for anxiety. They said usually 
it was in my head, or I was just anxious and stuff like exaggerating symptoms of 
being hypochondriac. 
Preventing CLD. All nine participants when asked how they would have 
prevented CLD declared that awareness of the disease existence in Los Angeles County 
and the disease symptoms are key to prevent the disease. The participants expressed the 
need of awareness, more awareness which must exist not only by the public, but 
primarily by physicians. One of the participants stated: 
  Knowledge of the disease and awareness. Just knowing that it exists, that it’s in 
Southern California and having doctors that would be aware of the disease and 
take it seriously it would have made an enormous difference.  
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Advice on prevention. Each of the participants expressed her/his ideas depending 
on their experience of the disease in a slightly different way, but all the participants had 
in common tick checking, immediate seeking medical attention, and education on the 
disease. A few examples of advice on prevention included: 
Participant 1; “Be cautious of where you hike, be cautious about being outdoors. 
As well as always check yourself after being outdoors for any ticks or unusual 
bites. If I had the knowledge I would have been able to better find my diagnosis, 
and treat more effectively and sooner”. 
Participant 2: “So, it’s just important to do tick checks, I would have loved if I 
had known to do tick checks. I would have avoided certain areas where they 
would be kind of hanging out. Wearing protective clothing, so that I would be 
able to catch it earlier. Really it was just a huge bummer that had I known been a 
little bit more aware, I never would have gone through it” 
Participant 3: “Use essential oils as tick repellent when outdoors, hiking, on in the 
wilderness such as lemon eucalyptus, lavender, black seed oil. Take care of the 
immune system and do not mask symptoms and emotions” 
Participant 6: “That is a big question. I mean there are a lot of answers, from a 
like simple standpoint, it’s really be aware of ticks no matter where you live, 
because unfortunately they may be anywhere even in your backyard. No matter 
where you live you should be always aware of ticks. If something does happen 
you need to make sure that you go to a Lyme literate doctor right away. 
Immediately, if you have strange symptoms go to a doctor right away, like a 
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doctor who knows what they’re doing and knows how to prescribe antibiotics 
right away. It will go away, it will not turn into chronic Lyme” 
One of the participants; however, had a very different answer when it came to advice to 
others on prevention:  
There is one theory that if you take antibiotics early, then you could prevent from 
having chronic Lyme. I don’t know if I believe that is true, what I see is a lot of 
people taking antibiotics early based on the advice. And then six months, a year 
later or maybe they go through a traumatic experience such as a car accident or 
maybe they get a divorce or whatever, and then they get sick all over again, but 
they are not really thinking about the Lyme that they had before. Because they 
thought they treated it with the four weeks of antibiotics, or the two weeks of 
antibiotics recommended. So, I’m not sure that I believe that there is anything that 
you can do to cure or treat to keep from having chronic Lyme, other than build 
your overall health. Other than deal with your past traumas and your stressors and 
all your emotional stuff, and try to have better strategies for moving forward. 
Diagnosis/Personal Story: Issues getting diagnosed. Eight of the nine 
participants were diagnosed by IGeneX Laboratories and one by the CDC Lyme testing 
algorithm. Time to diagnosis ranged from months to years from the onset of symptoms. 
All the participants expressed problems getting diagnosed as illustrated by the following 
reactions to the question on difficulties encountered being diagnosed: 
(a) Many, first within myself as I didn’t know what was going on inside my body. 
Second with the doctors because they were unable to diagnose me, and kept 
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telling me that it was all in my head, and that what I was feeling wasn’t 
necessarily an illness but instead something that could be fixed with anti-
depressants and such. Third, within my family because they didn’t know what I 
was going through either. So, it was hard for them to understand exactly what I 
was feeling because of the lack of knowledge of Lyme disease among everyone 
really. 
(b) Was accused by doctors that it was all in my head. I was seen at hospitals for 
anxiety attacks, tested for many autoimmune diseases and viral infectious 
diseases; lupus, West Nile, Hepatitis B and others. 
(c) Have symptoms since very young, and went undiagnosed for years. After 
visiting various doctor finally, a doctor had Lyme testing on his radar and ordered 
the test which came back positive. It took a year since I had to pay out of pocket 
$360. 
(d) In High school was never diagnosed and the symptoms subsided, until 8 years 
later when the symptoms returned more aggressively and I was diagnosed within 
a couple of months. 
(e) Took 15 years to get diagnosed and many “oologists”; dermatologist, 
cardiologists, rheumatologist, endocrinologists, gastroenterologist, and 
chiropractors and nutritionists. 
(f) Took two years to get diagnosed after being treated for mental illness; treated 
with electroshock, bipolarity and Fibromyalgia. 
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Research Question 2 
RQ2 explored the perceived severity of CLD impact on the lives and decision-
making processes of the qualifying participants chosen for the study. Two subthemes 
belonging to the “Diagnosis” theme (issues getting diagnosed and reaction to diagnosis) 
and a new category “Impact of CLD” with a main theme “Challenges of Having CLD” 
and three subthemes emerged pertaining to this question from the interview questions 8 
to 14. I found that the severity and duration of the symptoms affected participants’ 
physical, family, social, and emotional life to a high degree of impact on their everyday 
life and their decision-making process.  
Diagnosis: Reaction to disease diagnosis. The following phrases described the 
reactions of the participants once CLD was diagnosed: “Relief, scared, not know what to 
do next”, “angry at first then relieved knowing I could treat something and could get even 
better and eventually cured”, “relief to know my condition had a name, but struggled 
believing it was the right diagnosis”, “not really feeling nothing, accepted what it was”, 
“it was hard to comprehend I had CLD, tested a few times to finally accept it”, “at first I 
thought it was ridiculous until saw a program on a girl bed ridden with CLD and many of 
the symptoms I had”, and “doctor kept it confidential for a while because they were 
afraid of my emotional response, but it was great news and I knew it was at least curable, 
it was scary but it wasn’t as demeaning as all the labels given to my condition” 
Symptoms. The plethora of symptoms described by the participants started with 
flu like symptoms, fatigue and tiredness, dizzy, feeling unbalanced, anxiety, and muscle 
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weakness which progressed to central nervous system involvement described by four 
participants as follow: 
Participant 3: “Joint pain, noise bleeds all the time, dizzy, light headed, migraines, 
chronic fatigue, burning sensations coming down the spine, digestive issues, 
anger, rage, stress anxiety, hyperthermia, and gastroparesis. Hand, legs, shin, feet 
pain, neuropathy, tendinitis, anxiety, anger, depersonalization, derealization, 
electrical sensation on left side of brain, seizures like reactions; body lock up, 
tremors, sense of impending doom, paralyzing fear.” 
Participant 4: “Body aches, congestion, brain fog, disorientation, memory loss, 
slurred speech, cognitive impairment, light headed, sensitivity to light and sound 
at the same time, tachycardia, arrhythmia, low blood pressure, PoTS syndrome, 
constant fevers, chills, dehydration, head rush, hyperthermia, vision distortion, 
mild hallucinations, sadness, anxiety, terror of dying.” 
Participant 7: “Symptoms will vary from vaginal issues: yeast infections, 
vaginitis, pain in the vaginal walls, to gingivitis, had numbness on the center of 
nose, lips, tongue, and throat that will come and go. Had heart problems; 
palpitations, cognitive issues. Memory lapses, speech problems, vision 
disturbances, temporary loss of vision, sensory experiences, and chemical 
sensitivities, unable to drive or work.”   
Participant 6: “Chronic fatigue, air hunger, chronic inflammatory response; pain 
in muscles, tendons, and joints. SIBO, chest pains, double vision, bed ridden, 
acute stress response, phono phobia, headaches, nausea, pain behind the eyes, 
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dizziness, severe muscle weakness, difficulty swallowing, weak neck muscles, 
and feeling faint.” 
Impact of CLD: Challenges of having CLD. The participants’ challenges of 
living daily for days, months, and even years experiencing various symptoms, many of 
the symptoms at the same time; day and night affected their physical, family, social, and 
emotional life to a high degree.  
Physical Health. Chronic Lyme disease is a debilitating disease where the 
progression of symptoms as expressed by the participants caused them weight loss, made 
them undernourished and weak, and challenged them to move around and be involved in 
the activities previously involved, unable to walk, drive or carry a normal life. Three 
participants described their physical condition as follow: 
Participant 1: “There was a point where I did drop down to about 87 pounds, and 
that was deathly scary as I looked skeletal and unnourished, which I probably 
was. Now I’ve gained some weight and I look better, but I still feel unnourished 
within myself. 
I can’t go out any place. I stay in the house most of the time, because of my 
difficulty swallowing; I can’t eat out or go out to a restaurant. I can’t go out to see 
people. I also get seizure-like attacks if I get in the car, where I would say shake 
like a seizure. I’m really to the point where I have no kind of life. My life is in 
bed, and that basically it. My daughter she is staying with my parents right now, 
because of the fact that I really can’t physically take care of her fully. I mean she 
is 17 years old, but it is hard to do anything with and for her.” 
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Participant 6: “Bedridden, unable to do for myself. Developed comorbidities such 
as sclerosis, autoimmune predisposition and coinfections of Babesia, 
Mycoplasma, Bartonella, Candida and parasites. Neurological symptoms: 
concentration problems, memory lapses, trouble forming words, trouble following 
conversations. Suicidal thoughts and actions.” 
Family/Close relationships. All the participants expressed how CLD affected 
greatly their family life and close relationships with friends, siblings, parents and 
spouses. These statements represent their experiences: 
(a) Affected greatly with family and friends unable to participate in activities as 
before and with my children unable to spend time together very low energy to 
take care of them as wanted to. My husband left.  
(b) Brother and relatives very supportive. Parents not understanding, they both 
told me to suck it up! Told I was fine, just anxious. 
(c) Had to take care of myself, as a child I was told I was lying or faking it. Illness 
have made me develop a self-filtering devise for whom my real friends are and 
have healed after a long time to be able to get close to my parents. 
(d) Friends and family including my husband did not know what to do. Friends 
did not really help or knew how to help, they didn’t offer to cook, baby sit, and 
walk kids to the park. I would say think it like I have cancer, what would you do? 
Bring us food, help take care of our kids, like all these thing, people didn’t get 
that. 
(e) Friends were scared. Friendships have changed now, I have different friends. 
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Social Issues. Social life for all the respondents was also greatly affected and for 
some it ceased to exist as they did not have the energy to go out and socialize. Three 
participants expressed:  
Participant number 2: “Life basically went down the drain, unable to hang out 
with friend’s low energy to socialize, no control, extreme frustration, sadness, 
symptoms lasted, and lasted, and lasted.” 
Participant 6: “Social life disappeared was not able to engage.” 
Participant 7: “I had no social life for years, recently able to socialize for short 
time. This is not my fault. I got a bite by a tick or something and it took 
everything that I could do. Took away my ability to work, cook, clean, have fun, 
took away my ability to be a lover…took my life.” 
Emotional Issues. Emotional issues were one of the subthemes that emerged in 
which lots of sadness and anger was expressed from all the participants who also referred 
to psychological and neurological involvement as the root of their emotional instability. 
Words such as fear, easily depresses, detached; not feeling for others, traumatic, feeling 
alive, but not really living, no empathy or sense of compassion, and apathetic were 
spoken. Some of the participants expressed: 
(a) Sadness, lot of suffering, but not angry just suppressed lots of feelings and it 
was just dark, very dark and cried a lot, became apathetic, dazed out. 
(b) Anger, feeling of dying. Emotions change, unable to handle life or being 
normal; crying fits, laughing fits, psycho thoughts of hurting yourself or others. 
(c) Had to have a lot of emotional trauma healing. Did not have much empathy or 
sense of compassion until recently. Emotionally and psychologically affected. 
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(d) Every level of torture because there is physically and emotionally pain. Being 
in bed where you cannot do anything. There is family and friend’s rejection, 
inability to do for yourself, there is brain malfunction; so, you lose your brain and 
you are just stupid. 
Research Question 3 
 RQ3 explored the perceived benefits of treatment that impacts the lives and the 
decision-making process of the study group.  
Interview questions 15 to 22 queried the participants on the effectiveness of 
treatment to reduce or cure the illness and the impact on their decision-making processes. 
The category “Management/Treatment” with the primary theme “Recovery from CLD” 
and 3 secondary subthemes emerged. Five of the participants (56%) have tried multiple 
treatments at the same time including a combination of conventional antibiotic treatment 
and complementary and alternative medicine (CAM), three participants (33%) decided to 
try one treatment modality at a time and see what the results were before changing 
treatment, and one of the participants (11%) decided to take herbal remedies and 
nutritional supplements only. There were different degrees of perceived benefits of 
treatment received and not one specific treatment or a combination of given treatments 
that have benefited the participants towards recovering from CLD, the benefits of the 
treatments were rather dependent on everyone’s response to treatment at time of 
intervention.  
Management/Treatment: Recovery from CLD: Only one participant claimed to 
have achieved 100% recovery. Four participants rated their recovery to be between 80-
90% and are currently in maintenance treatment modalities of herbals, supplements, and 
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healthy diets; two participants have partially recovered to 60-70% where they have 
relapses on and off when not taking medication on the regular basis; and the other two 
participants of the study group were in the acute stage of the disease.  
Treatments received. The list of treatments the participants have tried are 
compiled in the following table:  
Table 5  
List of treatments 
Antibiotics Herbals Supplements Miscellaneous Specific 
Protocol 
Rifampin 
Cefuroxime 
Amoxicillin Nyastatin  
Nizac 
 Doxycycline 
Augmentin  
Flagyl Azithromycin  
Amoxicillin  
low dose antibiotics 
Lomatium 
dissectum  
herbal 
mixtures  
lemon grass  
olive leaf 
extract 
walnut  
plantain 
Piniella,  
Samento,  
Banderol  
Japanese 
knot-weed 
Oregano oil 
turmeric 
Glutathione  
Nutrametrix  
Vitamin C IVs  
hlorine dioxide  
Miracle Mineral Solution 
(MMS). 
 Low dose amino therapy  
deliberate dieting high 
protein and fats such as 
Vitamin D  
grass fed butter 
essential oils 
silver  
IV immunoglobulins  
acupuncture 
energy frequencies  
coffee enemas 
metal chelation 
castor oil packs 
infrared lamps 
sauna detox  
salt baths  
ozone treatment  
nasal activation 
histamine  
UV light  
IV Chemotherapy 
Stem cell transplant 
Chinese formulas  
Dr. Stephen 
Buhner protocol 
Cowden protocol  
Bee venom 
therapy 
parasite treatments  
Guaifenesin 
protocol  
Natural holistic 
and Homeopathic  
GAPS health 
work remedies  
Indigo 
biofeedback  
Bartonella and 
Lyme Treatment 
Stool transplants 
Rife machine -
ONDAMED 
Infusions 
 
  
Effective treatments. When asked about the treatment that have worked the best 
the participants have different responses, but it seems herbals, antibiotics, and bee venom 
are the most mentioned effective treatments from the study group: Participant 1: 
“Combination of treatments especially acupuncture and herbal treatments, lowering stress 
level”; participant 2: “Long antibiotics treatment (one and half year) felt better after 8 
months and the Stephen Buhner herbal treatment are the best”; participant 3: 
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“Antibiotics”; participant 4: “Bee venom therapy healed me from the cellular level, 
normal blood pressure, normal heart rate, normal oxygenation”; participant 5: “I believe 
all help in some way, but Bee venom is working for me”; participant 6: “Rife machine 
and traditional Chinese medicine using visceral manipulations and little acupuncture”; 
participant 7: “Did not rush into treatment. Being flexible and in tune with my own body. 
Partnering with the right practitioner”; participant 8: “On ONDAMED for three years. I 
can eat a little bit more”; and participant number 9: “Herbals, gut protocol, and a full 
detoxing program. Silver has also worked well for me”. 
 Acquiring treatment information. All the participants agreed on how they 
obtain CLD treatment information; the Internet, Facebook, and the L.A. Lyme group 
website.  
Research Question 4  
RQ4 states, to what degree do perceived barriers impact the lives and decision-making 
processes of different ethnic groups with average levels of socio-economic status, 
education, and third-party coverage?  
 Data collected from open-ended core questions 23 to 27 on perceived barriers 
impacting the lives and decision-making processes of participants covered challenges 
encountered when in obtaining treatment; insurance coverage, treatment inadequacy, and 
transportation issues. Respondents indicated a high degree of influence on perceived 
barriers on their live and decision-making process. 
Challenges of having CLD: Challenges obtaining treatment. The number one 
challenge for all the study participants when asked about challenges encountered 
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obtaining treatment was financial issues. Insurances cover laboratory tests and antibiotic 
treatment, but do not cover many of the treatments especially herbals and naturopath 
doctors’ expenses was communicated by all the participants. Participant number 6 
expressed the magnitude on the cost of treatment: 
“Have spent almost $20,000 in miscellaneous treatments, $10,000 in Rife doctor, 
and $3,000 in Lyme literate doctor, co-pays and occasional IV, and lots of out of 
pocket in Chinese medicine and doctors too”. 
Participant number 9 who has been critically ill for extended amount of time expressed: 
“My challenge is money, I am in debt for over $45,000 and bankrupt. Also, 
distance for care and treatment by good providers who are familiar with Lyme 
disease. Many times, will drive somewhere for care and slept in the van 
overnight”  
Relating to treatment inadequacy as another challenge experienced, one participant 
replied:  
I was misdiagnosis since childhood until 22 years old.  
Another participant expressed:  
I was misdiagnosed as bipolar. I was also a victim of mistreatment with too strong 
dose of antibiotics orally that destroyed the digestive system. No one told me 
about a PICC line for IV long term use of antibiotics. 
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Transportation issues to receive treatment were common to seven participants who were 
too sick to drive themselves to their health care practitioner’s appointments and the 
following responses by two of the participants illustrate the issue: 
Participant 1: Yes, I encountered transportation issues accessing treatment; many 
LLD are outside the Los Angeles area too far to drive or get transportation to 
appointments.    
Participant 6: Transportation issues is a big one since my parents are in their 70’s, 
I sometimes get rides from friends, use Uber for appointments which are very 
expensive, or just miss my appointments. 
Research Question 5 
 RQ5 explored the degree “cues to action” impacting the life and decision-making 
process of the study’s participants.  
 Actions that trigger a decision to change behavior include the individual 
motivation to internal and external cues that trigger action to take place regarding 
recovering from CLD (Burke, 2013).  Internal and external triggers were found to affect 
cues to action in everyone in various degrees. Internal triggers degree of impact on the 
live and decision- making process varied depending on the individual’s physical and 
emotional health status, and stage on the road to recovery from the disease. However, 
external triggers expressed by all the participants in the form of support from family, 
friends, and the community either the lack of it or its availability influenced in high 
degree daily life and decision-making process the management of CLD.  
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Under the primary theme “Recovery from CLD” internal cues to action included 
activities the participant got involved that trigger a change of behavior and motivational 
goals and plans on the road to recovery. 
Beneficial activities combating CLD. Some of the internal cues to action 
triggers the participants mentioned benefiting combating CLD were: “stress management, 
meditation”, “spirituality, meditation, energy healing, slowly back to exercise”, 
“exercising few minutes daily, stay balanced, eat properly, and rest properly”, “energy 
work, spiritual healer, practicing yoga and strength training to build the muscles and 
physical strength”, “sweating to release toxins, accepting being vulnerable, and 
surrender”. 
Participant 5 expressed his way of finding healing: 
 Learning to let go, it’s about how the mind interprets the situation, the situation is 
going on but you cannot control it, 60must change the way you and your mind 
reflect it. Look at the positive and empowering yourself like in trauma and not 
allowing it to affect me and my relationship…changing my mind and my 
relationship to it. 
Inspiration to recover. When the participants were asked on what inspire and 
motivate them to recover from CLD each of them had a personal goal (internal trigger) 
which motivated them to recover from the disease as a vision for the future for 
themselves or for others. The only participant who claims to be completely healed shared 
her vision:  
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Seeing other women heal. What motivates me is when I can see where people 
with CLD aren’t free, where their hang-ups’ are, and I want to get in there and 
help them be free of them to benefit from treatment.  
One of the participants 80-90% on the recovering road is motivated to go on healing and 
treatment by not forgetting her life goals before CLD:  
My goals and aspirations in life before becoming ill and now that I am almost 
recovered from the illness are basically the same even though I’m no longer the 
person who I used to be before becoming ill. I still hold on to the goals that I have 
for myself such as finishing school and having a career for my children and for 
my family.  
A participant in the 60-70% way to recovery expressed: 
Do not want to live for me only, want to help others to recover and change the 
world in awareness on CLD, health in general and wellness.  
And one of the participants in the acute phase of the disease is inspired by remembering 
who she has been all along: 
 I think part of me is a fighter, I have always been a fighter, and when somebody 
tells me I couldn’t do something I always want to prove them wrong. I always 
have a little bit of hope that I will do something one day to stop this thing and 
help others. 
External cues to action fall under the category “Influences on Care”, primary theme 
“Support” and the secondary themes “Family and friends” and “Community”.  
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 Influences on Care: Support. An external trigger expressed by all the 
participants was support. Support either the lack of it or its availability from either 
family, friends, or the community influences in high degree daily life and decision-
making process on the management of CLD.   
Family and friends. One of the participants who is on the way to recovery 
believes support from family and friends is key in recovery as she expressed:  
Support from family and friends is very helpful in overcoming CLD and really 
any type of illness” she also expressed “in my circumstance feeling almost 
recovered I’ve had a great deal of support all throughout my illness by my family 
and friends. 
On the other hand, participant 6 who has been sick for many years expressed her 
frustration with her family’s lack support: 
 Many times, not there, it has been very challenging to get the family and my 
friends’ support needed, it makes me feel sad and depressed they just do not try to 
understand what I am going through, or even get informed on Lyme and ways to 
help me, sometimes they have been very abusive which does not help me at all.  
  Community: all the participants find support from social media and from the 
Los Angeles Lyme group.  
 Participant 1: “The social groups are definitely supportive and their help 
meaningful overcoming the challenges of Lyme disease. Because you get to relate 
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what others who are going through the same things that you are, and having those 
relationships help.” 
 Participant 5: “Sure, the community like the Los Angeles Lyme community itself 
has been a lot of support for me, and I’ve have made new friends from the group 
who have been very supportive. We try to help each other as much as possible 
with information on treatments, and get together for social activities, forums, and 
meetings motivating each other, and changing success stories.” 
There were only two participants who found support by their church members as 
expressed: 
 Participant 1: “Churches yes, people from the church have helped me cope, I 
would say. In terms of having a greater outlook as to why we suffer. As well as to 
just coming over my home and just by holding my hand, praying with me, and be 
there for me with whatever I’m going through.” 
 Participant 9: “I had always had a church system I tried to work in and I’ve had a 
great church support system. My church has branches wherever I go and I can go 
and I can beg for help wherever I am and for whatever I may need and find some 
kind of assistance. So, they’ve been very supportive overall. I made a whole new 
list of church friends from my church family.”  
One of the participants was very upset of the kind of treatment received by her church: 
 I was part of a church group, and I felt like they were not very supportive through 
my illness. I remember yelling at one woman, she kept asking me to take care of 
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things even though I was sick, I was a church leader actually, and I had to drop 
out of all my activities because I was too sick in bed and she kept calling me and 
asking me to do for them instead of offering help or assistance; why didn’t she 
offer to make a meal, or baby sit, help me clean or offer help for my family? 
Research Question 6 
RQ6 stated: To what degree does self-efficacy impact the lives and decision-making 
processes of different ethnic groups with average levels of socio-economic status, 
education, and third-party coverage?  
 Data collected from open-ended questions 32-35 answered this research question. 
As mentioned earlier, self-efficacy is directed affected by the level of the individual’s 
confidence in their ability to perform a behavior successfully (Behavioral change Models, 
2012). The participants communicated low degrees of confidence in the health care 
system and public health agencies and expressed ways in which public health, health care 
providers, family, friends, and the community can help those living with CLD in their 
decision-making process.  
 Support: Public Health. All the nine participants expressed the lack of 
involvement of public health agencies including the CDC in recognizing the 
existence of CLD, testing for the disease, and spreading awareness. When asked 
about what public health can do more efficiently for CLS patients, the following 
responses were obtained: 
(a) Recognize the disease as Chronic, spreading awareness.  
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(b) Take the disease and situation more seriously. Find ways to fix the problem 
and not call CLD a syndrome. 
(c) Education and awareness, develop and offer testing for CLD, offer low dose 
immunotherapy and new treatments available for affordable prices. 
(d) Awareness of how big CLD is affecting everyone and ticks are everywhere 
and how LD is so transmissible so something must be done to mitigate this crisis 
right away. Second diagnosis are wrong completely wrong, the CDC algorithm is 
a joke. There is a lot of misinformation and misdiagnosis of CLD. 
(e) Becoming allies in movements, lobby as representatives for awareness in 
CLD since those affected are too sick to have marches, to demonstrate. 
(f) Government agencies are antiquated and evidence based practices are stuck on 
Western medicine. PH needs to apply new practices such as reaching people 
where they are and new methods giving hope and help in progressive ways. 
Accepting the severity of CLD, based counseling in cases of healed patients and 
practicing a holistic approach. 
(g) Must have CLD therapists to be able to talk. Must have more of that because 
we go through hell with this disease. I have no one to talk to me. We need 
somebody to talk to and to boast on our disease. 
(h) Get the word out that LD is a pandemic, inform of the toxic environment that 
affects CLD, and that not everyone bitten by a tick or other LD infected insect 
does not have to get so sick if treated properly. Awareness and protection when in 
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the woods of essential oils and natural Lyme tick repellants. Information about 
detoxing of all the garbage on GMO and toxins in the environment. 
Health care: All nine study participants expressed their frustration and 
disappointment with the conventional health care system expressed as follow: 
1. The health care system does not do much for me except blood test panels, our 
health care is based on insurance pay not really care for people’s well-being and 
besides they do not have enough knowledge on disease treatment. 
(d) Need more awareness of the disease at all levels to create empathy by 
emergency room doctors and the health care system knowledge of alternate 
treatment not just antibiotics.  
(c) It is an absolute joke. 
(d) Medical doctors are denying the sickness. No healthcare available to the poor 
experiencing CLD. It all must come from the top; the CDC and the Infection 
Disease Society of America must recognize CLD first.    
(e) Not much help there except for a few of those physicians who are Lyme 
literate and there is much more to learn and research to do and be available to all 
CLD affected. 
All the participants also expressed what family, friends, and the community can do better 
to support those living with CLD and impact their lives and decision-making process: 
 Family and friends: Phrases such as these were expressed by the participants: 
“they need to be more involved and conduct their own research of the disease and 
treatment options, and provide me with support in my lifestyle changes”, “be 
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sympathetic and have a good listening ear”, “educate themselves and be 
supportive and understanding of the disease; show compassion”, “Family and 
friends can do what was done for HIV/AIDS movement who made sure their ill 
loved one was seen as a patient; a human, not as detestable human being. CLD 
patients not seen as detested, but are being abandoned because people don’t 
believe we even have a disease.”   
Participant number 5 summarized his expectations from his family as follow: 
 “Some things that my family and friends can do to be supportive of my dealing 
with Lyme are: don’t tell me, things like, you don’t look sick. Don’t question why 
I do certain things that might seem odd to you. Take the time to call me and see 
me, and show you care. If you’re living with me, please help me create a peaceful 
environment. Talk to me in a loving caring way. Don’t tell me I’m selfish, and I 
don’t think of you, listen to my needs, work with me to get better, not against me. 
Respect my boundaries, don’t ask me what I did today. And ultimately be there 
for me.” 
 Community: Participants expressed their need for involvement of the 
community; neighbors, relatives, coworkers, church, agencies, and the general public 
with the following statements: “awareness and education”, “awareness, education and 
advocacy for better decisions in treatment, insurance coverage and financial support for 
the chronically ill”, “awareness, understanding the seriousness of the disease and the need 
for help in transportation and better management options”, “be more aware of what CLD 
is and try to understand that CLD is a devastating disease like cancer or ALS even though 
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it has not risen to the same awareness”, “provide rides to doctors’ appointments, grocery 
delivery, money help for treatment”, “offer support to go visit with people with CLD, 
cook for them, love them, take kids for an hour or so they can have a break; but the 
process cannot be dictated to them. Be available to them no matter what it is”, and “need 
a lot of support in every level. Any help is good; like rides, watching TV or movies with 
me, just having their company. Friends can bring a cooked meal once in a while”. 
Summary 
In conclusion, based on the data analysis this study provided insights into the 
health beliefs, lived experiences, and the impact on the decision process of young adults 
of different ethnic groups with average levels of socioeconomic status, education, and 
third-party coverage in the Los Angeles County living with CLD. All the participants in 
the study based on research question 1 agreed that neither their health status previous to 
CLD plethora of symptoms experienced nor knowledge of how they acquired the disease 
affect in any degree the likelihood of acquiring comorbidities. The likelihood of 
acquiring comorbidities that accompanies CLD depends on awareness of the individual 
and the health care providers of the existence of the disease in the Los Angeles County 
and timely diagnosis.  
Research question 2 explored the perceived severity of CLD impact on the lives 
and decision-making processes of young adults in L.A. County living with CLD. It was 
found that the severity and duration of the symptoms affected their physical, family, 
social, and emotional life to a high degree on their everyday life and their decision-
making process.  
148 
 
The third research question explored the perceived benefits of treatment that 
impacts the lives and the decision-making process of the study group. I concluded based 
on the extensive amount of data obtained from the participants on the subject that there is 
not one specific treatment or a combination of given treatments that benefits CLD 
patients to a high degree towards recovering from the CLD, but that rather the benefits of 
the treatments are dependent on a combination of several factors such as the individual’s 
stage of the disease at time of intervention, insurance coverage, and socioeconomic status 
to pay for alternate treatments. Perceived barriers or challenges encountered when 
receiving treatment impacting the lives and decision-making process of the study group 
were found to be insurance coverage, treatment inadequacy, and transportation issues 
explored in research question 4. Respondents indicated a high degree of influence on the 
perceived barriers in their lives and the decision-making process. 
Research question 5 explored the degree “cues to action” impacting the life and 
decision-making process of the study group. Internal and external triggers were found to 
affect cues to action in everyone in various degrees. Internal triggers degree of impact on 
the live and decision- making process varied depending on the individual’s physical and 
emotional health status, and stage on the road to recovery from the disease. However, 
external triggers expressed by all the participants in the form of support from family, 
friends, and the community either the lack of it or its availability impact in high degree 
management of CLD on the lives and decision-making process of the study group.    
Lastly, research question 6 explored the degree self-efficacy that impact the lives 
and decision-making processes of different ethnic groups with average levels of socio-
economic status, education, and third-party coverage in Los Angeles County. It was 
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found that all the participants have a low degree of confidence in the health care system 
and public health agencies. In addition, the participants expressed ways in which public 
health, health care providers, family, friends, and the community can help those living 
with CLD manage the disease on their daily life and their decision-making process.  
The following and final chapter of this study is chapter 5. This chapter offers key 
findings concisely summarized including how the interpretations of the findings compare 
to the literature and how the study extends to current CLD knowledge. I also discuss the 
limitations of the study and make recommendations for further research that are grounded 
in the strengths and limitations of the study as well as the literature reviewed in chapter 2. 
Finally, I present potential positive social change implications of the study.   
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
 I conducted this study to obtain insights into the health beliefs and lived 
experiences of Los Angeles County chronic Lyme disease (CLD) young adult patients 
and to examine the impact the disease has on their daily lives and the decision-making 
process. In Los Angeles County; an ethnic, educational, and socioeconomic diverse 
population area (CDPH, 2013; California LD Association, 2015) both patients and 
practitioners fail to recognize the disease, resulting in misdiagnosis and delayed treatment 
(Ostfeld, Lane, & Briggs, 2011). Long term CLD consists of many nonspecific symptoms 
affecting various body systems and consequently the individual’s quality of life (Drew & 
Hewitt, 2006; Stricker, 2007; Borgermans et al., 2014).  
There is a lack of knowledge in previous studies about CLD patient’s experiences 
and the impact on young adults’ health behaviors in the Los Angeles County (California 
LD Association, 2015). The purpose of this study was to address the gap in the literature 
by examining the impact that chronic Lyme disease (CLD) has on the health promoting 
behaviors of ethnically diverse, insured, young adults from similar educational and socio-
economic backgrounds in Los Angeles County based on their lived experiences. The 
qualitative hermeneutical phenomenological inquiry approach, allowed me to draw upon 
lived experiences of the participants to gain a deeper understanding and appreciation of 
the impact of CLD on their lives and their decision-making process (Rudestam & 
Newton, 2015). The use of semistructured interview questions format provided lived 
experiences insights of CLD patient’s life and the impact on their personal, social, 
professional, and decision-making processes (Smith & Osborn, 2013).    
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The key findings of this study based on Chapter 4 analysis of the in-depth, face-
to-face interview responses of nine young adult participants living with CLD in Los 
Angeles County revealed that patients with CLD daily lives are marked with substantial 
limitations physically, socially, and emotionally due to their decline in health status. 
Perceptions on susceptibility, severity, barriers, and benefits of treatment for CLD are 
similar. Most of the participants reported wellness and good to excellent health prior to 
CLD. Lack of awareness of the existence of the disease and mode of transmission by both 
the general population and health care practitioners in Los Angeles County leads to poor 
prevention measures, misdiagnosis, and mistreatment. Some of the participants have 
lived years improperly diagnosed with CLD.  
Once diagnosis was established most study participants expressed their relief to 
have a name associated with their symptoms and a hope for effectiveness of the 
prolonged use of antibiotics and/or complementary alternative medicine (CAM) therapies 
directed towards killing the bacteria, controlling the symptoms, and eventually curing the 
condition. Anger, fear of dying, and sadness was a common reaction to CLD diagnosis. 
Difficulties in obtaining treatment for CLD included mainly financial issues; since most 
insurances do not cover long-term antibiotics and CAM therapies. Other issues in 
obtaining proper treatment are lack of Lyme literate medical doctors (LLMD) accessible 
in metropolitan areas and transportation to the long-distance location of the LLMD 
practice. Some CLD patients are willing to try almost anything as a possible cure to the 
condition. Some of the participants experienced multiple bee bites on a regular schedule 
from months to years in the treatment, or trying the latest protocol or treatment shared by 
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CLD recovered patients in the Lyme disease social groups or the Internet. Family, 
friends, and community support are key in the recovery from CLD. The health care 
system and public health involvement in awareness, prevention, and research for new 
diagnostic tests, as well as affordable treatments, and advocacy to care for CLD patients 
is warranted.  
Interpretation of the Findings 
The limited number of studies found in the literature on the lived experiences of 
those diagnosed with chronic Lyme disease (CLD) not only in Los Angeles, California, 
but nationwide indicate that the researchers in the field of epidemiology have just barely 
began its involvement performing qualitative studies on this disease. CLD develops 
because of delayed diagnosis and treatment of Lyme disease; the most prevalent and 
reported tick-borne infection in the United States (Stanek et al., 2011; Levi, Kilpatrick, 
Mangel, & Wilner, 2012) rendering CLD a condition of increasing public health 
importance (Aronowitz, 2011; Horowitz, 2013). The following subsections will address 
some of the gaps in the literature and explain how this study findings not only compares, 
but also enriches the current literature.  
Demographic Gap in the Literature 
 Previous phenomenological qualitative studies on CLD were conducted 
exclusively on Caucasians participants in a wide age range from 20-69-year-old in Lyme 
disease endemic geographical areas (Drew & Hewitt, 2006; Ali, Vitulano, Lee, Weiss & 
Colson, 2014) which does not relate to the racial/ethnic diversity background, age group, 
or endemic area classification of those affected in Los Angeles County, California. This 
gap in the literature was explored in this study by selecting a group of participants with 
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diverse racial/ethnical background, education, and socioeconomic status with an age 
range from 18-40 years old. Insights into health beliefs and lived experiences in this 
study provided similar results as those obtained on previous qualitative studies on CLD.  
The similar findings included decline in health status, considerable limitation of 
daily activities, frustration being diagnosed, financial stress, contrasting patient-doctor 
relationships, and variety of therapies to treat CLD. The findings of this study not only 
confirm what has been found in the current peer-reviewed literature, but extends 
knowledge on the challenges of being diagnosed and provide rich data about the 
experiences of becoming diagnosed with CLD including how the family, friends, social, 
and emotional life is affected by the disease.  
Changes in Health Status  
 All the participants reported good well-being to excellent health prior to onset of 
sudden symptoms. The participants expressed a progression of the symptoms starting 
with flu-like symptoms followed by myalgia, fatigue, anxiety, fever, chills, headache, and 
muscle weakness characteristic of the primary stage or stage I of CLD presentation 
(Horowitz, 2013). Only one patient recalls a rash or presentation of erythema migrans 
(EM) which according to the literature occurs in only 60-80 percent of patients following 
the bite of an Borrelia burgdorferi (Bb) bacteria infected tick bite (Biesiada, Czepiel, 
Lesniak, Garlicki, & Mach, 2012; Ljostad & Mygland, 2013).  The symptoms progressed 
to secondary stage or early disseminated stage manifested by neurological involvement 
(neuroborreliosis); mental fogginess, inability to concentrate, memory lapses, confusion, 
intense headaches, migraines, photophobia, pain behind the eyes, vision distortion, mild 
hallucinations, irritability, depersonalization, derealization, tremors and involvement of 
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other organs (Miklossy; 2012; McKechnie, 2016). Two study participants had progresses 
to late chronic disease or tertiary stage after years of initial onset manifested with 
difficulty moving around, joint pain, profound fatigue, problems concentrating, reading, 
temporary loss of vision, and psychiatric symptoms (Logigian & Steere, 2012; Holtore, 
2015).  
Five participants reported the onset of the myriad of symptoms associated with 
CLD after the occurrence a stressful life-changing event. Two women reported symptoms 
starting after the birth of a second child combined with the stresses of a new home, job, 
and school demands. Two male participants reported onset of CLD after moving away 
from home and starting college, and one participant reported symptoms that progressed in 
severity after a traumatic car accident. The data provided by this study may be associated 
with the characteristic stealth pathology of Bb. As studied by Stricker (2007) stealth 
pathology refers to mechanisms used by Bb to evade immune response which include 
immunosuppression; genetic, phase and antigenic variation; physical seclusion; and 
secretion of factor to engage in autoresurrection a dormant organism. This study finding 
suggest that stressors in the life of a previous infected individual in which the bacteria are 
dormant may trigger the onset of CLD symptoms and disease presentation.  
Difficulties Being Diagnosed 
 Lack of knowledge on the proper evaluation of Lyme disease key symptoms by 
health care practitioners as well as timely and appropriate treatment leads to patients 
being diagnosed with an array of conditions including Epstein-Bar virus, multiple 
sclerosis, fibromyalgia, chronic fatigue syndrome, and psychiatric conditions has been 
reported in various studies (Bransfield, 2012; Horowitz, 2013; Holtore, 2015). In this 
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study, participants reported not only problems getting diagnosed, but misdiagnosed with 
lupus, West Nile virus, hepatitis B, Myasthenia Gravis, in addition to the aforementioned 
conditions. Some of the participants were accused of being hypochondriac, crazy, and the 
disease to be all in their heads; as also indicated in previous studies on CLD patients 
(Bransfield, 2012; Ljostad & Mygland, 2013).  
 Horowitz (2013) and Hersh et al. (2014) stated that coinfections such as 
Anaplasma, Babesia, Bartonella, and Ehrlichia to name a few transmitted by an infected 
tick bite also might be present in CLD patients making diagnosis and treatment more 
challenging. Participants in this study reported laboratory confirmed coinfections mainly 
Babesia and Bartonella exacerbating their CLD symptoms with increase fatigue, 
headache, joint pain, ophthalmic problems, seizures, and cognitive dysfunction as also 
indicated by the CDC (2014) and other authors (Berghoff, 2012; Horowitz, 2013; CLDA, 
2015). 
 This study also confirms the findings that highly specialized laboratories such 
IGeneX in California (Horowitz, 2013) is reliable and accurate diagnosing CLD with 
their IgG Western blot protocol in which two of six band detected are diagnostic criteria 
of Lyme disease (See Figure 6). (Haley, 2011; Schutzer, et al., 2013; IGeneX, 2015). As 
discussed in chapter 4 eight out of nine study participants reported diagnosis of CLD by 
IGeneX tests. Most of these participants in this study had tested negative by the CDC 
algorithm multiple times before being tested positive by IGeneX laboratories. Only one 
participant reported confirmed diagnosis of Lyme disease by the CDC testing algorithm. 
The CDC’s two-tiered serology testing algorithm for IgG is diagnostic of Lyme disease if 
five out of 10 bands present (Johnson, 2011; Lee, Vigliotti, Jones & Shearer, 2014). 
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According to the literature, the CDC testing algorithm is 87% reasonably sensitive in 
disseminated neurologic disease caused by B. burgdorferi (Hinckley et al., 2014; Lee, 
Shapiro, 2014; Lee, Vigliotti, Jones & Shearer, 2014) which differs from the findings in 
this study. However; this study findings confirm that diagnostic challenges of CLD may 
be due to the various existing genospecies of Bb in California causing a somewhat 
different syndrome with somewhat different clinical presentation, which in turn makes 
clinical and laboratory diagnosis a challenge (Buhner, 2005; Center for Food Security 
and Public Health, 2011). 
Aspects Affected  
 The significant and measurable decline in physical health status and intellectual 
acuity experienced by CLD patients interfere with all aspects of normal living and 
functioning (Bransfield, 2012; Ljostad & Mygland, 2013). Aspects affected identified in 
the literature include home life, marriage, employment, social interactions, and emotional 
well-being (Bransfield, 2012; Medalia & Revhein, 2012). The physical burden of the 
disease expressed by all the participants in this study as extreme fatigue, musculoskeletal 
pain, and cognitive dysfunction persisting for long periods of time even years affected 
their quality of life not only physically, but socially, and emotionally. The findings in this 
study support the literature citing the challenges of living with CLD affecting close 
relationship with parents, siblings, spouses, and friends; impairment in their ability to 
work and study; lowered health quality status posing greater activity limitations; and 
more mental health days.  
The study’s qualitative design allowed interviewees to provide detail account of 
their daily lives coping with the disease and provided additional insights that extends the 
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current knowledge. In addition to the impact of CLD on the physical, social, and 
emotional life; the interviewees provided account of the financial burden of the disease 
and increased utilization of health services many of which are not covered by health care 
insurances. The financial burden of CLD management found in this study support the 
findings of Johnson, Wilcox, Mankoff & Stricker (2014) in the literature where the 
authors used the CDC health related quality of life (HRQoL) indicators to compare CLD 
to other chronic conditions in the quality of life survey. The authors concluded that the 
significant burden of CLD symptoms demands more out of pocket medical expenses 
compared to the general population.  
Treatment Modalities Effectiveness  
 The minor clinical improvement of CLD symptoms after the use of antibiotic 
treatment with either a monotherapy or a combination of antibiotics and repeated or long-
term antibiotic therapy was evidenced in CLD trials conducted by Fallon, Petkova, Keilp, 
& Britton (2012). This study supports the findings of the trial; 78 percent (n = 7) of the 
interviewees had been in some form of antibiotic combination for short or long amount of 
time after CLD diagnosis experiencing only minor improvement after treatment. The 
frequent occurrence of the Jarish-Herxheimer (JH) reaction or exacerbation of symptoms 
after beginning antibiotic therapy or its prolonged use experienced by the study 
participants also supports the literature. JH is a temporary worsening of symptoms due to 
the combination of the bacteria dying and the body’s immune inflammatory response 
(CDC, 2013; CDPH, 2013; Horowitz, 2013; Perrone, 2015).  
 Natural CLD treatment as the herbals and nutritional supplements used in 
complementary and alternative medicine (CAM) protocols inhibit the inflammatory 
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process, reduce bacterial circulating load, and results in elimination of Bb from the 
tissues leading to the repair of the damage caused by the bacteria (Buhner, 2016). This 
study not only supports the findings of Buner (2016), but also enriches the knowledge on 
the effectiveness of CAM and new CLD effective treatments such as Bee venom therapy.  
 Evidence on the effectiveness of additional natural treatments such as 
acupuncture, homeopathy, probiotics, massage therapy, and exercise on helping the body 
to get rid of the infection; reducing inflammation, and restoring the immune system 
found in the literature (Whitmont, 2012; Gardner, 2015; Zerbe, 2015) is also supported 
by the participants in this study. The participants in this study found relief of symptoms 
when they used additional natural treatments either by themselves or as part of their 
hybrid protocol with CAM treatments. A participant reported that after her herbal 
treatment was complete and followed additional maintenance natural treatments she has 
not experienced a relapse of the disease even though the participants discontinued CAM 
protocol at some point.    
Prevention 
 The literature stated “education” as the best prevention measure against Lyme 
disease and the development of CLD (CDC, 2010; CDPH, 2014). Education referred by 
the authors to prevent CLD in various ways; tick avoidance, proper tick removal, 
appropriate dress when outdoors, application of repellants, and maintenance of the 
environment (CDC, 2013; Britain, 2013). This study supports the literature prevention 
measures and further extends prevention as being aware of the existence of the disease in 
Southern California and Los Angeles County. The participants in this study alluded as 
prevention measures acquisition of knowledge of CLD existence not only by the general 
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population, but also by health care practitioners. In addition, the participants expressed 
that medical doctors must get education and awareness of diagnostic tools and effective 
treatment modalities for the different stages of the disease. The media must be involved 
in bringing awareness and promoting campaigns to prevent CLD by radio, television, and 
movies; and advocacy groups must lobby to bring awareness for the development of new 
testing procedures and new drugs and therapies to combat CLD.  
Theoretical Framework 
 The dimensions of the Health Belief Model (HBM) constructs provided the 
framework that guided this study for the development of the research questions and the 
basis for data analysis and discussion of the findings. The HBM theory created by Kurt 
Lewin in 1947 served as basis for the further application of health behavior prediction in 
public health programs by Hochman, Rosenstock, and Kegels in the 1950s. The HBM 
constructs are perceived susceptibility, perceived severity, perceived benefits, perceived 
barriers, cues to action, and self-efficacy. I considered the dimensions of the HBM 
constructs in this study to focus on the lived experiences and perceptions of the study 
participants to understand CLD presentation, challenges, health care options, diagnostic 
methods, treatment options, health benefits, and the beliefs and expectations of CLD 
affected young adults.  
  Good to excellent health status before CLD and knowledge of how the 
participants acquired CLD bears no weight on the disease course or diagnosis if the 
general population and health care practitioners are not aware of its existence in Los 
Angeles County. Duration and severity of the constellation of debilitating symptoms 
experienced by CLD patients affect them physically, socially, and emotionally on their 
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daily lives and their decision processes. The treatment chosen whether conventional 
antibiotic therapy, or hybrid treatment of CAM and antibiotic therapy benefit individuals 
differently depending on the stage of the disease where it may decrease the symptoms, 
but not cure the disease permanently. There is not one available protocol or combination 
of therapies effective for every single person, a fact that adds to the frustration and many 
times hopelessness feelings when dealing with the disease diagnosis. In addition to the 
challenge of finding the right treatment fitting individual anatomical and immunological 
needs, there are other barriers when obtaining treatment such as insurance coverage and 
transportation issues to obtain what may be an effective treatment and proper health care. 
Therefore, family, friends, and community support are essential to trigger motivation and 
encourage management of the disease. Likewise, support from public health agencies and 
the medical health care system in bringing awareness of the existence of CLD in Los 
Angeles County and the severity of the disease are essential for the establishment of 
policies based on patient-centered approaches on research of new diagnostic tools and 
effective treatment of the disease.  
Limitations of the Study 
I considered potential limitations to the trustworthiness of this study results when 
I chose the phenomenology nature of this qualitative study design. There were several 
limitations to the study that were addressed; first, the small sample size. Recruitment of 
participants and analysis of the data took place on the continuous basis to ensure no new 
data appeared and all concepts in the theory were well developed (Morse, 2015). Second, 
generalizability; phenomenology does not generate generalizable data (Patton, 2002). 
Since the findings of the study are specific to Los Angeles County, I leave the 
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interpretations of the findings up to the reader to apply to a wider population. I have 
provided in this study sufficient contextual description and information of promoting 
behaviors of young adults with chronic Lyme disease (CLD) captured in the candid, 
transparent, and rich responses to the interview questions to enable the reader to make 
such a transfer (Shenton, 2004). Third, subjective interpretation of the data. I used 
acknowledgement of my own bias as a method of dealing with them (Rajendran, 2001). 
As the data went through my mind, I confronted my opinions and prejudices by talking to 
myself of my own presuppositions, experiences, and actions during the research process. 
To further address for bias in the interpretation of the data, a verification panel was 
engaged to examine the data interpretations against the transcripts as well as an 
independent qualitative researcher to examine the raw data and interpret its findings using 
the same coding system and NVivo tools I used to establish inter rater reliability.   
In addition, I took several measures to encourage transparency, promote trust, 
confidence, and openness of the participants. I spent sufficient time with the respondents 
sharing my experiences of knowing someone close to me with CLD and remained in the 
field until achieved data saturation, thereby establishing a rapport. Additionally, to ensure 
that the participants could articulate in less than one hour their experiences in managing 
the disease, a validity panel reviewed the semi-structured interview questions to facilitate 
an understanding of the health promoting behaviors of young adults with CLD. A form of 
triangulation was used which involved the use of a wide range of participants 
racial/ethnically, culturally, and financially diverse viewpoints and experiences verified 
against each other (Rajendran, 2001; Patton; 2002, Shenton, 2004). Participants were 
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giving the opportunity to read the interpretation of the information captured in the 
interview to ensure that those were their intended words (Guba 1981; Patton, 2002).  
 Recommendations  
 Qualitative research studies on chronic Lyme disease (CLD) are in the 
introductory phase of the condition severity and the experience of diagnosis with the 
disease. This study examined the gap in qualitative research studies on CLD restricted to 
a geographical area where the disease is endemic (Connecticut, USA) and the knowledge 
of CLD is prevalent. In addition, the participants in previous studies were a racial/ethnic 
homogenous (Caucasian) group. This study constitutes the first one of its kind in Los 
Angeles County, a non-endemic geographical area where there is lack of knowledge of 
the existence of the disease, prevention, diagnosis, and treatment. The participants in this 
study was composed of a racial/ethnic, education, socio-economic and third party 
coverage diverse group. I recommend further studies where the African-American 
population of Los Angeles County are better represented. The findings in this study 
contribute to the knowledge base of CLD experiences of a group of participant’s 
representatives of the diverse racial/ethnic, educational, and socioeconomic population of 
Los Angeles County.  
The assessment of health promoting behaviors of young adults diagnosed with 
CLD and the impact of the disease on their daily lives and their decision-making process 
revealed a need for education and awareness on the existence of CLD in Los Angeles 
County. To reach not only the general population, but also health care practitioners and 
providers further studies need designing and dissemination to spread knowledge on CLD 
and the experiences of those affected by the condition. In addition, studies on the impact 
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of CLD on the individual’s physical, family, social, emotional, and physiologic life 
warrant its development. There is the need for further studies that acknowledge the urgent 
need of existing social programs that assist CLD patients. Another recommendation is 
continuous research with CLD affected individuals in different age group and at-risk 
populations. Participant number 7 expressed the fact that the disease transmission can 
take place from an infected mother to the unborn child, as expressed and confirmed by 
diagnostic testing: 
 “So, it wasn’t until I saw a holistic pediatrician, and I was there with my second 
baby daughter like barely alive, just like poof of my disease passed to the baby when her 
test came back positive for Lyme that she was properly treated to prevent progression to 
CLD.” 
Moreover, the possibility of sexual transmission of CLD needs further exploration. 
 In addition, this study identified the importance of support in the management and 
recovery from the disease. Programs that educate family, friends, and the community on 
how to offer support to CLD affected individuals needs development and establishment 
by health care and public agencies as expressed by participant number 8: 
 “Must have CLD therapists to be able to talk to. The health care and public health 
agencies must have more of that because we go through hell with this disease. I have no 
one to talk to me who knows about the disease. We need somebody to talk to and to boast 
on our disease not psychologists or present therapist who have no idea of CLD 
presentation and how to cope with it.”  
The knowledge gained from this study in addition to the areas elucidated in need 
of further exploration and assessment can be used to influence local, state, and federal 
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policy to develop better insurance coverage of diagnostic laboratory testing, treatment, 
and care of CLD affected individuals as well as development of more reliable laboratory 
testing technology and effective treatment protocols.   
Implications 
Potential Impact for Social Change 
The potential to create a positive social change from the findings in this study on 
health behaviors of young adults with chronic Lyme disease include:  
1. Contribution to the limited current information about the lived experiences of 
young adults with CLD regarding health behavior; impact of CLD on the 
physical, social, emotional, and psychological life; challenges in diagnosis 
and treatment of the disease; and impact on the decision-making process in 
CLD individuals’ private and professional life. 
2. Influence the development of health care and public health practitioners’ 
programs to assist CLD affected individuals, their families, and the 
community where they live to manage the disease, such as therapy and 
counseling by CLD literate health care practitioners. 
3. Enhance awareness of not only of the existence of Lyme disease in Los 
Angeles County, but how the disease misdiagnosis and inadequate treatment 
lead the development of CLD; an emerging epidemic.  
4. Influence providers and the public to work collaboratively to retard the spread 
of this disease and safeguard the health and safety of society. 
5. Influence local, state, and federal policy on third-party coverage on the 
diagnosis and treatment options of CLD. Currently, health insurance providers 
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have limited coverage of Lyme literate health care practitioners, diagnostic 
tests, and only short-term antibiotic therapy as an option to treat the disease.  
6. Development of prevention measures and dissemination of such measures to 
an audience where the disease have been and neighboring areas.  
7. Generation of rich data that provides the opportunity for further research on 
CLD, its proper diagnosis and effective treatment. 
8. This study may also serve as a positive catalyst for societal change by altering 
health promoting behaviors of the public based, in part, on the lived 
experiences of the participants.  
9. Finally, it is my sincerest desire to see this study lay the foundation for future 
qualitative inquiry in the nature and scope of CLD in the U.S. and abroad. 
In addition, to the areas where the findings of this study have potential for 
positive social change, the results of this study will be disseminated to spread awareness 
of CLD and knowledge on the experiences on being diagnosed with the disease via 
multiple venues including presentations at local public health agencies, medical clinics, 
professional conferences, and peer-reviewed journals. I will also intend to share these 
study findings at the Los Angeles Lyme disease group meetings and the Southern 
California American Society for Microbiology symposium.  
Conclusion 
 This study provides insights into the health beliefs and lived experiences of young 
adults with chronic Lyme disease in Los Angeles County where the general population 
and health care practitioners are not aware of the disease existence. It is my hope that the 
results of this study will raise public health awareness of the impact of CLD on the life of 
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young adult affected by the disease. Most participants were in excellent health prior to 
infection by a tick’s bite carrying the Lyme disease causing bacteria and coinfections. 
Participants experienced a marked declined in health status because of the disease not 
being recognized or properly treated. Participants also reported going any length not only 
geographical to find a Lyme literate practitioner, but also in willing to try CAM providers 
and miscellaneous therapies. Many participants experienced invasive therapies such as 
long-term use of antibiotics affecting their intestinal normal flora and developing 
secondary chronic conditions, multiple bee bites for extended period, and new treatment 
protocols with no clinical history of effectiveness.   
 Further qualitative and quantitative research studies on CLD may elucidate the 
urgent need of awareness of the disease existence not only in Los Angeles County, but 
also on the West coast of USA. Studies such as this one highlights the need for 
immediate action taken by health insurances to become more involved in offering 
coverage on CLD for their clients. Lastly, these study findings may prompt scientist and 
public health the need of new technology to recognize, diagnose and treat the disease.   
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Appendix A: List of Bacteria Responsible for Lyme Disease 
 
  
Bacteria responsible for Lyme or Lyme-like disease and other Borrelia sp. 
belonging to the Borrelia burgdorferi sensu lato complex, and other tick-borne 
micro-organisms isolated in humans 
  
Bacteria responsible for Lyme Disease belonging to the Borrelia burgdorferi 
sensu lato complex:  
Borrelia burgdorferi sensu stricto                      North America, Europe, North Africa  
Borrelia afzelii                                                    Europe, Asia  
Borrelia garinii (several serotypes)                  Europe, Asia, North Africa Borrelia 
bavariensis (previously B. garinii OspA serotype4)  
Bacteria responsible for Lyme-like disease:  
Borrelia lonestari                                                      North America  
Borrelia miyamotoi (also cause of relapsing fever) Europe, Asia, North America  
Non-identified spirochete                                          Brazil  
Bacteria occasionally isolated in cases of Lyme-like disease  
Borrelia spielmanii, Borrelia bissettii, Borrelia andersonii, Borrelia valaisiana,  
Borrelia americana, Borrelia kurtenbachii,   
Novel Borrelia sp. close to elapsing fever Borrelia  
Other Borrelia sp., belonging to the Borrelia burgdorferi sensu lato complex with 
unknown or poorly documented pathogenicity:  
Borrelia japonica; Borrelia turdi, Borrelia sinica; Borrelia tanukii, Borrelia 
lusitaniae, Borrelia californiensis, Borrelia carolinensis, Borrelia yangtze  
Borrelia sp. responsible for relapsing fever Louse-borne relapsing fever: Borrelia 
recurrentis Tick-borne relapsing fever:  
At least15 Borrelia sp. including Borrelia crocidurae       Africa  
Borrelia miyamotoi (cause of Lyme-like disease)  
Other human tick-borne infections  
PARASITES: Babesia microti, Babesia divergens  
BACTERIA: Ehrlichia chaffeensis, Anaplasma phagocytophilum, Rickettsia sp., 
Coxiella burnetii,  
Francisella tularensis, Candidatus Neoehrlichia mikurensis  
VIRUSES: Several Flaviviridae (including Tick-borne encephalitis virus),  
 Bunyaviridae (Crimean-Congo hemorrhagic fever)  
 
Source: Perrone, C. (2015). Critical review of studies trying to evaluate the treatment of 
Chronic Lyme Disease. La Presse Medicale, 2015(44), 828-831.  
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Appendix B: Complementary and Alternative Medicine Treatment of Lyme Disease 
 
Complementary and Alternative Medicine Treatment of Lyme Disease  
Antibiotics   Herbal Remedies  Nutritional Supplements  
 Doxycycline  
Minocycline  
Amoxicillin  
Augmentin  
Azithromycin  
Biaxin  
Erythromycin  
Vancomycin  
Clarithromycin  
Cefuroxime 
axetil  
Penicillin  
Ceftriaxone  
Rifampin  
Flagyl  
Plaquenil  
Imipenem  
Colloidal sliver  
  
  
Samento  
Cumada  
Burbur  
Allicin  
Dragon’s blood  
Cat’s claw  
Devil’s claw Echinacea Citriodiol 
(lemon eucalyptus extract)  
Astragallus  
Nettle  
Gingko biloba  
Curcumin  
Oregano tea  
Boswellia  
Parsley extract  
Red chili pepper (capsaicin)  
Quercetin  
Omega-3 Fatty Acids  
Coenzyme -Q10  
S-Adenosylmethione  
Grapeseed Extract  
Magnesium  
L-Carnitine αLipoic acid 
Dimethylglycine  
Vitamin B-complex  
Methylcobalamin  
Vitamin C and D  
Hydrolytic enzymes  
Mushroom Extract and Beta-
glucan  
Thymic enzymes  
Pycnogenol  
N-Acetylcysteine and 
Glutathione  
Probiotics  
Royal Jelly  
  
Source: Vojdani, A., Hebroni, F., Raphael, Y., Erde, J., and Raxlen, B. (2009). Novel 
Diagnosis of Lyme Disease: Potential for CAM Intervention. Evidence Based 
Complementary Alternative Medicine 6(3), 283-295.  
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Appendix C: Informed Consent 
  
Informed Consent Form  
Title of Research:  Health Promoting Behaviors of Young Adults with Chronic Lyme Disease  
 
Researcher’s Name and Title:                  Name of the Researcher 
                          Doctoral Student at Walden University  
 
Researcher’s Contact Information:          The Researcher’s Contact Information 
  
You are being asked to participate in a research study because you are 18 to 40 years old, residents of the Los Angeles 
County, clinically diagnosed with Chronic Lyme Disease, and have received or are receiving medical treatment or 
intervention including antibiotic therapy and or complementary and alternative medicine treatment. Please ask the 
researcher to explain any information in this form that you do not understand. If you would like to participate in this 
study, please respond to this e-mail with the words “I Consent,” see the statement of consent below.  
 
PURPOSE OF THE STUDY:  
The purpose of this study is to explore the impact that Chronic Lyme Disease has on the health promoting behaviors of 
ethnically diverse, young adults from similar educational and socio-economic backgrounds based on their lived 
experiences. In addition, this research is being conducted to partially fulfill the requirements of a doctoral dissertation.  
 
STUDY PROCEDURES:  
If you respond to this e-mail with “I Consent,” you will be asked to participate in an interview. The interview will last 
about 60 minutes and may or may not be followed by a shorter interview of 15 to 30 minutes duration to clarify 
questions if needed. You will be asked some questions about how you acquired Lyme Disease, how you were 
diagnosed, symptom you have experienced, how the Chronic Lyme Disease has affected your everyday life, treatments 
you have being under, and your views on recovery from the disease.  
The interview and any follow up interview will be recorded to capture all this valuable information on Chronic Lyme 
Disease. The recordings will also be transcribed to allow the researcher to analyze the information. 
The transcripts of the interview(s) and its interpretations will be available for your review which may take 15-20 
minutes so that you can verify the validity of the interview transcripts and the credibility of the findings.  
 
 
NUMBER OF PARTICIPANTS  
It is expected that approximately 10 – 12 individuals will participate in this study.   
 
RISKS AND DISCOMFORTS:  
Since this research consists only of a face to face interview, no physical risks are expected as a result of participation. 
While this is not expected, it is possible that the nature of some of the questions may be recalling situations during the 
course of your Chronic Lyme Disease condition that may be upsetting or uncomfortable. If you become upset or 
uncomfortable at any time, please tell the researcher. While every effort will be made to keep your personal 
information confidential, a breach of confidentiality is also a risk of this study.  
 
CONFIDENTIALITY:  
All study records will be kept in a locked cabinet in the researcher’s place of residence. Documents containing 
information obtained from you during the study will not have your name or any other personal identifying information. 
A permanent record number (PRN) will be assigned to identify your records. Only the researcher will have access to 
the study records and the link between the assigned PRN and your personal information. The link will be kept in a 
locked cabinet in the researcher’s place of work, but separate from the other study records.  
The recording(s) of your interview(s), and follow up conversation if necessary, will be transcribed by a company that 
provides this professional service. Only the PRN will be connected to the recording. Once the written transcript is 
received by the researcher, only the PRN will be used to link the document to your personal information.  
There may be some instances where records which identify you, such as the email where you responded “I Consent,” 
may be looked at by the Walden University Institutional Review Board (IRB). The IRB is responsible for ensuring that 
all Walden University research is conducted in compliance with the University’s ethical standards and applicable U.S. 
federal regulations. While these parties are aware of the need to keep your information confidential, total 
confidentiality cannot be guaranteed. All study records will be kept by the researcher for five years. After that time, all 
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of the study documents will be destroyed by shredding. The results of this research may be presented at meetings or in 
professional journals; however, you will not be identified in these presentations and/or publications.  
 
 
VOLUNTARY PARTICIPATION, ALTERNATIVES, AND WITHDRAWAL:  
Your participation in this study is voluntary. You have the alternative to not participate. Even if you begin the study, 
you may refuse to answer any questions. You may stop your participation at any time and you do not have to explain 
your decision. This consent form is not a contract. Your participation may also be ended without your consent if the 
researcher feels it is not in your best interest to continue (for example, if you become upset by the questions).  
 
BENEFITS:  
You may not receive any benefit from participating in this research; however, results from this study may posit ively 
impact other individuals, the community, and society by shedding light on the nature and scope of Chronic Lyme 
Disease from your perspective.  
 
COSTS OF PARTICIPATION:  
There will be no costs to you as a result of your participation.  
  
REIMBURSEMENT FOR PARTICIPATION:  
You will not be paid for your participation in this research.  
  
CONTACTS FOR QUESTIONS, COMPLAINTS, CONCERNS:  
If you have any questions about your rights as a participant or complaints regarding this research, please contact the 
Walden University Institutional Review Board at 001-612-312-1210 or irb@waldenu.edu. 
If you have any questions about the study itself please contact the researcher Patricia Bolivar at 
patricia.bolivar@waldenu.edu. 
 
 
STATEMENT OF CONSENT:  
• I have read this consent form in its entirety.   
• All of my questions have been answered to my satisfaction.  
• I may contact the researcher about the study at any time if I have further questions.  
• The researcher will answer any other questions I may have.  
• If I want a copy of my consent to keep for my records I will print the e-mail correspondence.  
• I agree to the recording of my interview and a follow up interview. 
 
To give consent to the preceding, please respond to this e-mail with the words “I Consent.”   
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Appendix D: Recruitment Flyer 
 
 
Chronic Lyme Disease Research Study  
  
• If you are 18-40 years old, live in Los Angeles County, and 
have been diagnosed with Chronic Lyme Disease, you may be 
eligible to participate in a research study investigating health 
promoting behaviors of young adults living with Chronic 
Lyme Disease 
  
• This study is part of my PhD dissertation in Public Health at 
Walden University 
 
• Participation consists of a single one-hour interview 
 
• The interview may be followed by a 15 to 30-minute phone 
call to clarify any questions if needed  
  
Please contact:  
  
Researcher’s Name 
Contact Cell Number 
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Appendix E: Approval letter from the Los Angeles County Lyme Disease Association 
 
Letter to the Los Angeles County Lyme Disease Association 
 
 
My name is (Researcher’s Name) and I am a Public Health doctoral candidate at 
Walden University. I am conducting a dissertation research to examine the impact that 
Chronic Lyme Disease has on the health promoting behaviors of ethnically diverse young 
adults from similar educational and socioeconomic backgrounds based on their lived 
experiences. I am requesting your written permission to distribute the attached flyer at the 
next monthly gathering and to post at the group’s private website.  
As you are aware, there is a general lack of awareness of Lyme Disease and Chronic 
Lyme Disease in the Los Angeles County. Perspectives from the participants will give 
healthcare providers and the public a deeper insight into the impact Chronic Lyme Disease 
has on the personal and professional lives of affected young adults.   
This study will probe into the holistic needs of young adults living with by Chronic Lyme 
Disease and the effectiveness of conventional and non-conventional treatment modalities. 
This study is intended to increase awareness of the nature of Chronic Lyme Disease in Los 
Angeles County where infection rates are growing so that health care providers and the 
public can work collaboratively to retard the spread of the disease and safeguard the health 
and safety of society.  
I would welcome a telephone call from you to discuss any questions you may have 
concerning the study. I can be reached at or by email at.sbcounty.gov or. Looking 
forward to hear from you!  
 
Sincerely,  
Researcher’s Name 
PhD candidate at Walden University  
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Appendix F: Social Media Invitation to Study Participation 
Social Media Invitation to Study Participation Facebook and LinkedIn Chronic 
Lyme Disease Study Invitation  
 I am reaching out to you today because I am working on my dissertation for a doctorate 
degree in Public Health/ Epidemiology at Walden University. If you have been diagnosed 
with Chronic Lyme Disease (or know someone who has been diagnosed with Chronic 
Lyme Disease), are 18 to 40 years old, live in Los Angeles County, are willing to give me 
a one-hour recorded interview, and want to increase awareness of the nature and scope of 
Chronic Lyme Disease in Los Angeles County where infection rates are growing; please 
contact me to become my study participant.  
  
Thank you in advance for your consideration!  
  
Patricia Bolivar, CLS, PHM, MSc, CPH 
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Appendix G: Respondent Screening Form 
 
Respondent Screening Form  
  
Demographic Information  
  
Name: ______________________________ Date of Birth: __________________ Age: 
_____  
Address: 
____________________________________________________________________  
Phone Number: _______________________ Email: 
__________________________________  
  
Race/Ethnicity:  
White □    White Hispanic □   American Black □     African Black □  Asian □ 
American Indian/Alaskan Native □  Native Hawaiian/Pacific Islander □  
 
Inclusion Criteria:                                    Exclusion Criteria:  
Los Angeles County Resident: □Yes                                      □No                   
Age group 18-40: □Yes             □No  
 
Chronic Lyme Disease diagnosed by: 
□Clinical disease definition          □Self diagnosis 
□ Confirmatory laboratory diagnostic tests 
 
Treatment Received: □Yes             □No  
  
Inclusion Criteria Eligibility met:  
 YES □                    NO □  
  
Authorized to be recorded during the interview:  
YES □                    NO □  
  
Date________________  
PRN _______________  
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Appendix H: Interview Core Questions 
 
Interview Core Questions  
Research Questions  Interview Questions  
  
Research Question 1  
To what degree do different ethnic groups 
with average levels of socio-economic 
status, education, and third-party 
coverage, perceive the likelihood of 
acquiring comorbidities related to 
Chronic Lyme  
Disease (CLD)?  
  
1. How did you acquire CLD?  
  
2. How was your health before 
CLD?  
  
3. Was there anything you could 
have done to prevent CLD?  
  
4. What would be your advice to 
others on how to protect 
themselves against CLD?  
  
5. Is there anything you could have 
done to prevent progression of 
acute Lyme Disease to CLD?  
  
6. How were you diagnosed with 
CLD?  
  
7. What difficulties did you 
encounter getting diagnosed 
with CLD?  
 
Research Question 2  
To what degree does the perceived 
severity of CLD impact the lives and 
decision-making processes of different 
ethnic groups with average levels of socio-
economic status, education, and third-
party coverage?  
 
 
8. How did you react when you 
first learned that you had CLD?  
  
9. How has CLD progressed since 
diagnosis?  
  
10. What symptoms have you 
experienced since diagnosed 
with CLD?  
  
11. How has CLD affected your 
physical being?  
  
12. How has CLD affected your 
close relationships? 
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13. How has CLD affected your 
social life?  
  
14. How has CLD affected your 
emotional life? 
 
  
Research Question 3  
To what degree do the perceived benefits 
of treatment impact the lives and 
decision-making processes of different 
ethnic groups with average levels of socio-
economic status, education, and third-
party coverage?  
 
15. What CLD treatments have you 
received?  
  
16. How have the treatments 
worked for you?  
  
17. What treatment has been most 
beneficial?  
  
18. What treatment has been least 
beneficial?  
  
19. How do you get informed on 
available CLD treatments?  
  
20. What treatment would you 
recommend to someone who has 
been recently diagnosed with 
CLD?  
  
21. How effective has conventional 
health care treatment for CLD 
being for you?  
 
22. How have literate (LLD: doctors 
with experience and knowledge 
in treating Lyme Disease) Lyme 
Disease doctors helped you with 
CLD? 
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Research Question 4  
To what degree do perceived barriers 
impact the lives and decision-making 
processes of different ethnic groups with 
average levels of socio-economic status, 
education, and third-party coverage?  
 
 
23. What challenges have you 
encountered in obtaining 
treatment for CLD?  
  
24. How has your insurance 
coverage managed your CLD 
treatment claims?  
 
25. What kind of CLD treatment 
inadequacy have you 
experienced?  
  
26. What kind of transportation 
issues, if any have you 
encountered accessing your 
CLD treatment? 
 
27. What tactics do you think will 
be most beneficial to you to 
overcome CLD? 
 
Research Question 5  
To what degree do the cues to action 
impact the lives and decision-making 
processes of different ethnic groups with 
average levels of socio-economic status, 
education, and third-party coverage?  
 
 
28. What kinds of support (family, 
friends, community, church, 
support groups, health care 
providers, etc.) have you had 
since diagnosed with CLD?  
  
29. How have these support groups 
influenced you in dealing with  
CLD?  
  
30. What kind of activities are you 
involved in that affect you 
positively living with CLD?  
  
31. What inspires and motivates you 
to recover from CLD? 
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Research Question 6  
To what degree does self-efficacy impact 
the lives and decision-making processes of 
different ethnic groups with average 
levels of socio-economic status, education, 
and third-party coverage? 
 
32. What can public health do more 
effectively to care for patients 
living with CLD?  
  
33. How has the health care system 
impacted your CLD recovery?  
  
34. What can your family and 
friends do to best support you 
with CLD? 
 
35. How can your community 
(neighbors, church, businesses, 
health care practitioners, etc.) 
support you living with CLD? 
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Appendix I: Informed Consent Participant Log 
  
Informed Consent Participant Log 
 
Name  PRN  Screening Date  “I Consent” email received date Status  
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Appendix J: Content Validity Panel 
  
Content Validity Panel 
  
Name Field of Expertise 
Larry C. Shelton Behavioral Sciences 
Alexander Del Rosario Sociology 
Yvonne Ortega Education 
Lynette Eusebio Public Health 
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Appendix K: Survey/Interview Validation Rubric for Expert Panel 
  
Survey/Interview Validation Rubric for Expert Panel - VREP©  
  
Name of Reviewer: __________________Review Date:___________________  
 
Criteria        Operational Definitions 
Score 
1=Not Acceptable (major 
modifications needed) 
2=Below Expectations 
(some modifications 
needed) 
3=Meets Expectations 
(no modifications needed 
but could be improved 
with minor changes) 
4=Exceeds Expectations 
(no modifications needed) 
Questions NOT 
meeting standard 
(List page and 
question number) and 
need to be revised. 
Please use the 
comments and 
suggestions section to 
recommend revisions. 
1 2 3 4 
Clarity 
  The questions are direct and specific.            
  Only one question is asked at a time.       
  The participants can understand what 
is being asked.  
   
 
 
  There are no double-barreled 
questions (two questions in one).  
     
Wordiness 
  Questions are concise.            
  There are no unnecessary words.       
Negative Wording 
  Questions are asked using the 
affirmative (e.g., Instead of asking, 
“Which methods are not used?” the 
researcher asks, “Which methods are 
used?”)  
          
Overlapping 
Responses 
  No response covers more than one 
choice.  
          
  All possibilities are considered.       
  There are no ambiguous questions.       
Balance 
  The questions are unbiased and do 
not lead the participants to a 
response. The questions are asked 
using a neutral tone.  
          
Use of Jargon 
  The terms used are understandable 
by the participants.  
          
  There are no clichés or hyperbole in 
the wording of the questions.  
     
Appropriateness of 
Responses Listed 
  The choices listed allow participants 
to respond appropriately.  
          
  The responses apply to all situations 
or offer a way for those to respond 
with unique situations.  
     
Use of Technical 
Language 
  The use of technical language is 
minimal and appropriate.  
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  All acronyms are defined.       
Application to 
Praxis 
  The questions asked relate to the 
daily practices or expertise of the 
potential participants.  
          
Relationship to 
Problem 
  The questions are sufficient to 
resolve the problem in the study  
          
  The questions are sufficient to 
answer the research questions.  
     
Measure of 
Research Question 
1 
 The questions adequately measure 
this construct of the HBM: Perceived 
susceptibility  
          
Measure of 
Research Question 
2 
 The questions adequately measure 
this construct of the HBM: Perceived 
severity  
          
Measure of 
Research Question 
3 
 The questions adequately measure 
this construct of the HBM: Perceived 
benefits  
          
Measure of 
Research Question 
4 
 The questions adequately measure 
this construct of the HBM: Perceived 
barriers  
          
Measure of 
Research Question 
5 
 The questions adequately measure 
this construct of the HBM: Cues to 
action  
          
Measure of 
Research Question 
6 
 The questions adequately measure 
this construct of the HBM:  
Self-efficacy  
          
Permission to use this survey, and include in the dissertation manuscript was granted by 
the author, Marilyn K. Simon, and Jacquelyn White. All rights are reserved by the 
authors. Any other use or reproduction of this material is prohibited.  
 
Comments and suggestions:  
________________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_______________________________________________________________________
_____ 
Source: Simon, M. and White, J. (2016). Survey/Interview Validation by an Expert Panel. 
Retrieved from http://dissertationrecipes.com/  
  
  
217 
 
Appendix L: Completed VRP by Validation Panel 
  
Completed VRP by Validation Panel 
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Appendix M: Content Validity Panel and Results 
  
Content Validity Panel and Results 
  
Name Profession Possible 
Score 
Score 
Obtained 
Items Percentage 
Larry C. 
Shelton 
Behavioral 
Scientist 
64 N/A Accepted, but did not 
return rated 
questionnaire 
Alexander 
Del Rosario 
Sociologist 64 60 93.75 
Yvonne 
Ortega 
Educator 64 60 93.75 
Lynette 
Eusebio 
Public Health 
Microbiologist 
64 63 94.03 
    
Total average congruency percentage obtained: 93.84  
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Appendix N: Original Core Interviews sent to Validation Panel for Review  
  
Original Core Interview Questions Sent to Validation Panel for Review 
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Appendix O: Participants Activity Log 
  
Participants Activity Log 
  
  
Name  
  
PRN  
  
Screen  
Date  
Approval  
  
Consent 
Date 
email 
 
  
Interview 
Date  
Follow up 
clarification 
if any  
 Date  
  
Transcript  
Review 
Date  
  
Interpretation  
Review Date  
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Appendix P: Study Protocol 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study Protocol  
Health Promoting Behaviors of Young Adults with CLD 
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Table of Contents  
  
Schedule of Procedures ________________________________ 3 
Respondent Screening Form ________________________________ 4 
Demographics ________________________________ 4 
Inclusion/Exclusion Criteria ________________________________ 4 
Consent Process ________________________________ 5 
Informed Consent Form ________________________________ 6 – 7 
Interview Guide ________________________________ 8 
Interview Core Questions ________________________________ 9 – 11  
Data Collection Process ________________________________ 12 
Data Transcription ________________________________ 12 
Data Analysis Process ________________________________ 13 
Interpretation of the Findings ________________________________ 14 
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Schedule of Procedures  
1. Check for eligibility by checking for inclusion and exclusion criteria during 
screening evaluation of respondent. Upon determination of eligibility the 
researcher will assign a unique Permanent Record Number (PRN) to the 
participant’s record.  
2. Send Consent Form and Core Questions to eligible respondent.  
3. Upon receipt of signed informed consent, schedule date and time for the 
interview.  
4. Conduct interview  
5. Send recorded interview to transcriber within 48-72 hours of finalizing the 
interview process.  
6. Receive transcribed interview and start data analysis.  
7. Continue process of selecting eligible candidates until sufficient data is 
obtained and saturation is achieved.  
8. Interpret the findings.  
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Respondent Screening Form  
  
Demographic Information  
  
Name: ______________________________ Date of Birth: __________________ Age: 
_____  
Address: 
____________________________________________________________________  
Phone Number: _______________________ Email: 
__________________________________  
  
Race/Ethnicity:  
White □    White Hispanic □   American Black □     African Black □   Asian □ 
American Indian/Alaskan Native □   Native Hawaiian/Pacific Islander □  
 
Inclusion Criteria:                                    Exclusion Criteria:  
Los Angeles County Resident: □Yes                                      □No                   
Age group 18-40: □Yes             □No  
 
Chronic Lyme Disease diagnosed by: 
□Clinical disease definition          □Self diagnosis 
□ Confirmatory laboratory diagnostic tests 
 
Treatment Received: □Yes             □No  
  
Inclusion Criteria Eligibility met:  
 YES □                    NO □  
  
Authorized to be recorded during the interview:  
YES □                    NO □  
  
Date________________  
PRN _______________  
PRN _______________  
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Consent Process 
The researcher will review the following items with the eligible respondent:  
1. The purpose and nature of the research.  
2. The study procedure and the interview length will be explained.  
3. The reason for the need to record the interview will be clarified.  
4. The voluntary nature of the research will be discussed including withdrawal 
from the study at any time.  
5. Procedures to maintain confidentiality will be explained.  
 The researcher will make sure to:  
1. Provide opportunity to the participant to ask questions.  
2. Place an enrollment note in the participant’s record when the process of 
consent is completed.  
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Informed Consent Form  
Title of Research:  Health Promoting Behaviors of Young Adults with Chronic Lyme Disease  
 
Researcher’s Name and Title:                  Name of the Researcher 
                          Doctoral Student at Walden University  
 
Researcher’s Contact Information:          The Researcher’s Contact Information 
  
You are being asked to participate in a research study because you are 18 to 40 years old, residents of the Los Angeles 
County, clinically diagnosed with Chronic Lyme Disease, and have received or are receiving medical treatment or 
intervention including antibiotic therapy and or complementary and alternative medicine treatment. Please ask the 
researcher to explain any information in this form that you do not understand. If you would like to participate in this 
study, you must respond to this e-mail with “I Consent,” see the statement of consent below.  
 
PURPOSE OF THE STUDY:  
The purpose of this study is to explore the impact that Chronic Lyme Disease has on the health promoting behaviors of 
ethnically diverse, young adults from similar educational and socio-economic backgrounds based on their lived 
experiences. In addition, this research is being conducted to partially fulfill the requirements of a doctoral dissertation.  
 
STUDY PROCEDURES:  
If you respond to this e-mail with “I Consent,” you will be asked to participate in an interview. The interview will last 
about 60 minutes and may or may not be followed by a shorter interview of 15 to 30 minutes duration to clarify 
questions if needed. You will be asked some questions about how you acquired Lyme Disease, how you were 
diagnosed, symptom you have experienced, how the Chronic Lyme Disease has affected your everyday life, treatments 
you have being under, and your views on recovery from the disease.  
The interview and any follow up interview will be recorded to capture all this valuable information on Chronic Lyme 
Disease. The recordings will also be transcribed to allow the researcher to analyze the information. 
 
NUMBER OF PARTICIPANTS  
It is expected that approximately 10 – 12 individuals will participate in this study.  
 
RISKS AND DISCOMFORTS:  
Since this research consists only of a face to face interview, no physical risks are expected as a result of participation. 
While this is not expected, it is possible that the nature of some of the questions may be recalling situations during the 
course of your Chronic Lyme Disease condition that may be upsetting or uncomfortable. If you become upset or 
uncomfortable at any time, please tell the researcher. While every effort will be made to keep your personal 
information confidential, a breach of confidentiality is also a risk of this study.  
 
CONFIDENTIALITY:  
All study records will be kept in a locked cabinet in the researcher’s place of residence. Documents containing 
information obtained from you during the study will not have your name or any other personal identifying information. 
A permanent record number (PRN) will be assigned to identify your records. Only the researcher will have access to 
the study records and the link between the assigned PRN and your personal information. The link will be kept in a 
locked cabinet in the researcher’s place of work, but separate from the other study records.  
The recording(s) of your interview(s), and follow up conversation if necessary, will be transcribed by a company that 
provides this professional service. Only the PRN will be connected to the recording. Once the written transcript is 
received by the researcher, only the PRN will be used to link the document to your personal information.  
There may be some instances where records which identify you, such as the email where you responded “I Consent,” 
may be looked at by the Walden University Institutional Review Board (IRB). The IRB is responsible for ensuring that 
all Walden University research is conducted in compliance with the University’s ethical standards and applicable U.S. 
federal regulations. While these parties are aware of the need to keep your information confidential, total 
confidentiality cannot be guaranteed. All study records will be kept by the researcher for five years. After that time, all 
of the study documents will be destroyed by shredding. The results of this research may be presented at meetings or in 
professional journals; however, you will not be identified in these presentations and/or publications.  
 
VOLUNTARY PARTICIPATION, ALTERNATIVES, AND WITHDRAWAL:  
Your participation in this study is voluntary. You have the alternative to not participate. Even if you begin the study, 
you may refuse to answer any questions. You may stop your participation at any time and you do not have to explain 
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your decision. This consent form is not a contract. Your participation may also be ended without your consent if the 
researcher feels it is not in your best interest to continue (for example, if you become upset by the questions).  
 
BENEFITS:  
You may not receive any benefit from participating in this research; however, results from this study may positively 
impact other individuals, the community, and society by shedding light on the nature and scope of Chronic Lyme 
Disease from your perspective.  
 
COSTS OF PARTICIPATION:  
There will be no costs to you because of your participation.  
  
REIMBURSEMENT FOR PARTICIPATION:  
You will not be paid for your participation in this research.  
  
CONTACTS FOR QUESTIONS, COMPLAINTS, CONCERNS:  
If you have any questions about your rights as a participant or complaints regarding this research, please contact the 
Walden University Institutional Review Board at 001-612-312-1210 or irb@waldenu.edu. 
If you have any questions about the study itself please contact the researcher Patricia Bolivar at 
patricia.bolivar@waldenu.edu. 
 
MEMBER CHECKING STEP: 
Once you send an e-mail stating “I Consent” you must contact the researcher via phone number at 626-259-9527.  The 
researcher will then ask you a few questions to confirm your eligibility to participate in this study.  This member 
checking step will take only ten to fifteen minutes.  If found eligible, the phone call will be concluded with scheduling 
your interview with the researcher for the study. 
  
STATEMENT OF CONSENT:  
• I have read this consent form in its entirety.   
• All of my questions have been answered to my satisfaction.  
• I may contact the researcher about the study at any time if I have further questions.  
• The researcher will answer any other questions I may have.  
• If I want a copy of my consent to keep for my records I will print the e-mail correspondence.  
• I agree to the recording of my interview and a follow up interview. 
To give consent to the preceding you MUST respond to this e-mail with the words “I Consent.”  This 
will ensure you are agreeing to participate in this study. 
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Interview Guide  
  
The research will establish trust with the participant by sharing information on 
professional experience: clinical and public health scientist, investigator, reasons for 
interest in CLD research, and reemphasize the importance of the study.  
By the time the interview takes place the participant would have had the opportunity to 
read the core questions that were mailed previously at the time the consent form was sent. 
The researcher will ask the participant if the participant had read the questions and will 
start the interview. The core questions serve as a guide for the interview as additional 
questions will emerge as the interview process proceeds.  
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Interview Core Questions 
Research Questions  Interview Questions  
  
Research Question 1  
To what degree do different ethnic groups 
with average levels of socio-economic 
status, education, and third-party 
coverage, perceive the likelihood of 
acquiring comorbidities related to 
Chronic Lyme  
Disease (CLD)?  
  
8. How did you acquire CLD?  
  
9. How was your health before 
CLD?  
  
10. Was there anything you could 
have done to prevent CLD?  
  
11. What would be your advice to 
others on how to protect 
themselves against CLD?  
  
12. Is there anything you could have 
done to prevent progression of 
acute Lyme Disease to CLD?  
  
13. How were you diagnosed with 
CLD?  
  
14. What difficulties did you 
encounter getting diagnosed 
with CLD?  
 
Research Question 2  
To what degree does the perceived 
severity of CLD impact the lives and 
decision-making processes of different 
ethnic groups with average levels of socio-
economic status, education, and third-
party coverage?  
 
 
15. How did you react when you 
first learned that you had CLD?  
  
16. How has CLD progressed since 
diagnosis?  
  
17. What symptoms have you 
experienced since diagnosed 
with CLD?  
  
18. How has CLD affected your 
physical being?  
  
19. How has CLD affected your 
close relationships? 
 
20. How has CLD affected your 
social life?  
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21. How has CLD affected your 
emotional life? 
 
  
Research Question 3  
To what degree do the perceived benefits 
of treatment impact the lives and decision 
making processes of different ethnic 
groups with average levels of socio-
economic status, education, and third 
party coverage?  
 
23. What CLD treatments have you 
received?  
  
24. How have the treatments 
worked for you?  
  
25. What treatment has been most 
beneficial?  
  
26. What treatment has been least 
beneficial?  
  
27. How do you get informed on 
available CLD treatments?  
  
28. What treatment would you 
recommend to someone who has 
been recently diagnosed with 
CLD?  
  
29. How effective has conventional 
health care treatment for CLD 
being for you?  
 
30. How have literate (LLD: doctors 
with experience and knowledge 
in treating Lyme Disease) Lyme 
Disease doctors helped you with 
CLD? 
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Research Question 4  
To what degree do perceived barriers 
impact the lives and decision-making 
processes of different ethnic groups with 
average levels of socio-economic status, 
education, and third-party coverage?  
 
 
36. What challenges have you 
encountered in obtaining 
treatment for CLD?  
  
37. How has your insurance 
coverage managed your CLD 
treatment claims?  
 
38. What kind of CLD treatment 
inadequacy have you 
experienced?  
  
39. What kind of transportation 
issues, if any have you 
encountered accessing your 
CLD treatment? 
 
40. What tactics do you think will 
be most beneficial to you to 
overcome CLD? 
 
Research Question 5  
To what degree do the cues to action 
impact the lives and decision-making 
processes of different ethnic groups with 
average levels of socio-economic status, 
education, and third-party coverage?  
 
41. What kinds of support (family, 
friends, community, church, 
support groups, health care 
providers, etc.) have you had 
since diagnosed with CLD?  
  
42. How have these support groups 
influenced you in dealing with  
CLD?  
  
43. What kind of activities are you 
involved in that affect you 
positively living with CLD?  
  
44. What inspires and motivates you 
to recover from CLD? 
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Research Question 6  
To what degree does self-efficacy impact 
the lives and decision-making processes of 
different ethnic groups with average 
levels of socio-economic status, education, 
and third-party coverage? 
 
45. What can public health do more 
effectively to care for patients 
living with CLD?  
  
46. How has the health care system 
impacted your CLD recovery?  
  
47. What can your family and 
friends do to best support you 
with CLD? 
 
48. How can your community 
(neighbors, church, businesses, 
health care practitioners, etc.) 
support you living with CLD? 
 
At the end of the interview ask if the participant has any comments to add or any 
questions to be further clarified. Remind the participant that he/she may receive a follow 
up phone call if any clarification of any question response is needed. Thank the 
participant for his/her time spent and the information provided for this important and 
significant study.   
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Data Collection Process and Data Transcription  
    
1. Record all interviews using an Olympus WS-321M digital voice recorder.  
2. Send recorded interview to the selected transcription services within 24-48 
hours. The researcher selected the transcription services provided by Kongo 
Isaac <isaac@academictranscription-services.com>  
3. Upload the interviews into the secure drop box account via the link provided 
by the transcription service. The link that the researcher will be using will be 
https://goo.gl/5xkZl9  
4. Receive transcribed interview and check for accuracy of the recording by 
checking the transcription against the tape.  
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Data Analysis  
1. Read and reread the transcript becoming familiar with the content and write 
notes on the data quality. Identify any gaps in the information, contradictory 
and ambiguous responses, and if the research questions have been answered.  
2. Organize the data into a list of significant statements grouped in meaning 
units or themes.  
3. Identify meaning units, words, sentences, and paragraphs conveying similar 
meanings.  
4. Begin coding by combing the data for themes, ideas, concepts, keywords, and 
categories and marking similar text passages with a code label which can be 
easily retrieved later for further comparison and analysis.  
5. Create a new code if a theme is identified from the data that does not fit the 
existing codes.  
6. Use a coding sort to collect similar coding texts using a qualitative software 
package such as NVivo 10 for Windows. The researcher will use NVivo from 
QSR International set of tools to assist the researcher analyze, manage, and 
shape the data.  
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Interpretation of Findings  
  
1. Synthesize the data.  
2. Answer the following questions: What is important in the data? Why is it 
important? What can be learned from it?  
3. Explain how all the different themes fit together.  
4. Explain the overall meaning of the responses supplied by the participants.  
5. Contextualize findings in the research.  
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Appendix Q: The National Institutes of Health Certificate of Completion 
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Appendix R: Non-Disclosure Agreement for Transcription Services 
 
 
 
